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Abstract 
Background  
Knowledge and innovation transfer (KIT) is recognised internationally as a complex, 
dynamic process which is difficult to embed in organisations. There is growing use of 
health service-academic-industry collaborations in the UK with knowledge brokers 
linking producers with the users of knowledge and innovation.  
Aim  
Focused on KIT “agent” roles within Academic Health Science Networks and 
partnerships in England and Wales, we show how individual dispositions, processes 
and content contribute to desired outcomes. 
Methods 
We studied the KIT intentions of all Academic Health Science Networks in England, 
and the South East Wales Academic Health Science Partnership. Using a qualitative 
case-study design, we studied the work of 13 KIT agents purposively sampled from 
five networks, by collecting data from: observation of meetings, documentation, KIT 
agent audio-diaries, and semi-structured interviews with KIT agents, their line-manager 
and those they supported (“Links”). We also used a consensus method in a meeting of 
experts (nominal group technique) to discuss the measurement of outcomes of KIT 
agent activity. 
Findings  
The case-study KIT agents were predominately from a clinical background with 
differing levels of  experience and expertise yet shared the aim of improving services 
and patient care. Although outside recognised career structures, the flexibility afforded 
to KIT agents to define their role was an enabler of success. Other helpful factors 
included: time and resources to devote KIT activity; line-manager support and a team to 
assist in the work; and access and the means to use data for improvement projects. The 
organisational and political context could be challenging. KIT agents not only tackled 
local barriers such as silo-ed working but also navigated shifting regional and national 
policies. Board-level support for knowledge mobilisation together with a culture of 
reflection (listening to frontline staff), openness to challenges and receptivity to 
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research all enabled KIT agents to achieve desired outcomes. Nominal group findings 
underscored the importance of relating measures to specific intended outcomes. 
However, the case studies highlighted that few measures were employed by KIT agents 
and their managers. Using social marketing theory helped to show linkages between 
processes, outcomes and impact and drew attention to how KIT agents developed 
insight into their ‘clients’ needs and  tailored work accordingly. 
Limitations 
Level of KIT agent participation varied; line-managers and Links were interviewed 
only once; and outcomes were self-reported.  
Conclusions  
Social marketing theory provided a framework for analysing KIT agent activity. The 
preparatory work KIT agents do in listening, understanding local context and building 
relationships enabled them to develop ‘insight’ and adapt their ‘offer’ to clients to 
achieve desired outcomes. 
Future work 
The complexity of the role and the environment in which it is played out justifies more 
research on KIT agents. Suggestions include: longitudinal study of career-pathways; 
how roles are negotiated within teams and competing priorities managed; how success 
is measured; the place of improvement methodologies within KIT work; the application 
of social marketing theory to comparative study of similar roles; and patients as KIT 
agents.    
Funding details 
The National Institute for Health Research Health Services and Delivery Research 
programme. 
Word count: 498 
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Plain English Summary 
Information about how to make healthcare services better often fails to reach those who 
could use the knowledge. A new role is increasingly being used to help overcome this 
problem by linking-up those with important knowledge with those who should use it. 
We call these people knowledge and innovation transfer (KIT) “agents”. 
We followed 13 KIT agents from four Academic Health Science Networks in England 
and a regional network in Wales to see what they did and what helped them be 
successful in their roles. We interviewed them, their line-managers and people they 
helped, and agents kept diaries. We observed events and examined documents 
describing their roles. We held a meeting of “experts” to discuss how to measure the 
results of KIT agents’ work.  
Although the KIT agent roles varied, they all helped healthcare staff to use knowledge. 
They strengthened relationships with researchers, patients and others who are a source 
of helpful knowledge. These roles are valued by the people the KIT agents assisted but 
formal measures were rarely used to evaluate the impact of their work. They valued the 
KIT agents’ expertise, flexibility and “can-do” attitude. Insufficient time for the role 
sometimes made it difficult for the KIT agents. Having a supportive manager and team, 
time to do the job, and a clear purpose all helped. Successful KIT agents combined 
experience with strong people-skills to adapt what they did to the needs of the people 
they aimed to help.   
Word count 240 
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Scientific Summary 
Background  
Knowledge and innovation transfer (KIT) is a complex, dynamic and evolving process 
and a long-standing international challenge for organisations. Academic Health Science 
Networks (AHSNs) were set up in response to the Carruthers’ report, “Innovation, 
Health and Wealth: Accelerating Adoption and Diffusion in the NHS”, to encourage 
quicker transfer of new practice by fostering collaborations between academia, industry 
and health service. In this context our study sought to find out about the role of 
knowledge and innovation transfer (KIT) “agents” in AHSNs in England and in 
Academic Health Science Partnerships (AHSP) in Wales and what helped them to 
achieve of desired outcomes.  KIT agents (also known as knowledge brokers) are NHS 
and university-based staff, often with a clinical background, responsible for supporting 
the transfer and mobilisation of knowledge (broadly conceived) from knowledge 
producers to knowledge users (healthcare managers/practitioners/decision-makers). 
According to Walker et al.’s classification, factors enabling that relationship relate to: • Context: external (macro) and internal (meso) factors including policy shifts, fiscal 
restraint, organisational culture and leadership • Content: relevance and match with local priorities • Processes: actions undertaken by agents, and   • Individual dispositions (micro). 
Research Questions  
Our research addressed the following questions:  • What are commonly shared expectations of the KIT agent role?   • What, in practice, do KIT agents do?   • How does the work of KIT agents impact on healthcare planning and practice?   • How can KIT agents be best supported?   • What measures can be used to assess the impact of KIT activity?   
Methods  
The research, conducted in 2014-2015, used an in-depth qualitative case-study design, 
focused on a sample of KIT agents from AHSNs in England and an AHSP in Wales. 
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The study was enriched by the contribution of a project advisory group comprising 
NHS managers, chief executives, a funder representative, academics and patient 
representatives. Patient and public involvement (PPI) occurred through the advisory 
group and the nominal group; some case-study KIT agents worked directly to enhance 
PPI. 
Research ethics approval was obtained from Cardiff University (20/08/13) and the 
project registered on the Welsh portfolio (#15479). 
Theoretical frameworks 
Data gathering was shaped by Kirkpatrick’s framework: the participants’ reactions, 
learning gains, behaviour change and results (impact). This framework fits well with 
social marketing theory which we used to interpret our findings. 
Data collection and sampling 
A targeted review of literature was undertaken to identify existing KIT practices, 
barriers and enablers encountered, and outcomes. The findings supported robust data 
analysis, informed the nominal group process and provided context for consideration of 
findings.  
For the national mapping of KIT intentions, we collected data from 15 AHSN 
prospectuses and business plans, plus the South East Wales AHSP ‘Five Year 
Strategy’, and held telephone interviews with 14 of the 16 network or partnership leads. 
From this we drafted a typology of KIT agent roles which we used to inform the 
identification of our individual case studies. 
We purposively sampled 13 KIT agents from five of the 16 networks/partnerships. We 
collected a wealth of data from: observation of KIT events/meetings; semi-structured 
interviews with the KIT agents, their line-manager and those they supported (“Links”); 
and audio-diaries kept by KIT agents over 4-months. Despite notable disparity in data 
collection across agents and relatively low participation in audio-diaries overall, 
excluding meetings to negotiate access, we conducted 50 interviews (23 with KIT 
agents, 22 with Links and five line-managers), 20 observations, and received 6 hours 20 
minutes of audio-diaries. 
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To address the research question on impact, we used a consensus method in a meeting 
of experts (nominal group technique). Our nominal group comprised a purposive 
sample of eight people from England, Scotland and Wales. Some panel members held 
dual roles and the group included three knowledge brokers, three researchers/ 
academics, two network/policy leads, a senior information scientist and a PPI specialist. 
Analysis of case study data 
The analysis of the field-notes, documents, interview and audio-diary transcripts was 
both deductive and inductive. We used Walker et al.’s classification of factors as the 
basis of our analytic framework which we extended to include the Kirkpatrick levels 
and descriptive codes for the KIT agents’ background and role. This coding frame was 
supplemented by emergent themes and sub-themes (such as conceptual definitions). 
Data triangulation was achieved through using multiple data sources: what we heard 
from agents was corroborated with data from interviews with others and observations. 
Data were regularly discussed with the advisory group. Validation was also sought 
through presentations to research workshops and conferences and feedback to the KIT 
agents and their networks sites. 
Results  
KIT intentions 
The interviews showed that the networks were at different stages of development, 
started with different structures and had unique operational models. However, all 
pursued the aim of driving improvement through innovation. Fellowships or 
secondments were the most common strategies for supporting knowledge and 
innovation transfer during early network formation. We also noted the emergence of 
operational leaders with specific duties around promoting improvement and innovation. 
We labelled seven ideal-types in our general typology of KIT roles: the dedicated KIT 
Fellow, the dedicated KIT Lead, KIT within research role, KIT within operational role, 
project programme implementer, project implementer, and hobby project champion. 
The roles varied in terms of: how the KIT agent was supported; the duration of the role 
and the proportion of time devoted to the role; number of agents and whether in a team 
and the focus of activities (on research and data gathering or implementation). Other 
features included whether the role was aimed at clinicians, managers, or both; the 
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primary location of the KIT agent (NHS, universities or industry); type of training 
planned or received (knowledge brokering or improvement methodology, bespoke or à 
la carte); and strategy focus (health or wealth or both.)  
Case studies 
We noted similarities in Links’ and line-managers’ expectations of the KIT agents’ role 
(i.e. linking, engagement and knowledge management). This was a surprising finding 
given the differences in the KIT agents’ level of seniority, length of time in post, 
amount of time dedicated to KIT work and focus, i.e. service improvement, innovation 
or knowledge mobilisation. 
The KIT agents identified similar enablers (and barriers) operating at the micro 
(individual), meso (organisational or network) and macro (political and system) levels. 
These included:   • a clear expectation and definition of the role, agreed by the KIT agent and their 
line-manager; • adequate resources for KIT agents and line-managers to devote to projects;  • support for line-managers and KIT agents (and their teams); and  • access to data and their utilisation.  
The organisational and political context could be challenging. KIT agents were not only 
addressing local barriers such as silo-ed working but also navigating regional or 
national policies that often resulted in competing priorities. Those on short-term 
contracts or employed by networks lacked job security. The role required similar 
resources regardless of network maturity. Organisations with Board-level support for 
knowledge mobilisation together with a culture of reflection (listening to frontline 
practitioners), openness to challenge and receptivity to research enabled KIT agents to 
achieve desired outcomes. 
Assessing outcomes 
We drew on the nominal group exercise, the case studies and wider literature to explore 
possible measures which could be used to assess the outcomes of knowledge brokering 
activity. In our study proposal we described this goal as measuring impact. However, 
‘impact’ is problematic if narrowly interpreted as effects on target populations (such as 
better health for patient groups). An important generic point raised by the nominal 
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group was the need to relate measures to specific intended outcomes. Other issues 
raised related to the difficulty in demonstrating causality, the risk of overlooking the 
hard-to-measure, and the relevance of context. Findings from the case studies 
underscored the importance of linking measures to planned outcomes but highlighted 
that very few, formal assessment measures were employed by agents or their managers.  
In lieu of generic measures, we propose a set of principles and a framework for 
measuring more specific outcomes of knowledge broker activity. The framework is 
organised around five areas of contribution: inputs, activities, capacity development, 
behaviour and outcomes. We present example indicators, evidence and likely barriers 
and enablers to the achievement of desired outcomes. 
Applying social marketing theory 
Social marketing theory helped to reveal linkages between processes and outcomes and 
impact. 
All KIT agents sought to develop insight into their ‘clients’ (Links) which enabled 
them to tailor support to meet the specific needs of individuals and teams. Such insight 
helped them understand competition, that is, the factors that stood in the way of the 
individual's attention, willingness and ability to adopt behaviours which would 
facilitate change in relation to knowledge and innovation transfer. The KIT agents 
identified numerous competing factors including, for example: the lack of relevance of 
research; time pressures; lack of specific skills (in quality improvement (QI) 
methodology, for instance); lack of knowledge; lack of confidence; politics and 
territorialism; and lack of alignment between national and local programmes. In social 
marketing theory, an ‘offer’ is made. For example, KIT agents may offer to build 
capacity, capability and skills; support by listening, providing practical help and 
coaching; and making linkages. 
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Further themes employed in marketing are useful, including the perceived quality of 
the product or service: clinical and managerial experience was valued as it was felt to 
enhance agent credibility. Place or positioning: agents commented on the importance 
of face-to-face meetings to build relationships. Policy: increased emphasis on cost-
saving or particular patient safety targets could provide an impetus to do things 
differently. Segmentation and targeting: for example, the KIT agents talked of 
working with the willing and not pushing failing projects. 
Conclusions 
We review our research in relation to the questions in our proposal. 
What are the commonly shared expectations of the KIT agent role? 
Despite ambiguity at a detailed level, the role was about engaging with practitioners to 
help them improve services for patients. Their role was about making connections, 
motivating and influencing others, teaching and training and facilitating access to 
knowledge. 
What, in practice, do the KIT agents do? 
We found both variation and commonality across the agents. All tailored their activity 
to the needs of their clients. Across the case studies we have examples of KIT agents 
providing formal research evidence, introducing or developing approaches to healthcare 
management (QI methodologies, patient and public involvement) through formal 
training and support, project specific support (most often QI-related), and a focus on the 
growth agenda. All the KIT agents were involved in building relationships, typically 
intended to be finite.  
How does the work of KIT agents impact on healthcare practice? 
It was challenging to do this but we were able to draw attention to specific projects with 
measureable outcomes to which agents contributed. 
How can KIT agents be best supported? 
KIT agents could benefit from more individuals in their teams. Support from senior 
colleagues was essential and peer-support was valued. Flexibility with respect to how 
the KIT agent is managed is important: they were successful because they could adapt 
their role and way of working to the needs of their clients and work to their strengths.  
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What measures can be used to assess the impact of KIT activity?   
Generic measures would not adequately assess the impact of KIT activity as their goals 
and roles vary. Context is important. Logic models might be useful for planning and 
evaluation.  
Implications for Effective Knowledge Brokering 
On the basis of our findings we suggest five implications for knowledge brokering. 
Individual dispositions such as an attentive and proactive approach to the role and the 
work, and status (i.e. relevant practitioner experience) were centrally important to KIT 
agent success. Person specifications and recruitment processes would benefit from 
being reflective of these attributes. 
These roles take time to develop and require flexibility on behalf of the organisation. 
Longer-term views to assessing the roles are necessary, which we note might be in 
tension with short-term fellowships. A potential medium-term approach, as discussed 
by our nominal group, could usefully entail the use of case studies.  
Some agents expressed feelings of isolation. It would be fruitful to explore how 
communities of practice could be developed to counter this.  
Confusion about who leads and supports QI was a challenge for KIT agents and needs 
to be addressed to avoid duplication, territorialism and wasted resources. 
Multiple skills are required to use local data for service improvement. This raises 
implications for training. 
Implications for Future Research  
One over-riding conclusion is the need for research to further our understanding and 
use of knowledge broker roles in healthcare. 
• A longitudinal study of KIT roles could address: whether the perceived risks of 
taking on these roles is valid; post-KIT role career options; whether trained and 
experienced KIT agents get lost in the system; whether the results of KIT work can 
be sustained. There is significant scope to follow up on KIT agents that have been 
studied across a number of projects.  
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• There is a growing recognition that knowledge brokering roles are held within 
teams rather than individuals. Future research might focus on how these roles are 
negotiated, maintained and transferred within a team setting and identify the 
related outcomes and impacts.  
 • More work is needed in understanding how success is identified, credited or 
measured. Social marketing theory could provide a suitable theoretical framework 
for this and enable exploration of whether social marketing concepts could usefully 
guide KIT practice. 
 • The apparent shift from knowledge mobilisation to the application of improvement 
methodologies deserves further attention. The co-existence of QI and more 
traditional notions of research use within the same policy and funding streams 
needs to be unpicked. 
 • A comparative (country, sector, knowledge-based private sector) study of similar 
roles which are deemed attractive merits consideration. Those in the healthcare 
field could learn from other contexts where the roles are not perceived as risky. 
 • The nominal group exercise raised the importance of knowledge brokers linking 
with service users and other knowledge brokers; something rarely observed in our 
study. One proposition worthy of further study is whether patients themselves can 
take on knowledge broker roles.    
Concluding Remarks 
The role of KIT agents is varied, complex and evolving. The success they have in 
achieving outcomes differed in relation to individual, local and policy related factors. 
Given the sheer scale of the task and the environment in which they currently operate, 
the effectiveness of KIT agents needs a long-term view. They require senior-level 
commitment and support in organisations, training and networking opportunities with 
others in similar roles. The roles, and people who occupy them, need to be given time 
and support if they are to realise desired outcomes and impact.  
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Chapter 1. Introduction 
The focus of this research is NHS and university-based staff in knowledge brokering 
roles, how they link with knowledge and innovation and how they transfer this to the 
healthcare practitioner community. The transfer and mobilisation of knowledge from 
research into healthcare delivery is a long-standing international challenge.1-6 Sebba7 
highlights the economic, moral and academic imperatives for investing resources in 
improving research use. Alongside the need to base decisions on evidence (moral 
imperative) and the increasing need to demonstrate impact of academic research 
(academic imperative), the economic imperative to ensure the best use of limited 
resources and minimise waste is a timely concern. In a time of unprecedented financial 
restrictions,8 healthcare managers face the enormous challenge of purchasing and 
providing healthcare to an ageing population with increasing expectations. 
Management decisions about planning, commissioning and service delivery affect large 
populations and require large amounts of public money. Failure to inform practice with 
evidence limits the improvement of the effectiveness of health services, wastes money 
and potentially adds to the scale of preventable morbidity and mortality. 
It is in this context that our study sought to find out how to get the best out of 
knowledge and innovation transfer (KIT) “agents”, those NHS practitioners in 
knowledge brokering or mobilisation roles. 
Knowledge Mobilisation 
Gainforth et al.9 defined knowledge mobilisation as “putting research in the hands of 
research users” but the use of evidence is a complex, social and dynamic process.10 To 
inform decision-making in practice, research evidence needs to be “available to those 
who may best use it, at the time it is needed…in a format that facilitates its uptake” as 
well as “comprehensible to potential users and…relevant and usable in local 
contexts”.11 In healthcare, this process and associated organisational change is widely 
recognised as complicated, messy, evolving and fraught with challenge.12-14 For 
example, practitioners are alleged to lack the time, motivation and capacity to use 
evidence15, 16 or are overwhelmed by the quantity of diverse evidence.17-19 Research 
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reports may lack relevance, can be opaque and verbose20 and it can be a long time 
before they are released.21 Some argue that research output is dominated by a 
biomedical focus on drugs, tests and devices. Instead, Walshe and Davies22 suggest that 
the current “predominant concerns” relate to “pathway and process redesign, safety and 
quality; organizational issues like coordination, integration and networking; workforce 
issues like training and skill mix; and patient issues like experience, education and 
empowerment”. Addressing these concerns may require alternative models of 
knowledge creation in order to close the knowledge-practice gap.23,24 
The Policy Context 
There have been a number of efforts to build bridges between researchers, policy 
makers and the service providers and there is growing interest in using collaborations to 
address the research-practice gap.25,26 Some of these are institutional partnerships 
involving co-location of teams, shared resources and so forth, whilst others rely on key 
individuals to bridge. All aim to link knowledge and innovation producers and users 
through various means that may or may not include a formal knowledge broker or KIT 
agent. Our understanding of the work of these KIT agents remains poor, and examples 
of collaborations can provide insight into potential modes of and mechanisms for 
engagement. 
Linking Trusts and Health Boards to research teams through managers can help 
organisations use research findings in their own setting and enable them to set up 
service improvement projects to improve health and healthcare outcomes. The review 
led by Sir Ian Carruthers, “Innovation, Health and Wealth: Accelerating Adoption and 
Diffusion in the NHS”,27 placed innovation at the top of the service agenda setting out 
ambitious recommendations to encourage quicker transfer of new practice, ranging 
from infrastructure change to realignment of system incentives and promotion of high-
impact initiatives. Central to the Carruthers report27 is argument for “a more systematic 
delivery mechanism for diffusion and collaboration within the NHS by building strong 
cross boundary networks”. Although the proposals of the Carruthers’ report27 are clear - 
productive regional collaborations between academia, industry and the health sector to 
identify and spread innovation and so drive service improvement – its 
recommendations accommodate regional conditions. Capacity to access, understand 
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and use research knowledge is emphasised to “bring about a major shift in culture 
within the NHS, and develop our people by ‘hard wiring’ innovation into training and 
education for managers and clinicians”. The contents of this report complement these 
key policy themes. 
Academic Health Science Collaborations, Partnerships and Networks 
Following the Carruthers’ report,27 Academic Health Science Networks (AHSNs) have 
brought most NHS organisations in England into collaboration with universities. In 
England, 15 AHSNs were licensed in March 2013. AHSNs are tasked with aligning 
“education, clinical research, informatics, training and education and healthcare 
delivery” and improving “patient and population health outcomes by translating 
research into practice and developing and implementing integrated health care 
systems”.28  Like their predecessors, Academic Health Science Collaborations 
(AHSCs), the central aim of these collaborations is “knowledge mobilization, rather 
than research production”.22 As designated in “Innovation Health & Wealth”27 and the 
“Strategy for UK Life Sciences”,29 AHSNs are a systematic delivery mechanism for the 
adoption and spread of innovation at pace and scale through the NHS. The networks are 
designed to foster collaborations between academia, industry and health service and 
shared aims include diffusing innovation, putting research into practice, and promoting 
economic growth.30 They are expected to work closely with industry and funders to 
bring together researchers, managers, patient groups, planners and policy makers. 
 
Compared to England, infrastructure targeting knowledge mobilisation and innovation 
is not well funded in Wales. However, Academic Health Science Collaboration 
(AHSC) has identified knowledge transfer as a priority. The AHSC formed three 
regional hubs – in the North, South West and South East of Wales. In their initial 
period these hubs attracted small scale funding from Health and Care Research Wales 
(formerly the National Institute for Social Care and Health Research - NISCHR) but 
this ceased in 2014. The South East Wales Academic Health Science Partnership 
(SEWAHSP) became independent and continued to operate. SEWAHSP has two key 
objectives: to increase the speed and quality of ‘translational’ research and promote and 
support innovation in South East Wales.31 A national Task and Finish Group also made 
recommendations to Health and Care Research Wales on knowledge transfer policy.32 
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CLAHRCs 
Descriptive studies focused on how research does make it into practice point to the 
importance of close interpersonal relationships between researcher and user.33-35 This 
has been built into interventions that seek to develop opportunities for both parties to 
link and engage. In England these include programmes such as the National Institute 
for Health Research (NIHR) Collaborations for Leadership in Applied Health Research 
and Care (CLAHRCs) which were designed to address what Cooksey1 termed the 
“second gap in translation”, related to the failure of new ideas and tools to reach 
practice. CLAHRCs are serviced-led partnerships which aim to contract high quality 
applied health research, implement findings and increase NHS capacity to engage in 
research.36-39 In 2008, nine CLAHRCs were established and a second wave extended 
the CLAHRC reach with tapered funding (from NIHR) for 13 CLAHRCs. This is an 
indicator of the perceived success of the programme. 
CLAHRCs are the most established and evaluated programme in the UK.39-46 The 
reports to date highlight similarities and differences between structural and content 
features of the CLAHRCs and point to early successes and challenges. For example, 
successes include: strengthened networks and relationships;39,44,47 new organisational 
roles that ‘make sense to professionals’; collective action to improve practices48; and 
creating a culture of reflection and learning.47 More specific successes have also been 
reported. For example, the CLAHRC for Greater Manchester achieved success in 
improving patient services in chronic kidney disease.41,49 Although such results 
demonstrate the impact of CLAHRCs and how the collaborations can change the 
approach of organisations for the better,39,50 it is very difficult to demonstrate a causal 
effect given the complexity of what they are and what they are trying to achieve. We 
return to this issue in later chapters.  Walshe & Davies22 are more circumspect and 
conclude that “promising lessons” can be distilled from the collaborations in England, 
which amongst others include “the development of organizational capacity in 
knowledge mobilization”. Currie, Lockett, et al.43 usefully summarise key areas of 
uncertainty for CLAHRCs which include the problem of metrics. They note the 
following uncertainties:  
the balance of activity between research and implementation; whether research 
should be clinically or implementation focused; appropriate metrics for CLAHRCs; 
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whether CHAHRCs should orientate towards their academic or NHS partners; and 
whether CLAHRCs should focus upon individual behavioural or organizational 
/system level change. 
They argue that the dominant approach is research focused, fixed on changing 
individual behaviour rather than “wider scale organizational and system level change”, 
as favoured by those from a social science tradition.43  
Knowledge Brokers 
Embedded within the concept of knowledge mobilisation are the roles of knowledge 
broker and boundary spanner.51-53 Roles vary,42,54 but the essential feature is that they 
facilitate engagement between research and practice.55 With the aim of improving the 
transfer of knowledge and innovation, knowledge brokers seek to close knowledge gaps 
and foster knowledge responsive capacity and culture.5,56-59 
To facilitate knowledge mobilisation, many CLAHRCs used knowledge brokers, 
variously named.22,60 For example, in the first round of CLAHRC funding, the 
Cambridgeshire and Peterborough CLAHRC had a Fellowship Programme for 
clinicians, health and social care practitioners, and managers, to work alongside 
researchers; the Nottinghamshire, Derbyshire and Lincolnshire CLAHRC funded35 
‘diffusion fellows’ attached to their research projects.61 
The NIHR SDO Management Fellowship programme provided another example and 
one aimed exclusively at managers; an evaluation showed benefits from the interactions 
between the Fellows, their NHS colleagues and research teams, but also revealed 
challenges in maximising those benefits for the workplace.62 The NIHR SDO scheme 
was later merged with NIHR Health Services Research programme to create NIHR 
Health Services and Delivery Research (HS&DR).   
As knowledge broker roles grew in numbers and type across the UK, an interest group 
formed in 2014 looking at fellows in the system. Several organisations, including the 
Health Foundation, NHS Education for Scotland, NHS Improving Quality, NIHR, and 
Universities UK were involved in early data gathering exercises to understand the 
characteristics of the wide range of fellows and fellowship programmes that exists 
across the health and care system.  This exercise culminated in a one-day event, 
"Fellows Connect", bringing together quality improvement fellows from across the UK 
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to share experiences.63 At the same time, Berwick's report on “Improving the safety of 
patients in England” recommended a “national system of NHS Improvement 
Fellowships, to recognise the talent of staff and improvement capability and enable this 
to be available to other organisations”.64 This resulted in the creation of an initiative 
called Q for quality, led by the Health Foundation and supported and co-funded by 
NHS England, connecting people skilled in improvement across the UK. The Q 
initiative aims to grow to be a community of thousands of people: patient-facing 
frontline staff, managers, researchers, ‘patient leaders’, policy makers and others in 
order to accelerate improvements to the quality of care.65 Together these recent 
developments illustrate the interest and also the investment by national organisations in 
the UK in maximising the potential of knowledge brokers to improve the quality and 
safety of healthcare for patients.   
The Aims and Objectives of the Study 
The focus of this research is knowledge and innovation (KIT) “agents” (NHS and 
university-based staff in knowledge brokering roles), how they link with evidence and 
innovation and how they transfer this to the healthcare practitioner community. The 
study aimed to examine the work of KIT agents in practice in order to understand how 
the outcomes of their endeavours might be maximised. Our research questions are:  
• What are commonly shared expectations of the KIT agent role?   
• What, in practice, do KIT agents do?   
  -what is their conception of knowledge and innovation transfer?  
  -how to they see their role?  
  -with whom do they link?   
  -what are their principal activities?   
• How does the work of KIT agents impact on healthcare practice?   
• How can KIT agents be best supported?   
  -what are the barriers and enablers to them meeting their objectives?   
• What measures can be used to assess the impact of KIT activity?   
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Our objectives were to: 
1. map the innovation and knowledge transfer intentions of the new AHSNs and 
SEWAHSP;  
2. describe and characterise the roles of KIT agents and develop a typology of KIT 
agent roles; 
3. report the perceived impact of KIT agents on managers’ practice; 
4. investigate how KIT agents can be best supported; and  
5. generate a set of impact measures for assessing innovation and knowledge transfer 
activities.  
Concluding Remarks 
Each chapter in this report ends with concluding remarks. This chapter has established 
the importance of knowledge mobilisation in healthcare and provided the background 
policy context to the current position of initiatives designed to address the research-
practice gap. We extend this in Chapter 2 by providing a summary of the literature on 
knowledge mobilisation.  
Chapter 3 outlines the theoretical underpinnings, research study design and methods 
used. Chapter 4 explores the knowledge and innovation mobilisation intentions of the 
AHSNs in England and an AHSP in Wales and introduces a suggested typology of the 
different forms that knowledge innovation and transfer roles may take.  
The main reporting of the results begins in Chapter 5 with an overview of the case 
study KIT agents. They highlight both content-specific knowledge transfer challenges 
as well as generic mechanisms that support transfer.  We commence our discussion of 
our findings in Chapter 6. We look across all the case studies to discuss common 
barriers and facilitators reported by the KIT agents and explore how they can be better 
supported in carrying out their role.  
The focus of Chapter 7 is on assessing outcomes of knowledge brokering activity. It 
includes a report of the nominal group and also draws on the case study data and wider 
literature. In Chapter 8 we extend our discussion of outcomes by reviewing our 
findings through the lens of social marketing theory. 
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The final Chapter 9 brings together the main conclusions and implications of the 
findings, positioning them within wider literature and suggesting recommendations for 
future research. 
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Chapter 2. Learning from the Literature 
Introduction  
A targeted review of literature was undertaken to identify existing KIT practices, 
attributes of the successful agents (knowledge brokers, boundary spanners) and 
outcomes. This assisted learning from previous evaluations, supported robust data 
analysis, informed the questions posed in the nominal group and provided a solid basis 
from which to consider the generalisability of findings.   
Organised into six main sections, the review begins with a brief exploration of 
terminology from which we offer tentative definitions. We follow this with 
consideration of the models of knowledge transfer and mobilisation implicit in 
programmes designed to bridge the gap between research and healthcare practice. The 
particular role of knowledge brokers or knowledge and innovation transfer (KIT) agents 
- the focus of the study - is set out in the next section and we identify factors shown to 
enable or impede knowledge transfer and mobilisation generally in section four. We 
follow this with a section summarising current knowledge on outcomes and impact of 
knowledge and innovation transfer programmes. The literature review concludes with a 
summary of main messages and an identification of further research needs.  
Notes on the literature search 
This review updates and builds on work previously carried out by Bullock et al.66 thus 
literature searches for the preparation of the current document were limited to 
publications post-2010. A broad search was carried out on Web of Science, PubMed, 
Ovid MedlineR, Scopus, CINAHL via EBSCO and Google Scholar using appropriate 
forms of the terms, “knowledge AND transfer AND healthcare”, “knowledge” AND 
(transfer  OR  translation  OR  mobili*ation) AND healthcare”,  “innovation AND 
healthcare AND implementation”, knowledge AND (transfer OR exchange OR 
mobili*ation OR intermediatr* OR boundary spanners), “knowledge AND broker OR 
intermediary AND healthcare”,  and “CLAHRC”. In addition, we sourced earlier 
papers from the citations of relevant papers and were vigilant for notifications of 
papers/reports as they were published. We complemented the electronic search by 
hand-searching two key journals (Implementation Science and Journal of Health 
Services Research & Policy) and searching the NIHR library of completed projects. 
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Grey literature relating to KIT policy in England and Wales was also reviewed (See 
Appendix 1). 
Terminology 
In our proposal we adopted the language of the funding Call from NIHR 
(http://www.nets.nihr.ac.uk/__data/assets/pdf_file/0003/81786/CB-12-5002-04.pdf) 
and so refer to ‘knowledge innovation and transfer’ (KIT). Lack of conceptual clarity 
around the theme has been noted in the literature67 and is not helped by a confusion of 
terms, which are ill-defined and used interchangeably.68 In this section, we draw on 
extant literature to develop tentative operational definitions of knowledge, innovation 
and transfer. We did not seek to provide a comprehensive review of all terms and 
issues. 
Knowing knowledge 
Knowledge is perhaps the most easily grasped of our terms, but the most difficult to 
define. Some authors have classified knowledge according to the degree of analysis or 
inherent conceptual complexity.69,70 Furthermore, literature on knowledge transfer is 
not narrowly limited to the transfer of facts to answer ‘how’ questions. Rather, although 
knowledge in this context is seen to include facts and information, importantly it is also 
recognised as being about understanding. Knowledge in this sense can be both 
theoretical and practical, derived from education and experience. However, it is useful 
to illuminate the interpretation of terms as they embody implicit assumptions about 
how knowledge may be transferred, exchanged and mobilised. The different terms used 
are associated with different concerns and values, and these have practical 
consequences. Conceptualising knowledge as empirical information, facts or data 
decontextualises and commodifies it as something that can be ‘moved around’.4,71 Alavi 
and Leidner72 writing about the conceptual foundations of knowledge management 
describe the relationship between knowledge and values, experience and context. They 
explain how knowledge “originates and is applied in the minds of knowers” and how in 
organisations “it often becomes embedded not only in documents or repositories but 
also in organizational routines, processes, practices and norms”.72 This quotation raises 
the distinction between explicit knowledge, written and recorded in documents, and the 
implicit or tacit knowledge, held by individuals often without awareness of it and 
revealed in organisational customs.  
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Related to the tacit-explicit dimension of knowledge is whether it is understood as  
individual or social.72 The distance between tacit (residing in the individual, difficult to 
transfer) and explicit knowledge (socially and organisationally located) underscores the 
challenge of identifying, articulating and transferring individually-held knowledge.73-76 
Szulanski77 also describes how the “stickiness” of knowledge can hamper its 
movement, and distinguishes different points at which stickiness is important, including 
initiation stickiness (which may be affected by competing priorities, for example) and 
implementation stickiness.  
These issues are relevant to knowledge transfer and innovation as they define what 
counts as knowledge, and influence how and whether it can be transferred. A study of 
knowledge transfer necessarily gives greatest focus to explicit knowledge, and 
academic research in particular. 
Knowledge and evidence 
One issue that is particularly important in the healthcare context is the relationship 
between knowledge and evidence. ‘Knowledge’ and ‘evidence’ are contested concepts. 
In healthcare literature, ‘knowledge’ is often synonymous with ‘evidence’ and aligned 
with the principles of evidence-based medicine (EBM). Innvaer78 notes that a “call for 
evidence-based [decision-making] is also a call for the use of scientific methods in data 
collection and in the validation of information”. However, in healthcare, as well as 
evidence of effectiveness derived from traditional randomised controlled trials (RCTs), 
‘evidence’ needs also to encompass feasibility, acceptability and appropriateness.79  
The implicit position of the National Institute of Health Research (NIHR)80 in relation 
to this field of inquiry is complex. In the commissioning brief for this study, they noted 
the use of various terms and chose to adopt the term “innovation and knowledge 
transfer”. However, this did not appear to be associated with limited positivistic 
interpretation of research evidence and earlier, they recognised that “engagement with 
research is socially and organisationally situated and heavily dependent on local 
context”. In this interpretation, knowledge is socially-situated, generated by a number 
of participants and methods81 and intertwined with practice.82 It allows for the idea that 
knowledge can be co-produced and co-owned and recognises the importance of tacit 
knowledge associated with organisational norms and customs.72  Likewise, in the 
PARiHS framework (Promoting Action on Research Implementation in Health 
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Services)3, in addition to research, ‘evidence’ includes “professional craft knowledge, 
patient preferences and experiences, and local information”. Harvey and Kitson83 have 
recently introduced the i-PARiHS framework to reflect how “evidence is incorporated 
within the broader concept of innovation to reflect the dynamic and iterative way in 
which knowledge to inform practice is generated and applied”. Neither of these 
definitions fit well with more formal definitions of evidence.  
For clarity, we would prefer to hold the two terms as conceptually distinct, although 
connected, using the term ‘evidence’ to relate to a sort of ‘knowledge’ defined by the 
way it was generated. Yet, it is imperative that we use both terms as they are applied by 
the participants in the study in order to understand the terms and their significance from 
their perspective. Thus, knowledge transfer will include forms of knowledge as relevant 
to participants, not simply the transfer of research findings from the positivist tradition. 
The University of Toronto, Institute for Studies in Education, Research Supporting 
Practice in Education (RSPE)84 provide a potentially useful set of questions that help to 
clarify different aspects of knowledge and knowledge use. These questions are: 
What knowledge? (e.g. tacit, research, evidence, best practice) 
In whose interests? (e.g. organisations, researchers, practitioners, knowledge brokers) 
For what purposes? (e.g. change, influence, practice, decisions, empowerment) 
In what context? (e.g. communities, workplaces, universities, boards) 
What techniques? (e.g. guidelines, training and workshops, facilitation, communities 
of practice) 
With what impact? (e.g. instrumental, conceptual, changing practice) 
Innovation 
This study is interested in the transfer of knowledge and innovation. Thus, we need also 
to give attention to ‘innovation’, a term that has increased in usage since publication of 
the Carruthers’ report27 concerned with the adoption and diffusion of innovation in the 
NHS.  This report (“Innovation, Health and Wealth: Accelerating Adoption and 
Diffusion in the NHS”), places innovation at the top of the service agenda and sets out 
recommendations to encourage quicker transfer of new practice.  
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Carruthers’ definition of innovation built on Rogers’85 interpretation of innovation as a 
new idea, practice, or object but requiring that it is applied. According to Carruthers,27 
innovation is: “An idea, service or product, new to the NHS or applied in a way that is 
new to the NHS, which significantly improves the quality of health and care wherever it 
is applied”. Given the focus of our study on the benefits of innovation to patient care, 
this explicit inclusion of application in the definition seems helpful. 
Alongside policy runs a literature looking in more detail at aspects of innovation. For 
example, Terwiesch & Ulrich52 have drawn a distinction between innovation which is 
“conceptual” (new to a field) and innovation which is “contextual” (new to an 
organisation). This is a potentially helpful distinction allowing the term innovation to 
cover a range of the new ideas, services and products, from a particular organisation to 
“catch up” to the application of a scientific breakthrough to healthcare management and 
practice. 
Implicit in the application of new ideas, services and products is a change in 
organisation and or individual behaviour. Birken et al.86 explain that innovation 
implementation is a process in which organisational members become proficient in 
their use of a new practice. Walshe & Davies22 adopt a broad interpretation of 
innovation that encompasses both “clinical practice and service design” and they 
explain, “service innovation means people at the frontline finding better ways of caring 
for patients”. Innovation in this sense may not involve formal and explicit knowledge 
transfer, unless these better ways are transferred outward to other colleagues and 
organisations. Walsh and Davies’22 perspective serves as a reminder that the focus of 
our study is anywhere in the healthcare system that is relevant to managers’ ultimate 
role of improved care for patients within public service constraints, but with particular 
attention on the application of new ideas, services and products which are transferred 
into an organisation rather than those that emerge in an organic manner from within. It 
is also worth noting that whilst innovation can ‘go either way’ in terms of impact on 
care, most literature and policy appears to start from the assumption that innovation is 
good.  
In terms of the application of innovation, Brockman and Morgan87 argue that 
knowledge transfer facilitates innovation and Strach and Everett88 write that the ability 
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to seek and maintain knowledge transfer capability facilitates a higher level of 
innovation. Radaelli et al.89 found that individuals who share knowledge are also more 
likely to be engaged with creating and implementing innovations. This reflects a 
prevalent assumption that knowledge transfer is (or should be) a means to innovation. 
Knowledge is something you have; innovation is something you do. Innovation does 
not transfer; but knowledge about it does. 
Transfer 
The final element of KIT relates to transfer. This is a well-developed area of literature, 
NIHR in their commissioning brief noted the multiplicity of terms. Prefaced by 
‘knowledge’, ‘transfer’ is just one option of many. Others include: ‘exchange’, 
‘mobilisation’ ‘translation’, ‘management’, ‘mediation’, ‘dissemination’, ‘diffusion’, 
‘utilisation’. Likewise, those working in roles to support this activity attract a variety of 
labels including: ‘knowledge brokers’, ‘translators’, ‘boundary spanners’, ‘diffusion 
fellows’, ‘research navigators’, ‘research liaison officers’, and so forth.13 There is both 
confusion of terms and confusion in the meaning of terms.90 Knowledge translation, for 
example, can refer to the job of ‘translating’ lengthy and complex research reports into 
digests more suitable for busy practitioners; or it can refer to the translation of 
knowledge into action or practice arising from collaboration between researchers and 
practitioners;82,91 or the ‘transfer’ of research from one group to another with little 
interpretation or amendment7. 
Transfer needs to be understood in relation to definitions of knowledge and different 
models of knowledge and innovation transfer will prescribe the role for people and 
organisations responsible for enabling it. 
Knowledge Transfer Models 
Dominating policy thinking and the bio-medical research literature on knowledge 
transfer is a focus on the unidirectional linear flow of knowledge from one domain to 
the other. This transfer is intended to address an information deficit on the part of the 
practitioner.92 However, it is deficient to assume that the production of the “right 
research” will just get implemented by practitioners.22 The process is not simply one of 
transference, that knowledge or innovation is something that can be parcelled up and 
distributed to “grateful recipients”.81 The linear model, assuming a unidirectional flow 
of research-based knowledge19,56 and the term ‘knowledge transfer’ has been criticised 
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for over-simplifying “the messy engagement of multiple players with diverse sources of 
knowledge”.81 Knowledge flows not like water in a pipeline; rather, knowledge morphs 
and mutates as it is mobilised, being “personalised and recast” by the decision-maker.11  
In an interactive model, both formal and informal links between researchers and 
research users are emphasised and interpersonal and exchange relationships are seen as 
a means of bridging gaps.33,35,93 Interactive or exchange models are also called 
“partnerships models”,94 “knowledge conduit models”,95 “linkage and exchange 
models”,93 or “alliances,... collaborations, and coalitions”,96 as well as “mode two”45 
and “integrative”13 or “integrated” knowledge transfer.97 Positive deviations is another 
term used to refer to the adoption of ‘unconventional methods’ to facilitate 
organisational change.98 
Partnerships within an interactive model come in a number of formats.94,99,100 Davies, 
Powell and Nutley90 suggested six archetypes of knowledge mobiliser: knowledge 
product pushers; brokers and intermediaries of their own research; brokers and 
intermediaries of wider research; evidence advocates (champions for evidence-
informed practice); network fosterers (developing new ones and enhancing existing 
ones); and advancers of knowledge mobilisation (enhancing knowledge about KIT 
work). Within these archetypes, agents carry out three broad overlapping roles: 
developing and sharing research-based products; brokering; and implementation.90 
What is common is an expectation that the knowledge changes as a result of the 
interaction. Such co-produced knowledge demands a broad acceptance of what counts 
as evidence.33,101,102 However, as noted earlier, this interpretation fails to fit with the 
idea of legitimate research evidence in evidence-based medicine.101 A fuller discussion 
of linear and interactive models can be found elsewhere.66 
To address the commissioning brief, in this report we have adopted the term 
‘knowledge and innovation transfer’ (KIT) and describe those supporting this activity 
as ‘KIT agents’. However, in our application of the term, we wish to include that sense 
of interaction and mobilisation, not the limited narrow notion of linear transfer.   
The Role of Knowledge and Innovation Transfer (KIT) Agents 
In this study we use ‘KIT agent’ to identify those people responsible for supporting the 
transfer and mobilisation of knowledge (broadly conceived) from one group to another. 
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Potentially these groups have little contact with each other and perhaps little 
trust.51,70,93,103,104 UK examples of KIT agents to date include knowledge transfer 
associates,105 secondees,106 improvement fellows or diffusion fellows in CLAHRCs, 
former SDO management fellows, and innovation leads in Health Boards in Wales. The 
role-holder seeks to create a link between the two groups, acting as a bridging agent,107 
or linkage agent,108 or mediator.7,109 Typically, and of interest to our project, the two 
groups are producers of knowledge (for example researchers, although not necessarily 
based in universities) and users of knowledge (healthcare 
managers/practitioners/decision-makers).110 
KIT agent roles vary.42,54 Noting overlapping boundaries, Fisher111 distinguished four 
roles that grow in responsibility. The most limited role they labelled “information 
intermediary” which focuses on helping practitioners to access information from 
multiple sources. The second they labelled “knowledge intermediary”, a role concerned 
with helping practitioners make sense of and apply information. The third, “knowledge 
broker” which according to Fisher111 is about improving knowledge use in decision-
making. The most encompassing role is labelled “innovation broker” which is about 
changing contexts to enable innovation. Fisher111 relates these four roles to the 
functions of knowledge brokering detailed by Michaels.112 The six functions are: 
informing (disseminating content); linking (expertise to need for a particular issue); 
matchmaking (expertise to need across issues, disciplines); focused collaboration 
(building collaborative relationships around an issue); strategic collaboration (longer 
term relationships); and building institutions. These functions can be mapped against a 
continuum from linear dissemination to co-production of knowledge and represent an 
increasing intensity of relationship between knowledge producers and users.  
The limitations of the role of bridging agent, disseminating information between two 
organisations have been highlighted,39,104 suggesting that collaboration between 
organisations or groups is more effective. They maintain that bridging agents risk 
becoming gatekeepers or holders of knowledge and that this limits cross-collaboration 
and imposes pressure on the agent. Collaborative research partnerships were proposed 
as one mechanism to alleviate barriers to KIT.15,17,21,22,113 We note that a proportion of 
the literature, particularly relating to collaboration programmes, refers to relationships 
between researchers and clinical practitioners,114 with little on how managers interact 
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with research115 which may or may not be different to relationships between researchers 
and clinicians. Existing research14,66 suggests that in exploring how KIT works in 
practice both organisations and individuals need to be taken into account. Enthusiastic 
individuals can be stonewalled by indifferent organisations and organisations keen to 
learn and innovate can be hindered by reticent individuals, for example.  
In this study, the essential feature is that KIT agents facilitate engagement between 
knowledge (broadly conceived) and practice,55 with the aim of improving the transfer 
and mobilisation of knowledge and innovation. Those in such a role can facilitate 
dialogue between research and practice,7,93 creating awareness of both sides’ interests 
and functions116, and building relationships.54,57,117 By encouraging greater involvement 
of decision-makers in knowledge production and knowledge producers in decision-
making117-119 and managing the “messy engagement of multiple players”,81 these KIT 
agents or knowledge brokers help to dismantle the cultural and language barriers 
between the two worlds. They do this by translating knowledge into appropriate 
language, highlighting its relevance to practice and emphasising the cross-applicability 
of each sides’ work.11,57,116,117,120 More broadly, the role typically includes both ‘hard’ 
(obtaining and sharing diverse information) and ‘soft’ tasks (facilitating cross-group 
relationships, mentoring, coaching) to create a bridge across these knowledge gaps and 
foster knowledge-responsive capacity and culture.5,56-59 
Managing the “messy” process81 requires the broker to impose some form of structure 
on the process. There are a wide variety of models of knowledge transfer and 
mobilisation outlined in various fields of healthcare literature.117,121,122 Typically, 
methods include workshops or other professional development activities, written 
communication through print and electronic media and personal face-to-face contact, 
building linkage and exchange.57,93,123 Through negotiation and understanding, the 
knowledge being mobilised across specialisations and organisations is reframed into a 
mutually agreed upon version.124 In mobilising knowledge, the broker creates a new 
version which Meyer125 labels “brokered knowledge”. Brokered knowledge is 
“knowledge made more robust, more accountable, more usable knowledge that ‘serves 
locally’ at a given time; knowledge that has been de- and reassembled”.125 
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One further distinction relates to the location of the knowledge brokers; some are 
located within the organisation and others outside. Nystrom et al.126 suggested that 
locally-based R&D offices have the potential to act as KIT agents. An example of a 
separate organisation that supports knowledge mobilisation is IRISS (Institute for 
Research and Innovation in Social Services), a charitable organisation working with 
social services in Scotland. For those individuals in knowledge brokering roles within 
organisations, some may work across departments whereas the work of others may 
focus on teams within one department. This reflects an alternative classification of the 
brokering roles outlined by Gould and Fernandez.127 They differentiated between 
brokers who work within their own community (‘coordinators’), with a different 
community (‘itinerant brokers’), or ‘liaisons’, with incoming exchanges (‘gatekeepers’) 
and with out-going exchanges (‘representatives’). 
In concluding that approaches to knowledge brokering are varied and that a number of 
writers have grappled with distilling useful models, we note that when planning 
approaches and objectives, organisations make limited use of the theories and 
frameworks from the literature.90 The KIT agent is defined by their work with 
producers and users of knowledge (in this case, managers/decision-makers) in helping 
to transfer and mobilise knowledge. The best way to do this is unknown and is a central 
question of this project. 
Enabling Knowledge and Innovation Transfer  
There are a number of ways of organising the factors identified in the literature that 
enable KIT. Walker et al.128 offer one classification. Their four broad factors are: 
• Context: factors in the external and internal environment • Content: the changes being implemented (or knowledge being mobilised) • Process: actions taken by the change agents • Individual dispositions: attitudes, behaviours, reactions to change 
We use Walker et al.’s classification as an organising framework. It can be related to 
other frameworks such as PARiHS.129,130 In the PARiHS framework, successful 
implementation is represented as a function of the nature and type of evidence, the 
qualities of the context in which the evidence is being introduced and the way the 
process is facilitated. Both frameworks include a context factor; Walker et al.’s 
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‘content’ can be mapped to ‘evidence’ in the PARiHS framework; and ‘facilitation’ in 
PARiHS seems to capture Walker et al.’s128 ‘process’ and ‘individual dispositions’. The 
extended i-PARiHS framework131 incorporates the role of facilitation of an innovation 
with the recipients of the innovation in their “local, organisational and wider health 
system context”. This we would map to Walker et al.’s128 ‘process’ factor.  
Context factors 
Macro-level context factors relating to the wider social, political and economic 
environment in which the healthcare service, researchers, collaboration and KIT agent 
sit have been suggested to affect the success of KIT.6, 132 Factors in the external 
environment known to inhibit KIT include the rapid turnover of policies, ministers and 
civil servants. Major shifts in healthcare and other policy, singly and in combination, 
can have disruptive effects on knowledge transfer and mobilisation.56 
External context factors relating to funders or commissioners of research are a 
recognised, and under-researched, translational gap.90 At an organisational level, short-
term funding does not support sustainable partnerships.94,133 Operating within a “closed 
system or fixed budget”,134 commissioners with shorter time horizons risk losing the 
insight that can arise from longer-term studies and can be too preoccupied with 
immediate policy priorities, government targets and financial imperatives, all subject to 
change at short notice.94 Thematic funding has also been suggested to engender 
fragmentation.135 Restricted time and resources can also limit effective brokering or 
mobilisation.15,93,134  
Meso, or organisation-level context factors are often overlooked4,136 but have a major 
impact.134 A key factor in the internal context relates to the nature of the organisation– 
its attitude to research, to knowledge, to change – and the ability of the organisation to 
receive and process information.113,137,138 In tune with Currie, Lockett et al.,43 Kitson et 
al.3 reported that contexts which had “transformational leaders… learning 
organisations, and … feedback mechanisms” were better able to implement evidence 
into practice. A similar conclusion was reached by others: when attempting to 
implement innovations, organisations face challenges such as professional barriers, 
inertia139, misaligned incentives and competing priorities.139,140 The supporting 
infrastructure needs “effective and inspiring institutional leadership”141 as quoted in 64 to 
create a “consistent and psychologically safe culture”.134 An evaluation of CLAHRCs 
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revealed a lack of emphasis on leadership (the L in CLAHRCs) and concluded with an 
argument for the selection of leaders with a more systems-level approach who “have 
the capability to work across organisational and professional boundaries”.43 
King et al.99 explain variation in outcomes and impact by differences in “individual and 
organisational receptiveness” or state of preparedness of the workplace environment. 
Organisational value of using evidence may be limited.100  The organisational culture 
needs to be adaptive142 or absorptive if it is to make use of knowledge and increasing 
emphasis is given to organisational readiness.18,82,138,143 The level of an organisation’s 
“absorptive capacity”144-147 is defined as “a firm's ability to recognise the value of new 
information, assimilate it, and apply it to commercial ends”.146 This “adaptive and 
responsive capacity” is important to knowledge use in practice and is affected by the 
organisation’s “prior related knowledge, a readiness to change, trust between partners, 
flexible and adaptable work organisations and management support”.145 Implementing 
innovations is demanding – cognitively, emotionally, physically, and spiritually.139 If 
this capacity to learn, demand and generate new knowledge for the purposes of 
improvement is absent, then the impact of a KIT agent or knowledge broker is likely to 
be limited. Traynor et al.148 concluded that the use of knowledge brokers had increased 
both individual capacity (improved knowledge searching, appraisal and application 
skills) and organisational capacity (management support and policies) of the target 
group. 
Oborn et al.149 indicate that “absorptive capacity is a strategic level capability which 
should be developed and nurtured by leadership teams”. Differences in hierarchical 
structures, leadership, power and professional cultures130 contribute to organisational 
receptiveness and cross-professional communication.104,130,150 Cross-organisation and 
cross-discipline communication and collaboration is seen as vital.134,150-151 However, 
Tasselli150 reported that professionals tended to be “embedded in distinctive 
professional cliques”. 
Other studies have identified personal challenges for KIT agents around professional 
boundaries.137 Career pathways and progression may be uncertain for KIT agents, 
particularly those in dedicated knowledge brokering roles.133,§37 Support, in the form of 
collective forums (i.e. communities of practice) and a physical home137 help individuals 
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navigate the isolating aspect of the role. The provision of space benefits others: 
Dopson, Bennett, et al found that having access to “formative spaces”, removed from 
their organisational context, where managers could engage with knowledge aided their 
appraisal of research.115 
Content factors 
The work of some KIT agents entails the identification of the relevance of research to 
practice and the tailoring of findings to service need. Walker et al.128 use the term 
‘content factors’ to refer to the changes being implemented. It is perhaps more helpful 
to borrow from the PARiHS framework and include in the term issues around the 
nature of evidence or knowledge. Thus, content factors can also relate to the nature and 
type of knowledge (explicit or tacit) which may be more or less readily transferred and 
mobilised, and to the type of evidence, varying from research findings to professional 
experience and local information. It concerns the social nature of knowledge and 
evidence; what counts, to whom and when.  
Before knowledge or innovation can be implemented, the new evidence needs to be 
interpreted for the local context, integrated with existing knowledge and discussed. 
Arguably, decision-makers and researchers differ in their view of research;115,140 
researchers look at the information for academic rigour while decision-makers assess its 
local relevance.140 At both local and national level, new evidence may be supported or 
side-lined; it may address or be at odds with local needs;39,141,152 it may require change 
that is demanding (transformational and rapid) or the change may be incremental and 
require only fine-tuning. Relevance and benefit to the participants is an important 
enabler.153 Decision-makers are more likely to engage if the project suits their needs. 
For example, an evaluation of the Quebec Social Research Council’s (CQRS) 
partnership programme found that all respondents reported benefits to them as a reason 
for success. The research had relevance because it was linked to wider policy concerns 
(saliency).154 
Ross et al.152 too found that decision-makers were more likely to engage with the 
research team when the research questions aligned with their interests, but also where 
they perceived their contribution to be essential to the success of the project –for 
example, bringing local knowledge. Making a meaningful contribution drives 
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practitioners. Bartunek et al.75 suggested that short-term relationships, which focus on 
data collection, might result in the practitioners feeling exploited. Being able to help 
shape research questions is an important activity for some practitioners.155 
Competing agendas and priorities between partners can be a barrier to success156,157 and 
need acknowledging and managing.114,155-156,158-159 Academics and commissioners alike 
have recognised deficiencies in the communication of research findings across 
boundaries. Researchers felt they should be involved more closely in the calls for 
research proposals; commissioners were more concerned that the users of research – 
policy colleagues and public service managers – should be involved more closely to 
ensure prioritisation of practical over academic concerns.56 Commissioners found 
academics preoccupied with creating new knowledge suitable for publication in high 
impact journals rather than policy-driven outputs.56 Arguably, the ‘impact case studies’ 
that are a part of the Research Excellence Framework160 have gone some way to address 
this. However, a review of a sample of impact case studies indicated that impacts were 
relatively short-term, often with limited direct impact on patient outcomes such as 
morbidity and mortality, and with limited consideration of the processes and 
interactions which may lead to indirect impact.161 The time lag between the identifying 
a demand for new knowledge and its synthesis for use in decision-making has also been 
noted and decision-making timescales are short compared to research timescales.162 
Information relating to the “here and now” is more likely to be used.10 
Process factors 
In Walker et al.’s128 model, process factors refer to actions undertaken by the change 
agents. In this sense, agents include all those parties involved in the process of change, 
not just the KIT agents themselves. Gagnon163 suggests that all parties should “plan for 
collaboration with an explicit description of roles and responsibilities and a 
commitment to regularly assessing its effectiveness”. The lack of clarity of brokering 
roles can limit success.16,93,135,164 Against this, flexibility is also seen as important,66 
brokerage roles may differ for different individuals127 or at different times.165,166 Ross et 
al.152 conclude that individual partnerships need to be flexible; one-size does not fit all 
and finding the right person for the particular role is key.  
Agreeing roles, goals and expectations is a common recommendation.16,41,42,152,155,1,167 
Roles can take time to be established and may take on different forms based on specific 
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local organisations.168,169 One reason given for the success of the CQRS’s partnership 
programme was that participants were expected to show measureable results.141 Bullock 
et al.62 found examples of interactions between the knowledge brokers and their 
managers that resulted in frustration because expectations had not been openly 
articulated. Additionally, individuals in the roles will embrace brokering and linking 
functions at different paces or not at all.  In a study of hybrid physician-manager roles, 
the authors identified three different groups which they term ‘innovators’, ‘sceptics’ 
and the ‘late majority’ reflecting the different pace of role adoption.48 Collaborative 
policy setting has been suggested as a mechanism for ensuring needs-led evidence is 
produced but it was noted that this method can be more time consuming.170 
Collaborative partnerships seem to work best where there are effective links between 
researchers and practitioners. Communication and trust building, and motivation and 
commitment by all the organisations involved in the CLAHRC partnerships have been 
shown to be central to making collaborations work.36,49-50, 58 Effective solutions cannot 
be “developed from the knowledge base in the absence of those who will apply the 
knowledge”.171 The key to knowledge mobilisation impacting on organisational 
performance rests on “the transfer of knowledge to locations where it is needed and will 
be used”.72 KIT agents typically act as a facilitator of this transfer, using guided 
interaction to support the uptake and use of knowledge.172 Their work requires a “multi-
level, multi-strategy approach”.173 Current evidence suggests that there is benefit in 
gaining the bidirectional support of middle managers within organisations174: “they 
may disseminate information vertically from top managers to frontline employees and 
from frontline employees to top managers, and horizontally, across top managers and 
across frontline employees”.86 
Building successful long-term, trusting partnerships between knowledge producers and 
knowledge users supports the use of research in informing decision-making,175 however 
this takes time and commitment.137,152,156,159,176 Partnerships need people to attend 
meetings.152,155 Bartunek et al.74 suggest a number of physical links between the two 
communities – web-based discussion boards, practice-focused meetings and 
conferences. Baumbusch et al.91 explain how project meetings were used to feedback 
emerging findings for practitioners to action, and for practitioners to provide context 
that would assist interpretation of the findings. Kislov et al.40 describe such events and 
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artefacts as “boundary objects”. Others also write of the importance of co-locating the 
partners which facilitates not only formal face-to-face meetings but also informal 
discussion “at the water cooler”.137 
Knowledge transfer and innovation carries costs. For example, the time required to 
develop the necessary skills and relationships with organisations takes people away 
from other tasks and therefore imposes financial costs91,113 for both employers and 
decision-makers.152 Financial restrictions impedes knowledge mobilisation;159 those in 
the roles are often unable to use their backfill due to organisational pressures.106,177  
Individual dispositions 
Walker et al.’s128 final area of concern relates to ‘individual dispositions’. This focuses 
on the KIT agents themselves but needs to be located more broadly: KIT agents are 
limited by the context and the character and dispositions of their organisations and 
colleagues. Evidence suggests that other aspects influence their capacity to transfer 
knowledge and bring about innovation, not only factors to do with their disposition (for 
example patience and approachability).148 This includes their role and seniority within 
the organisation and how they are perceived by others, for example.66 Soper et al.44 note 
the importance of “understanding each other’s incentives and constraints”. 
However, the skills and attitudes of the KIT agent or knowledge broker are a recurrent 
theme in the literature. Alongside excellent communication skills,177,178 they need to 
have a good understanding of both the research evidence and policy issues and be able 
to transform that knowledge into something that is salient to their practitioner 
collaborators.91,159 Platt179 warned of the risk of relying solely on “intermediaries” who 
might not have the skills needed to interpret the evidence or be motivated by their own 
interests.  
There is argument that knowledge brokers in hybrid roles (clinical-managers for 
example) may be best placed for mobilising both explicit and tacit knowledge because 
of their membership of multiple communities.54 However, challenges may arise related 
to dimensions of their role and inter-organisational factors.180, 181 For example, those in 
hybrid roles have been found to show preference to one aspect of the dual role over the 
other, to only broker knowledge within their professional sector, or to not be best 
placed to reach all levels of the organisation.180,182-184 
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Mutual trust and respect are frequently reported as enablers.74,91,114,155,158,176 The issues 
of trust and reciprocity feature prominently in the management literature on planned 
collaborations.185,186 Other reported beneficial dispositions include: clinical credibility, 
being known and having a good reputation;60,187 and having good knowledge of the 
organisations’ culture.188-189 For those from outside sectors, willingness to learn about 
the other community is stated rarely,75,189 but would seem to be essential.  
For researchers to take part in interactive exchange models of knowledge mobilisation 
it is likely that they need to have accepted a broad notion of ‘knowledge’.75 
Researchers’ “arrogance” and power differentials can introduce problems.176 
Engagement with potential users of knowledge may be seen as signifying a lack of 
independence and objectivity in the work.57 Concerns about academic rigour and 
violations to objectivity can be off-putting to academics – “If what is required is for 
researchers to do what policy-makers want them to do, then research may fail to fulfil 
one of its most important functions, namely to be objective, reliable and unbiased”.190 
Ross et al.152 note that none of the researchers in their study identified this as an issue. 
Measuring Outcomes and Impact 
Knowledge brokering can be conceptualised as a set of complex social activities that 
are difficult to evaluate. Various studies have found it to be an effective strategy for 
knowledge mobilisation but few are explicit about what aspects of the role are most 
effective.191 Key questions are what types of brokering outcomes can and should be 
measured (for example increased evidence use, relationships and interactions between 
researchers and users, linkages and network, increases in capacity to use evidence) and 
how they can be adequately captured (for example via survey, interview, observation 
documentary analysis).34 
The ultimate test of success is the impact of the KIT agent on knowledge transfer, 
innovation and patient care. Kothari et al.192 compared the take-up of research reports 
on breast cancer prevention between practitioners, some of whom had helped prepare 
the report and others who had not. They reported that engaging practitioners in the 
discussion of findings and the preparation of the report improved their understanding of 
the limitations of the research and made them more likely to talk about using the 
research in future services. However, they also found that “interaction was not 
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associated with increased utilisation of research findings in programs and policies 
within the time frame of [the] study”. Despite this, it remains important to discuss 
whether and how process measures can assist monitoring and assess their links to 
outcomes that are otherwise assumed.  
The literature includes little on measurements of impact arising from research 
partnerships. Davies, Powell and Nutley90 found most use learning from informal 
experience, not formal evaluations. One suggested solution to the difficulty of 
evaluating knowledge brokering is to design research within a clearly articulated 
theoretical framework, which provides a basis for later evaluation of outcomes.193-194 
PARiHS may be such a framework3 and realist evaluations using clearly defined 
frameworks are gaining recognition as valuable ways of examining and evaluating 
complex interventions.60,195-196 
Sustainability was found to be a priority for trainee KIT agents.197 The NHS Institute 
for Innovation and Improvement Sustainability Model (SM) has developed a self-
assessment tool, which encourages reflection in three domains: process, staff and 
organisation. Doyle et al.198 concluded that the tool was potentially useful but 
emphasised the need for capacity building and facilitation for it to be implemented 
meaningfully.   
Demonstrating ways in which KIT agents facilitate desirable service outcomes is 
critical to many senior managers’ goodwill and willingness to ‘release’ staff to KIT 
agent roles, not least because there are costs for them.66 Data gathering for impact 
assessment is a cost to collaborations and there is clearly value in aligning (appropriate) 
approaches and measures sooner rather than later.  
Concluding Remarks 
This chapter has explored the relevant international literature on knowledge and 
innovation transfer and mobilisation highlighting it as a messy, complex, evolving and 
dynamic process. The use of ‘knowledge brokers’ (KIT agents in our study), people 
responsible for supporting the transfer and mobilisation of knowledge or innovation 
between producers (typically researchers) and users (healthcare managers/ 
practitioners/ decision-makers), is a common approach to addressing the KIT challenge. 
The literature identifies enablers to developing successful partnerships between 
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researchers and practitioners/ decision-makers. These factors relate to: context 
(external and internal, including policy shifts, fiscal restraint, absorptive capacity and 
leadership); content (for example, the relevance of research and its match to local 
priorities); processes (for example, expectations, flexibility, physical links); and 
individual dispositions (including extent of mutual trust and respect; KIT agents with 
the appropriate skills and attitudes and networks; researcher acceptance of a broad 
interpretation of ‘knowledge’). The impact of collaborations and the activity of KIT 
agents/knowledge brokers is hard to measure although there are some frameworks and 
tools worthy of further investigation. 
Given the growing interest in using collaborations to address the research-practice 
gap,22 one evident conclusion is the need for further research. Yet research about how 
partnerships between researchers and decision-makers facilitate knowledge exchange 
“is in its infancy”.51 Oborn et al149 remark that although collaborative engagement and 
reciprocal exchange “are increasingly common in health services ‘KT’ literature”, 
evaluation models “continue to focus on more linear and quantitative approaches”. This 
is insufficient for answering “which types of KT network is best?”. Oborn and 
colleagues149 conclude that future research needs to contend with the possibility that 
“‘best practice’ may be socially constructed, rather than scientifically and objectively 
determined”.  Waring et al.54 and Rycroft-Malone et al.42 point to the need for more 
research on knowledge brokers. The impact of collaborations and the activity of KIT 
agents/knowledge brokers is difficult to assess and despite the existence of some 
frameworks and tools, there is a need to apply and refine them in further research. 
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Chapter 3. Design and Methods 
The focus of this research was KIT agents (NHS and university-based staff in 
knowledge brokering roles) and the work they do in the knowledge mobilisation 
process with the healthcare practitioner and management community. The study aimed 
to provide insight into the outcomes and impact of KIT agents’ knowledge brokering 
with NHS managers and clinicians.  
The research used an in-depth qualitative case-study approach, focused on a sample of 
KIT agents drawn from across England and Wales. Data were gathered from 
interviews, audio-diaries and observations. By examining cases (KIT agents) from a 
number of discrete initiatives designed to facilitate knowledge mobilisation, the study 
aimed to reveal how these endeavours worked in practice and how benefits can be 
maximised. To address one of the research questions, we used a consensus method in a 
meeting of experts (nominal group technique). 
Study Design  
Theoretical frameworks 
Within the case study design, data gathering was shaped by Kirkpatrick’s framework199 
which provides a useful structure for ensuring data collection beyond immediate 
reactions to an initiative and has been widely used in business and education.200 The 
original Kirkpatrick framework comprises four levels. Level 1 is concerned with 
assessing the participants’ reactions to the activity: for example, did they think it was 
relevant to their needs? Level 2 relates to learning gains (knowledge acquired by the 
practitioners). Level 3 focuses on behaviour change as a consequence of participation 
(application of knowledge to practice). Level 4 is about impact (what difference 
changed behaviour makes). This framework fits well with social marketing theory and 
its focus on behaviour.  
In earlier work,62 we modified the framework to address known limitations200,201and to 
maximise its relevance to innovation and knowledge transfer within the NHS. These 
adaptations recognise that reactions, learning gains and behaviour change both 
contribute to outcomes and are themselves ‘impacts’; that they are linked to each other 
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and not arranged hierarchically; and that the processes and dynamics of initiatives 
(including motivations) and the wider context are important.62 
Our approach to data analysis is described later. In this we drew on other classifications 
or frameworks in the literature, notably Walker et al.’s128 work on factors affecting 
organisational change and the PARiHS framework.202  
To inform our understanding of the consequences and implications of our findings, we 
used social marketing theory. Social marketing is defined as “the systematic application 
of commercial marketing concepts and techniques to achieve specific behavioural goals 
relevant to the social good”.27 It is focused on understanding (“insights”) why people 
(for example NHS managers) do what they do now (in relation to innovation and 
knowledge) and what “competition” the new behaviour faces. Social marketing theory 
recognises that this may vary by subgroups and may require different kinds of support 
(“segmentation and targeting”). These insights can be used for “creating attractive 
exchanges”204 which can encourage the effective uptake of the new behaviour. Part of 
this is taking account of, and most likely modifying or adding an “offer”,204 such as an 
interactive event designed to help make frontline practitioners engage and learn more. 
The strength of such an approach is that it starts with investigating KIT from the 
perspective of people who are being asked to do it. It seeks to understand the meaning 
they attach to it, the barriers and enablers to doing it, without attempting to prejudge 
issues. The approach allows factors that challenge or enable KIT to be identified and 
context- specific solutions to be developed. Do different managers, clinicians, 
innovations, questions, healthcare organisations require different activities or transfer 
pathways? What are the implications for practice? For example, managers with limited 
access to IT and statistical support might find it impossible to apply modelling 
techniques, even if they know about them. The solution lies in improving hardware and 
support, not in communicating research findings differently. In another example, to 
enhance knowledge mobilisation in a setting where a KIT agent’s line-manager expects 
them to “deliver” without their support may need a solution which focuses on the line-
manager and not the agent. 
Advisory group 
A project advisory group was established which comprised NHS managers, chief 
executives, representatives of the HS&DR, academics with expertise in knowledge 
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mobilisation (including from overseas), patient representatives, and other partners. 
These are listed in Appendix 2 along with the main focus of each meeting). 
Primary communication with the advisory group was by teleconference preceded by 
emailed agenda and supporting papers. Nine meetings were held over the course of the 
study. The advisory group helped to resolve practical issues, acted as a sounding board 
for sampling, data collection and analysis decisions. Most notable was their 
contribution to the discussions of early findings. Throughout the project, we presented 
drafts and questions to the advisory group members who used their knowledge and 
experience to inform our way forward. As a group, they provided a strategic voice for 
service users and service leaders. By facilitating the on-going validation of research 
findings, the advisory group enhanced the credibility and relevance of the research 
project and contributed to early feedback of findings to stakeholder communities.  
Patient and public involvement 
As this project arose in response to a specific HS&DR Call for “research to improve 
knowledge transfer and innovation in healthcare delivery and organisation”, patients 
and public were not actively involved in identifying the research topic.204 Public 
involvement was defined broadly in the Call to include “local communities...members 
of the public, users of services, carers and minority ethnic groups as well as healthcare 
practitioners and managers”.204 Our proposal was developed with the direct input of 
research networks lead (de Pury), the director of an Academic Health Sciences 
Partnership (Denman) and a Health Board manager (Howell). They made a significant 
contribution to prioritising and adding detail and contextual understanding to the 
objectives. Their views and opinion of their needs regarding innovation and knowledge 
transfer shaped the detail of the questions we asked. 
Users are motivated to take part in research management when they feel they can make 
a contribution given their own expertise, experience and interest. For this reason, we 
focused our inclusion of patient representatives within the advisory group and the 
nominal group, where discussion could be informed by their first-hand experience of 
services.  
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Data Collection and Sampling 
We describe data collection methods in relation to three parts of the study: the initial 
mapping and typology development; the case studies; and the nominal group. 
Mapping and typology development 
For the national mapping of the knowledge and innovation transfer intentions of the 
AHSNs and the development of a typology of KIT agents we collected data from desk 
research and telephone interviews.  
Desk research (June-August 2013) 
The 15 AHSN prospectuses and business plan documents (versions submitted to NHS 
England for licensing in 2012) together with the SEWAHSP Five Year Strategy206 (July 
2012) were reviewed to understand their interpretation of knowledge mobilisation and 
their planned approach, in particular, their intentions to engage knowledge broker roles. 
The documents were scrutinised and searched for the terms fellow, associate, lead, 
broker, agent, manager, boundary, transfer, exchange, span, connect, linkage, mobilise 
and gap.  
Telephone interviews (November 2013 – February 2014) 
In order to supplement the initial mapping of knowledge mobilisation intentions as set 
out in the documentation of the respective networks, the managing directors of the 
networks were approached by email. The initial contact described the project’s aims 
and requested a 30-minute conversation, either in person or over the telephone, to 
understand their approaches to knowledge mobilisation. This was followed up with 
support staff to schedule the discussion and provide further background on the study’s 
aim and objectives. Interviews were conducted using a semi-structured interview 
schedule (Appendix 3). 
Fourteen of the 16 network managing directors (including SEWAHSP) agreed to share 
their regional approach to knowledge mobilisation. Most managing directors stated they 
were still in the planning and set up stages of establishing their organisation and 
therefore could discuss their intentions around the use of KIT agents but not specific 
individuals. Eleven telephone and three face-to-face meetings were held between 
November 2013 and February 2014 ranging from 20 minutes to one hour in length. 
Twelve of the 14 discussions were held with the managing director and the other three 
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were held with a named lead in the region. Two managing directors out of the 16 did 
not respond to multiple attempts to secure a discussion.  
Appendix 4 summarises the main findings of the document review stage and the results 
are described in Chapter 4. 
Case studies 
Sampling 
Using data from the intentions of the AHSNs and SEWAHSP, we purposively sampled 
five diverse sites from which we selected case study KIT agents. The five networks 
were selected on the basis of: 
• stage of network development (e.g. ranging from de novo to well established) 
• diversity in regional research infrastructure (e.g. established links with 
CLAHRCs/no CLAHRC; AHSC/no AHSC); 
• planned KIT roles within the region (e.g. part of core team, secondments, 
fellowships); 
• geographical diversity: largely urban/rural and north/south representation;  
• willingness to engage with the project. 
Our target population was KIT agents across England and Wales: individuals who 
facilitate the mobilisation of knowledge to practice; knowledge brokers who link NHS 
managers/clinicians and the developers of knowledge and innovation. In the national 
mapping exercise we delineated definitions and expectations of the KIT agent role. 
From this we drafted a typology of KIT agent roles which we used to inform the 
identification of our individual case studies. In making our purposive selection of 13 
KIT agents we actively sought variation of role, sampling within four of 15 AHSNs in 
place in 2013 and the first AHSP in Wales. We selected a number small enough to 
enable in-depth study of the work and impact of these KIT agents over time and yet 
provide good geographical coverage and system contrast. As a qualitative study, the 
sample size was necessarily small to enable richness and depth of data gathering and 
analysis. The specific innovations and knowledge that the agents helped to mobilise 
was diverse. This diversity enabled the detection both of content-specific knowledge 
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transfer challenges as well as generic mechanisms that support transfer and 
mobilisation.  
Data collection 
Detailed case studies of KIT agents and their work were the source material for 
describing the roles of KIT agents, their linkages, relationships and engagement 
activities and reporting the outcomes and perceived impact of their work on practice 
and management. They also provided data that enabled us to investigate how KIT 
agents can be best supported. We collected data from: observation of KIT events/ 
meetings; recurrent semi-structured interviews with agents and interviews with their 
key Links (NHS managers/practitioners); and where possible, audio-diaries kept by 
agents over four months.  
Observations 
We aimed to observe two to three activities of each case study agent. These were at the 
invitation of the KIT agent and included showcase events, reports to workplace 
colleagues, presentations of research, meetings to discuss progress on initiatives. These 
diverse, non-participant observations varied in length from relatively short meetings 
(less than two hours) to whole day events. Larger showcase events lasting a day were 
attended by two members of the research team; others were attended by one. Field 
notes were made, recording who was involved, what happened, reactions and 
reflections. They also provided opportunity for informal discussion with people with 
whom the agent linked. We collected copies of any documentation used during the 
event.   
Interviews 
a) KIT agents 
All interviews were audio recorded and transcribed. An initial, face-to-face lengthy 
interview was held with each of the case study agents. The schedule is presented in 
Appendix 5. In most cases further interviews were conducted. These provided 
opportunity to update on specific activities and further explore outcomes and 
perceptions of impact. One agent withdrew from the study after the initial interview.  
b) Line managers 
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We had contact with agents’ line-managers as part of arranging access and most agreed 
to a one-to-one interview, face-to-face or by telephone, depending on their preference 
(see Appendix 6 for the interview schedule).  
c) Links 
We also conducted semi-structured interviews with some of the key people with whom 
each agent linked. These Links were identified by the agent. Further detail regarding 
the background of the Links is presented in Table 1b and it should be noted these 
individuals do not represent the entire range of an agent’s network of contacts. The 
content of the interview varied depending on the nature and reason for the connection 
to the agent.  
Audio-diaries 
KIT agents were asked to keep diaries of activities and audio-recordings of their 
reflections on events and brokerage meetings. We explained the purpose of the audio-
diaries and how to make recordings at our first face-to-face meeting. All those who 
agreed to take part were requested to record an audio-diary of their experiences (via a 
personal Dictaphone provided for participants or using their own digital recording 
equipment if they preferred). These solicited audio-diaries captured participants’ sense-
making in action as they told their stories both to the researchers and to 
themselves207,208 and commented on outcomes and the potential impact that the role had 
on others. In order to enable participants to set the agenda for the content of their 
narratives we gave them one principal request: “Please tell us about something that has 
happened in your role as a KIT agent since the last time you left a message”. However, 
we also included specific questions in subsequent requests to follow up on earlier 
recordings. Participants were requested to record at least one short (two to three 
minutes) diary entry per week, over a period of four-months. However, despite regular 
prompts via text messaging or email, contributions were highly variable.  
Table 1a provides a summary of data collected from the case studies. Excluding set-up 
meetings, we have conducted 50 interviews (23 with KIT agents, 22 with Links and 
five line-managers), 20 observations, and received 72 audio-diary entries (6 hours 20 
minutes). This provided us with 46 hours of recorded data. 
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Table 1a: Overview of data collection for case studies 
Greenhills Riverside Moorlands Wetlands Homefields 
Agent: 
Background: 
James 
clinical 
Grace 
clinical 
Sophie 
clinical 
Amy 
clinical 
Isabelle 
non-clinical 
Fran 
clinical 
Jessica 
non-clinical 
Holly 
clinical 
Daisy 
clinical 
Erin 
non-clinical 
Janice 
clinical 
Chloe 
clinical 
Molly 
non-clinical 
Observations (n) 3 3 4 2i 1 1i 2ii 3ii 2ii 1 - - 3 
Agent interviews  
(n, mins) 2 (110) 2 (86) 2 (79) 2 (120) 1 (99) 2 (112) 4 (165)iii 3 (100)iii 2 (64)  1 (111) 1 (68) 1 (55) 2 (165) 
Line manager 
interview (n, mins) 1 (26) - 1 (56) - - - 1 (32) same LM same LM - 1 (50) - 1 (39) 
Link interviews  
(n, mins) 3 (118) 3 (135)  4 (143) 2 (79) 1 (66) 2 (107) 2 (54) 2 (57) - 2 (89) 1 (53) - - 
Audio-diary entries 
(n, mins) 10 (38) 11 (113) 4 (9) 12 (115) 5 (27) 
1 
(email: 
10 pgs) 
8 (24) 18 (21)  2 (8) - - - 2 (25) 
i
 Include 1 joint observation 
ii Includes 2 group observations 
iii
 Includes 2 paired interviews (29 minutes each) 
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Table 1b: Information on Line Managers and Links 
 
 Greenhills Riverside Moorlands Wetlands Homefields 
 James Grace Sophie Amy Isabelle Fran Jessica Holly Daisy Erin Janice Chloe Molly 
Line 
manager 
Chief 
Executive  
Chief 
Executive    Managing Director  
Senior 
Academic  
Managing 
Director 
Link  Doctor Doctor 
Lead 
Nurse 
Associate 
Medical 
Director 
Operational 
Lead Doctor 
Regional 
Lead 
Quality 
Director  Engineer 
Clinical 
teacher   
Link  Nurse Board Chair 
Lead 
Nurse 
Effectiveness 
Manager 
 
Lead 
Nurse Director 
Manager 
of Services  Director    
Link  Doctor 
Development 
Manager 
Chief 
Operating 
Officer 
          
Link    
Assistant 
Director           
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Nominal group 
Sampling 
A nominal group is a highly structured meeting of a panel of suitably experienced 
‘experts’.209 The size of the panel is typically eight to 12 experts. Our group comprised 
a purposive sample of eight people from England, Scotland and Wales. Through 
consultation with our advisory group, we identified the roles we wanted represented 
(knowledge brokers, researchers/academics, network/policy leads, information 
scientists, patient/public) and drew up a long list of potential members, informed by our 
knowledge of the field and the literature. To secure this group, we approached 28 
individuals in two main waves. We first approached 12 individuals and gained 
agreement from four. One of the 12 did not respond but all others replied and suggested 
alternatives we might contact if they could not themselves attend. In the second wave 
we invited a further 16 people; five agreed, two did not respond and the remainder gave 
apologies. All those who replied were interested but were unable to make the date 
either because of other commitments or workload. In the event, one of the nine 
expected attendees could not attend because of a hospital appointment and another was 
ill on the day. As this was an academic working in the field, we felt justified in 
including a member of the research team in the group, although this was not our 
original plan.  
Most members of the final panel of eight had dual roles. The group included three 
knowledge brokers, three researchers/academics, two network/policy leads, a senior 
information scientist and a patient and public involvement specialist. 
Data collection 
The panel took place on 10th June 2015 (10.00 to 15.30), in Cardiff and was facilitated 
by the project lead. In advance of the meeting the panel members were given 
background information. It was explained that what counts as knowledge or evidence 
can be broadly interpreted, including not only the results of research but also the 
analysis and use of an organisation’s data as well as knowledge gained from experience 
and practice. ‘Knowledge mobilisation’ was described as a term used to refer to the use 
of knowledge to develop practice and services and inform decision making. It was 
explained that the process of mobilising knowledge is not simple and linear; rather it is 
contingent on relationships and interactions. Knowledge brokers were described as 
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having an important role to play in this process. While they may include a diverse 
group of individuals (clinical and non-clinical based in various locations including 
universities, libraries, public health settings, primary and secondary care settings, 
Health Boards and Trusts), what they have in common is that they provide a two-way 
link between those who have or develop knowledge and those who use knowledge 
(practitioners). 
The steps of the nominal group process were: 
a. Silent generation of ideas in writing – The leader read aloud the question that the 
participants were to answer. This was clarified or modified as required following 
discussion. Then each participant was given a worksheet (with the question written 
at the top) and asked to take a few minutes to write his or her ideas. Discussion was 
not permitted at this point. 
b. “Round-robin” feedback of ideas – The leader asked each member to contribute one 
of his or her ideas summarized in a few words. These ideas were numbered and 
written on a flip-chart so they were visible to all members. The process continued 
until no further ideas were forthcoming. Discussion was not permitted during this 
stage. 
c. Serial discussion of ideas – Each of the ideas on the board was discussed in turn. 
The objective of this discussion was to obtain clarity and to air points of view, but 
not to resolve differences of opinion. 
d. Preliminary vote – The participants identified their top six items using a weighted 
voting system. The participants were given six voting cards (two 3-point cards; two 
2-point cards; and two 1-point cards). They select the six “most important” items 
from the total list and write these on the 3-, 2- and 1-point cards, according to the 
level of importance that they assign them (with 3 being the most important). Thus 
each participant submitted six cards; on each card was written an item number and a 
‘score’ (3-points; 2-points or 1-point). The cards were then collected and shuffled to 
maintain anonymity, and the votes read out and recorded on a tally-chart that 
showed all the items and the votes allocated to each.  
e. Discussion of preliminary vote – A brief discussion of the voting pattern was 
permitted. The purpose of the discussion was additional clarification, but pressure 
to change others’ votes was not permitted. 
f. Final vote – Step 4 was repeated.  
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Ethics and Approvals 
After seeking advice from a number of local, regional and national quarters (Cardiff 
University Research and Commercial Division and the Research Governance Officer, 
the National Institute for Social Care and Health Research –NISCHR- Clinical 
Research Centre, Aneurin Bevan R&D office and Queries NRES Health Research 
Authority), it was confirmed that the project was deemed service evaluation and 
therefore NHS research ethical approval was not required. Research ethics approval 
was then obtained from a Research Committee of Cardiff University (20/08/13) and the 
project registered on the Welsh portfolio (16/10/13; #15479). Prior to fieldwork, we 
obtained any required approvals from the AHSNs and from the Health Board for each 
of the agents in Wales. 
We prepared participant information sheets and consent forms (see Appendix 7) and 
sent these to all participants in advance of data gathering. Data were gathered in 
confidence and all individuals and places associated with the case studies were 
anonymised for analysis and presentation. 
Data Analysis 
The data from the mapping were summarised and developed into a typology of KIT 
agents which is reported in Chapter 4 and Appendix 4. The results of the nominal group 
are detailed in Chapter 7. In this section we explain the process of analysis of data from 
the case studies. The analysis of the field notes and documents, the interview transcripts 
and audio-diary data was both deductive (based on a priori coding themes) and 
inductive (emerging from the data). Data from all these sources was managed in 
Nvivo10.  
The process entailed a thematic analysis using an adapted framework analysis 
approach.209 This entailed developing a coding frame based on a priori themes derived 
from the research questions and wider literature supplemented by emergent themes 
identified through discussion with the research team and advisory group. We used 
Walker et al’s128 classification of factors influencing change as the basis of our analytic 
framework. This groups factors into four broad categories which we applied to our 
agents: context (factors in the external and internal environment); content (what 
knowledge or change was being transferred or implemented); processes (actions taken 
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by the change agents); and individual dispositions (attitudes and behaviours of agents 
and reactions to change). It would have been appropriate to adopt an alternative model 
such as the PARiHS framework.202 The overlap between these classifications has been 
shown (see page 18). As the starting point for our analysis framework, Walker et 
al.’s128 classification had utility. However, we notably extended this to include 
outcomes and impacts, conceptual definitions and descriptive codes for background and 
role. We used Kirkpatrick’s framework to report outcomes and impact in relation to 
reactions, learning gains and behaviour change. The coding frame is presented in 
Appendix 8.  
The process of data coding was undertaken by three members of the research team. To 
ensure consistent application of the coding frame, on four separate occasions we 
independently coded several pages of transcript and then compared our coding. We 
debated and agreed any variation. This led to the addition of subthemes and further 
clarification or elaboration of codes.  
The way we distributed transcripts between the coders facilitated greater sharing of the 
data such that rarely a researcher coded the interviews they had conducted. Team and 
advisory group discussion of the analysis helped to integrate themes and summarise 
findings.  
In reporting, we sought to analyse the work of individual agents, broadly within Walker 
et al’s128 classification, presenting a narrative of the agent and their work. These 
narratives draw directly from the agent and their Links’ accounts. Alongside this we 
take a broader look across agents in order to draw out general findings and implications 
for how models of knowledge mobilisation can be helped to work in future. 
Validation Processes 
We detail some of the strengths of the study in Chapter 8. Here we briefly detail the 
validation processes. Data, methodological and investigator triangulation219-221were 
achieved through the use of multiple data sources, conducting both interviews and 
observations of the agent’s work, and having at least two members of the research team 
working with each case study. These steps provided a broader understanding of the 
agents and their work. Particularly important was the voice of others who linked with 
the agents. Representing a variety of relationships and interactions with the agents these 
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key informants provided their own perspectives on the value of the work of the agents. 
The observations were an additional means of corroborating and expanding on how the 
agents saw their work. Multiple team members’ involvement in the data gathering, 
analysis and reporting of each case study also allowed the work to be viewed from 
more than one standpoint.  
Throughout the course of the project a number of mechanisms helped us to discuss, 
validate and disseminate our emergent findings. We utilised a range of opportunities to 
discuss with stakeholders including health service managers and leaders (two of whom 
were included in our research team). Data were regularly presented to and discussed 
with the advisory group (representing diverse stakeholders as described above).  
Another part of the validation process was through presentations to research workshops 
and conferences, notably the UK Knowledge Mobilisation Forum 2014 and 2015, the 
Health Services Research Network Symposium 2014 and 2015, a series of workshops 
and meetings to inform the knowledge mobilisation strategy for Wales, UHB Research 
& Development Conferences 2014 and 2015, and Fellows Connect meetings. 
At the end of the fieldwork, we offered feedback to the agents and their networks sites. 
These were taken up by two of the AHSNs (covering six agents) and the three sites in 
Wales. These meetings were discursive in nature and served to test out the validity or 
‘truthfulness’ of our findings.   
A final part of the verification process was achieved by drawing parallels with 
published studies in the field. Taken together these validation mechanisms strengthen 
the transferability of our findings. 
Caveats 
No study is perfectly designed and no research runs exactly as planned. We briefly 
review each part of the study here; a more detailed discussion of study limitations is 
provided in Chapter 8.  
We achieved our objective in the first mapping exercise and typology development on 
the basis of document review and discussion with 14 of 16 leads. Ideally we would 
have liked to have spoken to all 16.  
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Although we recruited more than the expected 10-12 case study agents for this study, 
not all participated as fully as we hoped or in the way we anticipated and the amount of 
data we have on each agent varies. Despite this, the quantity and quality of data we 
amassed made the job of systematic and thorough coding a time-consuming process. 
However, the variability means that we know more about the work of some agents and 
its effects more than others and we cannot make claims about the wider population of 
knowledge brokers. This is addressed to some extent by our process of validation which 
gives us confidence in the trustworthiness and transferability of our findings. Yet no 
research is free from bias and it is necessary to accept that analysis of interview data 
represents an account rather than observation of behaviour. We did not witness change 
in practitioners’ behaviours as a direct result of KIT agents’ activity. However, their 
accounts were largely corroborated from triangulating what agents claimed with the 
reflections of their Link interviewees and managers and our observations of events.  
From the nominal group we distilled important messages. However, the questions were 
challenging and there would be value in developing and extending the exercise to 
building on these initial findings. 
Despite enormous effort and persistence, we were unable to complete one aspect of our 
study. We planned to run action learning sets with groups of knowledge brokers. These 
were deigned partly as a means to ‘give back’ to our case study’s organisations, partly 
as a mechanism to disseminate early findings to stakeholders and partly to learn more 
about the support needs of knowledge brokers. Case study agents and those who 
participated in link interviews were invited to take part and invite others in their 
networks that they felt appropriate. Attempts were later made to a group of nurses 
engaged with knowledge mobilisation, public health staff with an interest in knowledge 
mobilisation and Research and Development leads across Wales to attend the sessions. 
Although in most respects this omission does not distract from our main findings, we 
remain disappointed that despite considerable effort and interest from potential 
participants, commitments and other pressures prevented them from engaging with the 
activity. 
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Concluding Remarks 
This chapter has presented a detailed account of our research methods in studying the 
KIT role within the context of the Academic Health Science Networks in England and 
the regional network in Wales.  With several caveats noted, we next turn to our 
findings.  
43 
 
Chapter 4. KIT Intentions across Academic Health 
Science Networks in England and a Regional Network 
in Wales 
The development of the AHSNs in England took place over several stages starting in 
2011 with the publication of “Innovation, Health and Wealth”.27 These new structures, 
tasked with supporting the identification, rapid adoption and spread of innovation and 
best practice across their regions, provided a unique opportunity to understand their 
intentions for individuals in KIT agent roles. About the same time, Academic Health 
Science Partnerships (AHSPs) were developing in Wales. Of three regional hubs across 
Wales, the first to be established was in the South East (SEWAHSP; others are in South 
West and North Wales). Their intentions are to better engage NHS organisations in the 
formulation of R&D strategies, encourage clinical participation in R&D, and to 
accelerate research and innovation transfer and mobilisation.32 
This chapter presents the results of our review of early AHSN and SEWAHSP strategy 
documents and our subsequent telephone calls with network managing directors 
regarding their intentions for individuals in KIT agent roles.  From these we present 
two snapshots in time: the first at prospectus (England) or strategy (Wales) stage and 
the second during early network development in late 2013/early 2014.   
We first provide a brief overview of the AHSN development stages to illustrate our 
study’s timing during network development (see Table 2). We then proceed to the 
results of these two reviews.  The methods for this phase are detailed in Chapter 3. 
Table 2: Timeline showing AHSN development and our study’s engagement30 
Timeline AHSN development 
Dec 2011 “Innovation, Health and Wealth” signalled a change in the innovation landscape in England, including the designation of AHSNs. 
Jun 2012 
The Department of Health invited expressions of interest from the NHS and 
partners to create AHSNs. This invitation outlined a core purpose of enabling 
the NHS and academia to work collaboratively with industry and to identify, 
adopt and spread innovation and best practice.222 
Sep 2012 AHSNs submitted their detailed network prospectus and draft business plans 
to NHS England. 
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Oct 2012 SEWAHSP Five Year Strategy launched.206 
Apr 2013 NHS England recommended that 15 AHSNs should be designated covering 
the whole of England. 
May 2013 NHS England confirmed the designation of 15 AHSNs.  
Jun – Aug 
2013 
Snapshot 1: Study team reviewed the AHSN prospectus documents and 
business plans and the SEWAHSP Five Year Strategy206 to understand their 
KIT role intentions. 
Aug 2013 All AHSNs submitted a year one business plan. 
Nov 2013 Final contracts were issued to all AHSNs for their ratification and signature in November 2013. 
Nov 2013 – 
Feb 2014 
Snapshot 2: Study team conducted interviews with network managing 
directors to understand their plans for KIT roles. 
Jan 2014 All 15 contracts returned and signed. England becomes the first country to fully implement a system of Academic Health Science Networks universally. 
Feb – Jul 
2014 Selection and confirmation of case study sites 
May 2014 – 
Aug 2015 Data collection across sites 
Results 
Snapshot 1:  intentions of networks at prospectus or strategy stage 
The AHSNs laid out their initial plans for their region in a prospectus document and 
accompanying business case in September 2012. Out of the 16 networks (15 AHSNs in 
England and an AHSP in Wales), the majority had plans in place to support KIT Agents 
or provide role support through training or buying time. The range of different 
approaches are summarised here and detailed in Appendix 4.  
Intentions for specific KIT roles 
Eight networks proposed a new or modified KIT role in the region often describing 
them as fellowships and/or secondments of various lengths, with or without protected 
time and targeting different clinical professionals, managers or academics or all three. 
The stated objectives of these schemes include: to create and build capacity and 
capability; to enable cross-fertilization between NHS, industry, voluntary sector and 
academia; and to spread innovation at the local level and to build an evaluation and 
learning culture.  
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Intentions for KIT role support 
Four proposed the development of a network supporting service improvement leads or 
change practitioners through training programmes or buying staff time. One network 
proposed both a specific KIT role and role support through communities of practice.  
Looking across both types of KIT intentions – fellowship-like or network-like 
approaches - the following features were noted: 
• Content: The majority proposed a focus on improvement. Specific content areas 
included innovation, leadership, evaluation, change management, knowledge 
mobilisation and knowledge translation. We noted that several networks use more 
than one content area in their description and it is likely that the differing level of 
detail makes it difficult to discern what is included within the broad terms used. 
• Regional assets: several networks focus on building on their region’s existing 
structures, including working with local universities as well as NIHR bodies such 
as CLAHRCS and AHSCs. 
Leveraging existing staff  
Three of the 16 networks did not describe specific KIT roles. Two of these focused on 
leveraging the skills of existing staff but it was unclear what support would be offered. 
The other network in this category deflected KIT role support to other organisations, 
for example an NIHR body in the region had the remit to expand the research active 
community and an educational body led clinical improvement training.  
Snapshot 2: Intentions of each network as described by their leaders 
We interviewed fourteen representatives of the sixteen networks to understand how 
their intentions for KIT roles were developing from the original prospectus.  At this 
stage a number of general observations were made about the networks: 
• They were at different stages of development. For example, this ranged from 
senior management teams in post with over 50 active projects to still recruiting for 
senior roles and agreeing priorities.   
• They started with different existing structures. This ranged from establishing 
completely new structures to inherited projects and staff from old structures (for 
example from HIECs and CLAHRCs). One interviewee commented “We have 
spent the last five years building relationships”. 
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• They had unique operational models. For example, models included: core 
network team providing central support along agreed themes; separate 
organisational entity working alongside partners; regional teams specialising in 
different aspects of the network’s clinical themes. 
• As a result of these differences, the operational challenges also differed. For 
example, some were challenged by the sheer size of their geographical footprint, 
others by trying to create partnerships where none had existed before, yet others by 
one dominant organisation within the network. 
• However, the core objective to drive improvement through innovation was 
common across all and the influence of the growth agenda was common across all 
sites in England. 
Role types 
Different types of KIT agent roles were identified across the networks.  Roles varied 
across a number of dimensions including how the agent would be supported by the 
network, duration of the role and percentage of time spent on the role, number of agents 
in each organisation and whether the role was focused on research and data gathering or 
the implementation of research findings. Other features included whether the role was 
aimed at clinicians, managers, or both; the primary location – NHS, university, 
industry; and the focus of the strategy delivered through the role – health or wealth or 
both. We also noted variation in relation to proposed training for agents: in knowledge 
brokering or improvement methodology; bespoke or à la carte. The various roles are 
summarised in Table 3 and we note that a number of networks proposed more than one 
type of role.  
We note that fellowship or secondment roles and network building activity were still 
the main strategies for supporting KIT roles during early network formation. However, 
we found that most networks “have moved on from the prospectus” (Managing 
Director, Network 750) focusing more on working with local organisations to deliver 
joint KIT support and less on introducing new training or protecting time. We also note 
the emergence of roles that are described as operational leaders with specific duties 
around promoting improvement and innovation. These differ from fellowships as they 
are seen as more permanent members of the network team.  Many network leaders 
describe these changes as a response to a funding shortfall and central policy changes.  
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Table 3: Summary of roles proposed 
KIT role type 
Roles 
[number of networks proposing 
role if more than one] 
Key features 
Roles with protected 
time and specific 
training programme 
Trust innovation lead                 
[3 networks] 
Nominated senior-level individual by organisation in network to receive 
training in improvement methods, leadership, strategy, data analysis, and 
other areas. This will create a community of practice and they will endeavour 
to provide network support.   
Service improvement fellows Working with local CLAHRC to make their fellowship programme more 
widely available. 
Local Education and Training 
Board (LETB)-funded 
professional fellowships 
Fellows receive training through a regional centre for evidence-based practice 
leading to a two-year MSc or three-year PhD plus additional support for a 
year to embed into the organisation.  
Roles with protected 
time but individually 
determined training 
Improvement Fellows 
Fellows based in partner organisations but supported for a specific period of 
time to work with the network core team on improvement project. They 
would be provided with peer support, IHI resources, data from local NHS 
providers and stable employment during the fellowship. 
Evaluation fellowships              
[2 networks] 
Fellows jointly supported by AHSN and Local Education and Training 
Board. Fellowships for clinicians to act as knowledge leaders.   
Secondments 
Industry secondment 
One post to be filled by an experienced manager from industry to deliver a 
number of clinical projects for the network. The post-holder was expected to 
work between primary and secondary care to broker change. 
Commissioner secondment 
Three senior commissioners seconded one-day-a-week to local universities 
to: bring NHS thinking to research, help academia develop network of ideas 
and contacts; learn about academic rigor, research & evaluation processes.  
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KIT role type 
Roles 
[number of networks proposing 
role if more than one] 
Key features 
Operational lead with 
knowledge role 
Operational directors 
Masters-level qualified ‘academic managers’ who can operate in both a 
university and hospital setting. Expected to seek grant income but rewarded 
with job security. 
Executive-level leads 
One lead per partner trust to have a role in locating innovations and 
presenting these to the network board. They would be provided with regional 
training. 
Programme managers/Hub team 
[2 networks] 
The network’s core team to provide objectivity and independence to advance 
projects. The core team comprises content experts and methodologists in data 
analysis, change management, and so forth. The methodologists will help to 
develop skills of individuals working in partner organisations. 
Champions Translators/Local champions    [2 networks] 
Innovation and research translation champions based in partner organisations 
and connecting with the network hub and national initiatives. Funding for 
their time will come from the partner organisation, not the network. 
Project-specific staff 
Clinical and management project 
leads 
[2 networks ] 
Frontline clinicians and managers to implement innovations in practice. The 
agents will provide support on a project-by-project basis. Funding for their 
time will come from the partner organisation, not the network. They may 
receive additional training or protected time depending on the project. 
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Role typology 
Based on the findings from the review of the network intentions and the discussions 
with managing directors and alternates, we developed our classifications into a general 
typology of KIT roles. These ideal-types are presented in Table 4.  We then plotted 
these ideal-types along a set of features related to: level of support or training; role 
duration; full or part-time; numbers in post; and extent of focus on research or 
implementation (Table 5).  
Table 4: Typology of KIT agent roles with illustrative examples 
Type Example 
Type 1: ‘Dedicated KIT Fellow’ 
Dedicated knowledge-broker role with 
formal capabilities training 
Fellows nominated by each partner organisation 
in network receive training in support of 
becoming a KIT lead.  
Type 2: ‘Dedicated KIT Lead’ Dedicated 
knowledge-broker role with mentoring 
support 
Transformational leads have access to peer 
network and core team with skills in evaluation 
and improvement methodology. For example, 
improvement fellows. 
Type 3a: ‘KIT within research role’ 
Service evaluator which includes KT 
role 
Select group of academically-oriented 
evaluators/researchers working on service change 
projects.  
Type 3b: ‘KIT within role’ 
Operational leadership with 
supported/informal knowledge role 
Select group of academically-oriented managers 
working on high-level service change projects 
(e.g. integration of services between primary and 
secondary care). 
Type 4a: ‘Project programme 
implementer’ 
Implementers on a project-basis: 
integrated projects 
AHSN core team identifies and manages an 
integrated programme of projects and works 
alongside staff in partner organisations to roll out. 
Staff may be supported through other 
organisations (such as Strategic Clinical 
Networks). 
Type 4b: ‘Project implementer’ 
Implementers on a project-basis: series 
of projects 
AHSN core team selects and manages a series of 
projects and works alongside staff in partner 
organisations to roll out, typically involved at the 
end of the project.  
Type 5: ‘Hobby project champion’ 
Informal project champions 
Clinician with ‘hobby project’ supported to 
develop their improvement/innovation and roll 
out to region. 
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Table 5: A mapping of KIT Agent ideal-types against role features 
High level of training provided Low level of training provided 
Dedicated KIT 
Fellow 
Dedicated KIT 
lead 
KIT within 
research role KIT within role 
Programme 
implementer 
Project 
implementer 
Hobby project 
champion 
Short duration of role Long duration of role 
Project 
implementer 
KIT within 
research role 
Dedicated KIT 
Fellow 
Hobby project 
champion Dedicated KIT lead 
Programme 
implementer KIT within role 
Part-time KIT role Full-time 
KIT within role Hobby project 
champion 
KIT within 
research role 
Project 
implementer 
Programme 
implementer Dedicated KIT lead 
Dedicated KIT 
Fellow 
Low numbers in post High numbers in post 
Dedicated KIT 
Fellow 
Dedicated KIT 
lead 
KIT within 
research role 
Programme 
implementer KIT within role 
Project 
implementer 
Hobby project 
champion 
Research focused role Implementation (adoption) focused role 
KIT within 
research role 
Dedicated KIT 
lead 
Hobby project 
champion 
Project 
implementer 
Programme 
implementer KIT within role 
Dedicated KIT 
Fellow 
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Case study sites 
Our case study site selection was informed by the mapping exercise described in this 
chapter. Specifically, five networks were selected from the range of planned KIT roles 
described in the typology in Table 4 and also the different stages of network 
development (i.e. from a de novo network to an established partnership in research and 
innovation). The features of the five selected networks and their proposed KIT roles are 
summarised in Table 6. 
Table 6: Features of the five networks from which case study KIT Agents were selected 
Stage of 
network 
development 
Types of KIT roles 
(from typology 
presented in Table 4) 
Regional 
infrastructure 
Network 
operational 
models & 
challenges 
Network approach to 
innovation/wealth 
creation 
de novo 
network 
Type 1: Dedicated 
KIT Fellow 
developed  
Type 2: Dedicated 
KIT Lead funded by 
network 
 
Integrated 
clinical research 
infrastructure 
Partners have 
had to work 
together in the 
past 
Main areas of activity will 
focus on the introduction 
of innovations into the 
NHS and innovations 
deriving from within the 
NHS and the facilitation 
of clinical trials. 
Established 
network with 
developed 
relationships 
with partners 
Type 2: dedicated 
KIT lead 
Type 3b: KIT within 
Role - operational 
leaders/academic 
managers 
Integrated 
CLAHRC, 
research 
networks, 
education and 
training 
Network 
working 
alongside 
partners 
Wealth creation applied 
across work 
Early in terms 
of structures 
but 
relationships 
are developed 
Type 3b: KIT within 
Role - core team has 
KIT roles; and 
innovation 
ambassadors 
Type 4b: Project 
Implementers on 
specific projects 
Type 5: Hobby 
Project Champions - 
clinical  
Well 
established 
CLAHRC 
 
Developing a 
regional centre 
for innovation 
and best 
practice 
Large 
geographical 
footprint with 
a couple of 
dominant 
players 
Network core team roles 
to link with industry 
Several 
projects 
underway and 
some staff in 
posts 
Type 3a: KIT within 
Research Role 
Type 4a: Project 
Programme 
Implementers  
Existing 
infrastructure 
not mapped to 
network region. 
Large, diverse 
region with 
core team 
being 
established 
Enterprise and investment 
is core work-stream 
Newly 
established 
structures 
with several 
projects 
underway 
Type 3b: KIT within 
Role - core team has 
KIT roles  
Type 4b: Project 
Implementers on 
specific projects 
Network 
connected with 
clinical research 
infrastructure. 
Creating new 
collaborations. 
Funding 
challenges 
Enterprise and investment 
is core work-stream 
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Concluding Remarks 
Two detailed snapshots have been presented in this chapter and Appendix 4 to address 
our project’s objective to map the KIT intentions of the networks. We have described 
KIT agent proposals including number and types of roles as well as main features and 
existing structures to support roles. This stage served as our sampling frame for case 
study selection as well as provided us with a starting point for understanding start-up 
conditions and the local context of the different network. 
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Chapter 5. The Case Studies 
We provide here short descriptions of each of the 13 case study KIT agents, their role 
and characteristics (dispositions), the context in which they worked, their focus 
(content),activities (processes) and who they work with (clients), and reported 
outcomes (using Kirkpatrick’s199 organisation of  reactions, learning, behaviour and 
results). This information is summarised in Table 7 at the end of this chapter and 
Chapter 6 provides a cross-case presentation of the findings. 
James 
The Agent 
James led a relatively new unit designed to improve services by supporting staff 
through the use of improvement methodologies, making space for innovation, and 
bringing organisations and people together to and, in the terms of their website, “co-
creating solutions”. A medical consultant by background, with significant experience in 
management and leadership roles, he directed the unit on a part time basis. He was 
viewed by colleagues as a robust and charismatic leader who, in his own words, was 
prepared to cause “constructive disturbance” and be the “grit” in the system. Near to 
retirement, James saw the importance of building trusting relationships and viewed his 
role primarily as: supporting co-production, helping people to feel valued, enabling 
them to take ownership and to “grow their own stuff”. His skills were complemented by 
his team who were recruited for their expertise in areas such as leadership, change 
management and patient safety.    
Context 
Although James characterised the internal organisational context as one of high level 
support from the Executive Team, he nevertheless felt pressure to demonstrate worth. 
Other challenges included handling territory sensitivities in relation to who provides 
change management training and, not alienating staff wary of change. In contrast, 
however, he also described parts of the organisation as ‘open’ and ‘healthy’ as 
demonstrated by two teams agreeing to his observing them. James also alluded to 
challenges arising from the changing external context: 
James: Demand has changed…. A&Es were built for 25 year olds with broken legs. 
The demand is now 85 year olds with six conditions, dementia and frailty. A&E is a 
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terrible place for them: no matter how you describe it, it is never going to work for 
these people. Or technology changes: well we used to do that with surgery, now we 
can do it with drugs. Or economics have changed: we used to have a million pounds 
to spend on this now we’ve only £750,000.  So all those things tell you that 
improving is not going to deliver. 
Content 
James worked across various clinical and non-clinical work streams, including waiting 
lists and care in the community. This often involved cross-organisational working, for 
example, with primary care, the local authority, charities and universities. 
Activities 
James deemed the leadership training was the most important part of his and the unit’s 
work. The unit also provided staff training in QI methods. Other activities related to 
brokering meetings between organisations for developing improvement projects. James 
repeatedly highlighted the importance of bringing people together to discuss solutions 
to problems. An innovative element of their approach was the application of 
mathematical modelling.  
Clients 
James worked with clinical leaders and managers in his senior-level role but also linked 
with others external to his organisation including patients. 
Outcomes  
James described how his initial attempt at developing an improvement culture “created 
a bit of hostility”. He revised his approach and talked about simply “having a 
conversation” avoiding others feeling intimidated by the consequences. 
Learning outcomes arose from leadership and QI training. James thought that the 
leadership training was “really nurturing a new breed of leaders”.   
Changed behaviour was also linked to James’ work. He was seen as pivotal in 
challenging “silo” thinking and working. One Link interviewee described his changed 
thinking thus: 
James Link: Other people that are not working… in your field of practice… 
actually when you talk to them … they’ve got the wider vision, if you like, of the 
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whole organisation…  So I could be quite silo-ed really in dealing with older people, 
but it makes me think, well, what I’m doing for the older people now can actually be 
transferred to mental health services. 
Tangible results from James’ work included joint research proposals, awards and QI 
projects linked to staff training. QI training was being embedded into appraisal systems, 
a step described by James as a mechanism for building capacity and critical mass. This 
was increasing the numbers of people engaging in projects which in turn was leading to 
desired cultural change in the organisation. Although in the timescale of the research 
we cannot demonstrate the impact of James and his unit’s work, he felt they were 
making strides in the right direction: 
James: When I started this off I interviewed all the Execs and they all said, ‘…. but 
it will feel different, the organisation’ and, it does now.  How much of that is related 
to us, how much of it isn’t, I don’t know. … And others are now looking to us to 
emulate the same thing. 
Grace 
The Agent  
Grace headed up a unit with a remit for improvement programmes and innovation. 
Clinically trained as a nurse, she had held a variety of roles in research and nurse 
education and had developed a very strong network of contacts in the region as well as 
internationally. She had received training in IHI methodologies and held an MBA. Her 
job was concerned with nurturing, guiding and developing clinical innovation and 
encouraging linkage. Grace explained that to develop trust and set up the conditions for 
learning she needed to ensure that her approach was transparent, open and encouraged 
sharing. She was known for her “personal skills to make things happen and to bring 
people with her” and “resilience” to cope with obstacles (Link interviewee). Another 
Link described her hard working approach and passion: “I know Grace is here till way 
past she should be in the evening… Grace is passionate. She believes in the cause”. 
Context 
Grace worked within a large NHS organisation located on the same site as a Medical 
School. At the time of the study she was seeking a better physical home for the unit. 
Grace’s response to Greenhills-wide initiatives, such as the high profile patient flow 
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programme, was similar to James: she saw them as both a challenge and an asset. She 
had experienced some difficulties engaging with some members of the collaborative. 
Content 
She described her focus as on problems “that matter to patients”. Examples included: 
electronic handovers, debriefing, the transforming theatres and scheduling programme, 
modernising health records, use of diagnostics, and patient pathways. 
Activities  
One of Grace’s chief activities was creating linkages and brokering relationships. One 
Link described her as a “key facilitator, gate keeper to the right people and the right 
departments and the right projects”.  The role included information sharing and 
maximizing “clinical innovation”. One Link reported, “Grace’s been very good at 
inviting me to various talks and every time I give a talk, people go ‘it’s amazing… why 
aren’t we doing more of this?’” Grace and her team tried “to bridge the gap” between 
the NHS organisation and the university “and move from translation to transformation”. 
She supported staff in developing and progressing their ideas: “through to business 
cases, contracts, and negotiating intellectual property, patents copyrights and all those 
good things” (Grace). Another Link also described how she helped write funding 
applications and got letters of support. 
Grace had established faculty meetings where quality and safety improvement projects 
were shared. The meetings brought together people from “research, education, clinical 
innovation, improvement, service delivery all in one room” and provided a network for 
those pursuing higher QI training. She herself was involved in providing improvement 
training to clinical teams and staff although she sought to focus increasingly on the 
strategic mandate - embedding an improvement culture in the organisation - rather than 
actually doing the improvement projects. 
A regular conference speaker, she engaged internationally with visits to or visitors from 
Sweden and the US, for example. She presented on “the pragmatic approach to 
implementation and also the learning and the experience of our group” (audio-diary).  
Clients 
Grace worked to bring together clinicians, academics and external stake holders (such 
as industry and the voluntary sector) with a view to solving problems.  
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Outcomes  
Reactions were generally positive. Her narrative about her work with a group of junior 
doctors working on improvement projects expresses their enthusiasm and the energy 
they created: 
Grace: We were all completely inspired by the positivity and the energy that was in 
the room. I had a couple of emails from some of the junior doctors afterwards, all 
fired up… 
One form of tangible learning arose from the QI projects. She reported that “to date we 
have about 100 people who have gone through the second level of the programme”. She 
thought that capacity development was contributing to “sustainable change across the 
organisation”. The development of the QI faculty was described by a Link interviewee 
as one of her “greatest achievements”. In terms of results, one project, the placement of 
nasogastric tubes had “significantly reduced the number of x-rays that patients were 
unnecessarily enduring” (audio-diary) and had led to an award for the work.  Another 
result related to bidding for and securing funding. She had had success with the Health 
Foundation, for example. 
Sophie 
The Agent  
Sophie started her career in a frontline clinical role and, following completion of 
healthcare management and leadership courses, worked her way up to a regional 
management position. She was well-known locally and had a wide-ranging knowledge 
of the organisation. At the time of interviewing, Sophie had been leading on all aspects 
of unscheduled care for two-and-a-half years. She reported directly to the Chief 
Operating Officer. After 18 months in the position, she took on an improvement role 
addressing patient flow and length of stay. This part of her role initially took all her 
time but after a year it had reduced to about 75% and was declining further. 
She was described by Link interviewees as “responsive”, “tenacious” and a problem-
solving, “can-do” person. While Sophie thought she was not good with the “softer”, 
“touchy-feely” side of management, a Link interviewee described her supportive side: 
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Link: When things aren’t going well, she will tell you and she would expect 
something to be done about it, but equally she’s highly complementary and 
supportive, very supportive. 
Context 
The organisation in which Sophie was based serves a culturally and economically 
diverse population of 300,000 and employed over 8,000 staff members. Problems 
pertinent to Sophie’s work included those arising from patients crossing authority 
boundaries and getting patients discharged into care homes. Despite this, emphasis on 
patient benefit provided a common motivator across organisations in the patch: 
“although the cultures are different across the organisations, they all want to do the best 
for their patients” (Sophie). She was well supported by her line-manager who was in a 
senior position. 
Content 
The need for an improvement programme was prompted by a crisis in service delivery 
arising from high occupancy and delays in the system. Sophie’s focus was streamlining 
patient flow. 
Activities  
Sophie’s work addressed unscheduled care and patient flow in two district general and 
three community hospitals across the regionSophie also mentored a clinician on 
secondment who supported the patient flow work.  
Sophie was very hands-on: she held twice daily meetings with nursing teams at the two 
general hospitals, regular in-depth meetings with ward managers and the wider multi-
disciplinary team, and weekly ward “walk-arounds” where she spoke to staff and 
patients. She observed, “I’m in the thick of it with them. So I’m not a distant leader of 
this change I suppose”. She was in the process of gradually withdrawing to let the 
Heads of Nursing run the process and she was looking for suitable people to help with 
the role in the future.  
At a team/management level Sophie gathered, brokered and disseminated information 
about performance from departments in an effort to challenge the culture around delays, 
encouraging them to be seen as “everybody’s responsibility”. Through sharing data she 
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hoped to minimise silo working and increase openness and visibility of performance – 
both good and bad. 
She also shared relevant literature, including from outside healthcare (for example from 
business). Outside the organisation, Sophie regularly presented the organisation’s 
achievements at conferences and national programme events.  
Clients 
She linked with all tiers of medical staff at these hospitals, liaising with departmental 
managers, clinicians and nurses and other frontline staff.  Sophie also linked with 
colleagues in other regions to manage patient flow. 
Outcomes 
Link interviewees valued Sophie as a sounding board and felt comfortable discussing 
options and decisions: 
Link: We work in a very stressful environment and … it’s highly valuable to have 
somebody that you feel comfortable approaching to get advice and somebody to just 
listen to you and she will help you to make your decisions really. 
Through Sophie, departments learned about each other’s performance. This had the 
effect of challenging the status quo: “It’s just challenging traditional practice, you 
know, historic practice and say ‘why do you do it like that?’”(Link). 
She was instrumental in creating a more target-driven atmosphere in which 
departmental performance levels were set and outcomes displayed on the intranet. 
Sophie met with teams regularly to review targets and set new challenges. She gave an 
example related to wait times: if the department meets a 12-hour target, they might be 
set the challenge of trying to average an eight hour target the following month. As a 
result, tangible service improvements were noted in several departments; ambulance 
handover delays were reduced from “hundreds of hours delayed a month” to fifty hours 
and surgery cancellations were greatly reduced.  
Amy 
The Agent  
A nurse by background, Amy was on a one-year secondment, working across patient 
safety projects but majoring on a specific sepsis project. She also facilitated several QI 
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projects with partner organisations. One Link commented how Amy is “very active, 
very involved” and had been “visible on the shop floor”. The Agent was known as a 
good communicator, both verbally and in writing. 
Context 
Riverside covers a large urban area known for medical discovery, healthcare innovation 
and education, yet also containing many socio-economically deprived communities. At 
the network-level, there was considerable variability within the partner organisations in 
terms of supportiveness. Other challenges included lack of resources to free up 
clinician’s time for improvement work and agents reported apparent confusion about 
overlapping mandates related to QI: 
Amy: It’s become quite apparent that there are quite a few groups in the hospital 
whose job is QI - like clinical effectiveness, like quality improvement, safety patient 
groups, and what is everybody doing? They’re not joined up.  
Amy described the immediate working environment as supportive. The three case study 
agents in Riverside used informal mechanisms from outside their department or line-
manager to make connections across the network and facilitate cross-fertilisation of 
ideas. 
Content 
Amy led an Authority-wide QI project on sepsis. 
Activities  
She applied IHI quality improvement methods and a large part of her role involved 
improving measurement, specifically how data were collected, shared and applied to 
inform practice within the Health Authority. Amy worked with the Information Team 
to “build mortality tracking software” This enabled staff to look at their own data in 
real-time. 
Amy was building capacity in the organisation by training and mentoring frontline 
clinicians in QI methods. This included delivering QI courses in various forms, leading 
learning sets, educating foundation doctors on sepsis during induction sessions and 
leading on training-the-trainer QI sessions. The mentoring involved regular meetings to 
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discuss challenges, measurement approaches and QI tools and provide direct support, 
where needed. 
Amy also took on other duties including supporting the development of a Health 
Foundation bid and helping to coordinate a site visit for an international delegation.  
This aspect of the role helped to ensure that she was “taking some of the shared 
learning from one partner to another”. 
Clients 
Amy worked with frontline clinicians in her knowledge brokering role. 
Outcomes  
In relation specifically to the sepsis QI project, initially there was some negativity and 
resistance to the methods and approaches proposed as well as on selected measures 
from which to judge improvements. Unwilling to engage with the data presented, 
reactions from some senior clinicians had been defensive. 
Despite this, others spoke of learning gains and a different way of thinking: 
Link: They’ve [Amy and the team] given us some really good feedback around what 
we need to be doing - how we can achieve our goal, how to approach things. … 
They’ve kept us on a track… How it’s changed now is that the teams are really 
starting to think about using the QI methodology 
The organisation had become more data driven, helped by the mortality tracking 
software which had contributed to driving improvement. She had been instrumental in 
improving processes around measuring and generating real time data for sepsis.    
Isabelle 
The Agent  
Isabelle had a policy background and after spending several years as both an in- and 
out-patient now worked to improve patient engagement. She held two part-time jobs 
but treated them both as full-time and admitted to working long hours to keep on top of 
both portfolios of work. Her KIT role was described as match-making across the 
network in terms of linking patients with those working clinically in a specific field and 
facilitating the involvement process. One Link thought that her personality, networking 
and influencing skills all contributed to her success in this role.   
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Context 
Isabelle worked at Riverside alongside Amy. 
Content 
Isabelle’s main activity was to build on the insights gained from public engagement. 
She worked with people to help them make good use of the date that they had acquired.  
Activities  
Her role was facilitatory; she built relationships, connected people and provided advice 
on involving patients.   
Link: I use her as a network…  So actually, you know, I need X group of patients. 
How do I get them? She’s quite inked in to all of those things….  It saves me thinking 
about it. 
Isabelle reported spending the first few months in the role working out what currently 
happened around patient and public involvement in the network and building 
connections with key individuals. One Link described it as a “huge mapping exercise… 
across Riverside, nationally, globally”.  
There was also a training and mentoring element to Isabelle’s work in order to build 
capacity for engagement. She was involved in planning both internal and external-
facing events for the network related to patient involvement and contributed to bi-
monthly webinars. 
Clients 
Isabelle’s matchmaking role meant she worked directly with patient groups, patient 
engagement leads and clinicians to improve patient engagement. 
Outcomes  
From her experiences of working with patient groups, reactions had been both negative 
(disruptive individuals with an agenda, difficult to recruit and engage) and positive 
(good access to people, worked well). Feedback on the learning set was said by Isabelle 
to be “overwhelmingly positive”. 
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She had developed learning about PPI involvement and was known to “get people to 
think differently” (Link).  She had created learning communities, both online and in 
person, and learning sets. 
In terms of tangible results, Isabelle, working with collaborators, had won an award at 
an ‘emerging leaders’ competition. Partner agencies had advanced their patient 
engagement strategies; for example, one had a patient and public engagement strategy. 
A notable ‘movement’ around patient involvement could be detected by Links:  
Link: What’s happened is people have gone, ‘wow!’ “What an energising, exciting 
opportunity. We want to maintain this…. 
Fran 
The Agent  
Fran was a trainee doctor on a one-year fellowship pursuing her interest in management 
and QI. For the latter part of her fellowship she worked part-time. She reported to the 
Medical Director. Fran was credited with getting initiatives off the ground through her 
“enthusiasm” and “commitment” and by understanding the challenges of working on 
the frontline. She was also approachable and diplomatic:  
Link: very, very, very nice. So she’s very approachable and she is really good at 
not… treading on anyone’s toes.  So she went about it in a really delicate way. 
Context 
Fran worked at Riverside alongside Amy and Isabelle. She described the work 
environment as supportive, where “everyone who works there is really passionate and 
enthusiastic” and “is really encouraging you”.   
Content 
Fran’s focus was on facilitating QI across a number of clinical areas. Examples 
included: treatment escalation plans; falls prevention; patient safety; and prescriptions 
at hospital discharge. 
Activities  
Her main activity was supporting clinicians in their own QI initiatives: 
Fran: So I’ve been doing a lot of work with frontline staff trying to get them to do 
quality improvement. So that’s for all junior doctors, non-medical allied health 
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professionals. So I’m coaching them through smaller projects that they’re 
undertaking. 
One Link interviewee explained how Fran had really helped her to progress her project, 
in part because of her understanding of the clinical setting: 
Link: in a way, it’s sort of access to supervision for me because she just asks the 
right questions… which is a luxury because nurses don’t get supervision. 
She taught QI methods, adapted QI training material for local audiences and 
professional groups as well as trained others to deliver courses after her departure. Over 
the course of the year, her role had shifted from supporting all the QI projects 
throughout the hospital to doing little direct support. That job had been taken on by 
Wendy in the Clinical Effectiveness Unit. 
She facilitated linkages, notably putting junior doctors in touch with a “tower block full 
of patient safety officers, the Board, the audit team or the Quality people”. She 
identified a notable achievement as “making sure we had buy-in from the Exec Team 
and getting them to Board meetings”. 
Links described how Fran helped them become more aware of how and where to 
disseminate their QI projects:  
Link: So she’s really good at making you aware of what you can do with your 
quality improvement work. I didn’t even know that you could publish it or I didn’t 
know that, you know, there would be events at other hospitals where people would 
discuss it, and she’s kind of like opened my eyes. 
Fran had suggested that the Link should present her work at a regional event. She did, 
and won an award. 
The Agent also picked up a number of tasks that she described as “ad hoc”. Examples 
included writing up a proforma for a team to adapt, developing elearning on QI and 
looking up evidence in the literature.  Fran also contributed to the development of the 
improvement advisor role within the network and set up a regional Falls Forum. 
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Clients 
Fran primarily connected with frontline clinicians in her role as well as facilitating 
linkages between these clinicians and hospital leaders (for example Executive and 
Board teams), as needed on a specific QI project. 
Outcomes  
Disinterest was an initial reaction from some: she commented, “I was trying to coax 
them into using the improvement methodology… and … nobody was really that 
interested in… taking on that approach”.  
Those she did work with developed learning in QI methods. Fran also spoke of her 
personal learning which included better knowledge of hospital systems: 
Fran: I think I understand structures of hospitals so much better - who does what - 
in a non-clinical sense actually more than clinical…. I’ve learnt a lot about not 
being a doctor in sort of knowing what other people do with their time. 
Fran’s role in training and mentoring frontline clinicians was credited with helping to 
drive projects further and faster, reaching outside the organisation through wider 
dissemination and to creating change in the individuals themselves.  
Tangible results included those she had helped winning awards and one trainee gained a 
QI fellowship based on the training provided by Fran. S/he stated that “the Fellowship 
wouldn’t have happened without her influence”.  
Jessica 
The Agent  
Jessica was a practice-facing academic who worked between commissioners and 
researchers and created linkages between academics and practitioners. She had a long 
history of working on the region’s KIT strategy in the CLAHRC and now provided 
senior oversight of the organisation’s evidence review and evaluation work. For Jessica, 
the importance of context meant that it was not possible to simply apply KIT templates 
in a formulaic fashion. She described her role as fostering knowledge interaction and 
implementation and supporting knowledge agents.  
Jessica was pragmatic and perceptive. One thing she found challenging was the lack of 
organisational affiliation and not having a practitioner background.   
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Context 
Moorlands covers a large geographical area with local variation in terms of 
demographics, political situations and drivers. The region had CLAHRC funding over 
2008-2013 but the network was relatively new at the time of the research. Projects were 
carried out across the region, in collaboration with a range of organisations, although 
relationships with industry were thought by the case study Agents to be less well 
developed.  
The KIT Agents in Moorlands had relative autonomy to manage their roles within the 
context of national drivers and network guidelines. Although Moorlands cultivated a 
collaborative environment, the pressure to deliver was palpable. Faced with changing 
political drivers, funding uncertainty and organisational reconfiguration, a general lack 
of stability in the region was noted by the Agents and influenced their thinking (i.e. 
only taking on projects that could be accomplished within a relatively short period). 
The Agents’ line-manager highlighted this uncertainty and emphasised the importance 
of demonstrating their contribution to improved patient care:  
Line-manager: We’ve got to be able to demonstrate that we are a resource in 
support of improved patient care in partnership with our members, but I think it 
could all come to a crashing halt if we don’t do that. So I think this next period is 
critical.  In terms of sustainability… I think the future is uncertain. 
Moorlands was transparent about its workings, posting on its website information about 
how projects were selected and commissioned and publishing outputs of recent 
projects. 
Similar to other regions across the UK, the challenge of freeing up time from clinical or 
managerial roles to work on implementation was noted: 
Line-manager: The hindrance is the extraordinary pressure under which the NHS 
is operating and the inability to lift one’s head in a senior management capacity 
above the parapet or as a middle management capacity. So it is the pure pragmatics 
of finding either the intellectual or physical capacity to implement change.  
A further challenge was noted by Jessica who reported how eligibility restrictions 
caused problems when recruiting to roles that cross NHS/academic boundaries.  
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Content 
A primary focus of Jessica’s work was commissioned and client-focused evidence-
based reviews. 
Activities  
Her role involved both the dissemination of specialist knowledge to practitioner 
collaborators as well as the sharing of tacit knowledge about the NHS environment with 
researchers which helped them to gain access to NHS sites and recruitment participants. 
She had also contributed to the development of an integrated clinical academic pathway 
for a cohort of Masters and doctoral students who sought to develop a clinical academic 
career.  
Jessica also provided support for others working in KIT roles. She counselled them 
about the problems they encountered and helped them to manage expectations. She 
encouraged other agents to adopt more reflective implementation practices.  
Clients 
Leading on evidence review and evaluation, Jessica worked with practitioners and 
academics. 
Outcomes  
Discussing the theoretical or more academic side of implementation with practitioners 
could sometimes be met with resistance: “unless you’re really lucky, the minute you 
start talking about the social science or theory of implementation it’s just like you can 
see like kind of the barriers go up”. 
The evidence reviews were well received and informed future practice:  
Link:  They have been excellent in producing the report for us in a relatively short 
period of time. … and making sure that actually it would be a helpful product for us.  
Jessica expected her work to shift thinking and work practices: 
Jessica: If I’m doing my job properly they start talking about implementation, 
knowledge brokers and community of practice and it just becomes the norm to them. 
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Holly 
The Agent  
Holly had a nursing background and had held director-level positions within her 
profession so was well-known and respected within the region. She worked one-day-a-
week as a KIT agent and the remaining time in one of Moorlands’ partner 
organisations. She was on the organisation’s executive group responsible for clinical 
programmes and provided the link between the board and what was happening at the 
coalface. 
The Agent’s communication skills, in what could sometimes be a difficult role 
(managing expectations with partners and promoting the Moorland’s work to external 
organisations) were highlighted by her line-manager. The benefit of successful 
implementation for patients was her key driver: “ultimately we want to just get this into 
practice for patients”. 
Context 
Holly worked in Moorlands alongside Jessica. One of her main challenges was getting 
practitioners to take time out of their clinical roles to engage in research and 
implementation. Other challenges arose from system reconfigurations and turnover of 
senior level staff; relationships had to be rebuilt and alliances re-established – “You’ve 
got people on side and then the next minute they’ve gone” (Holly). 
Content 
She summarised what she thought the clinical professionals wanted: “they just want the 
practical help, you know… ‘It all sounds marvellous - how can we get these into 
practice to improve patient safety?’ That’s what they want to know”.  
Activities  
Engaging with senior leaders and managers was a significant part of her role. Oversight 
of various network projects took up half her time. This entailed early identification and 
resolution of issues. If a project encountered a delay then Holly convened a meeting 
with the project manager, the principal investigator and the practitioners involved. For 
the other part of her role, Holly provided a link between NHS and academia. Through 
presentations and meetings, she brokered the benefits of using the network to both the 
clinical and academic sectors. She explained that the aim of these meetings was to 
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“procure relationships and establish contacts with senior teams across the partner 
organisations”. Through her project management and linkage work, Holly was able to 
suggest personalised, appropriate contacts for people. 
Her approach highlighted the need for organisations to be “on board” and supportive of 
new interventions and innovations.  
Holly: … more of the same is not the answer. We need to create a sustainable NHS 
and part of the way that we do that is to innovate and adopt and spread, and 
actually through coming on board with us and supporting implementation of new 
interventions.  
Other activities included working with a colleague in a consultancy role to create a set 
of priorities for the region, focused on local pressure areas. She had also developed a 
brochure on capacity building opportunities for organisations: “the short courses that 
we offer, research exchange placements, knowledge broker roles, PhD opportunities”. 
Clients 
Holly’s knowledge brokering role involved working with senior leaders and managers 
in NHS organisations and often connected these individuals with academics. 
Outcomes  
Holly’s line-manager noted that people were responsive to the brochure and other 
information/materials that she distributed. One Link interviewee expressed the value of 
the information which came from outside their own organisation: it was viewed as 
unbiased and therefore more readily accepted. Another Link interviewee however, 
highlighted that while the evidence reviews were useful, practitioners were busy and so 
the “easy one-liners” were most useful. Yet for another Link, the simple dissemination 
of evidence or information was not enough. She valued personal communication as a 
source of new information. 
As well as furthering individuals’ progress with their projects, Holly spoke of these 
linkages helping to form an interlinking “network of champions” to help with “general 
implementation in change adoption improvement work”. It was through the 
implementation of new interventions that she anticipated improved quality of care and 
cost efficiencies, although Holly’s line-manager acknowledged that these were slow 
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and gradual changes: “we all know from experience you have to keep drip, drip, drip, 
drip all these things”. 
Daisy 
The Agent  
Originally trained as a nurse and experienced as a service improvement manager, Daisy 
was working as a Research Fellow supporting implementation of the network projects 
as well as pursuing her own research. At the time of the study Daisy had only been in 
post for a few months. She initially found it difficult to balance the dual demands of the 
operation support of research-into-practice, and researching that process (her own 
research). Later she was assigned to a large, cross-organisational research project. She 
adopted a proactive approach; if she heard about a project that she felt she could 
contribute to or learn from, then she would request to take part in some way. 
Context 
Daisy worked in Moorlands alongside Jessica and Holly and noted their “strong team 
culture”. Although new in post, she was already aware of the uncertain future: 
Daisy: I am conscious, you know, everyone’s roles are being reviewed, that the 
environment that we’re working in might change, etc. etc.  So I think I’ve got to, sort 
of, be realistic about what’s really, really important to deliver in the next, what, 
three to six months. 
Content 
Her work aimed to improve thinking around implementation and use of evidence. The 
review topics to which she contributed were suggested by practitioners and developed 
in line with their needs. 
Activities  
She worked closely with project managers in organisations to understand the 
knowledge needs of users and where implementation challenges exist. In a context 
described by Daisy’s line-manager as one where clinical academics develop 
innovations but expect others to implement them, she saw Daisy’s role as being “about 
helping people think about their implementation and translation plans. Nudging them 
along the right way, or helping them develop networks”. 
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The complexity of the projects required a variety of methods rather than a set approach. 
Her methods were pragmatic but theoretically informed. She reported taking a 
systematic approach to the discussion of implementation with teams: “That’s when we 
really go through it in minute detail about the three areas of context, content and 
process”. Part of these discussions involved challenging teams to ascertain their current 
readiness and whether they were in a position of readiness for change. These steps were 
seen as “central to translation” and the development of “a resource that will make a 
difference”.   
Daisy also led on increasing the transparency of the network and its processes on their 
website. 
Clients 
Daisy worked with lead clinicians and others (for example project managers) proposing 
an improvement project within the network. 
Outcomes  
Importantly for organisations, the reviews were accessible and contained information 
that could be applied directly to aspects of their work. For example, one Link 
interviewee reported that the material was directly useful and employing the 
information in presentations was “very easy to do”. Link interviewees observed that the 
reviews were not oversimplified and succeeded in covering all aspects relevant to the 
topic: “So, you know, depending on who you are and what your interest is there’s sort 
of something in here for everybody” (Link). 
By publishing on the website a flow chart with timescales and identifying relevant staff 
members, she had improved communication both within the organisation and outside.  
Given her short time in post, it was difficult to identify changed behaviour or results. 
Daisy was aware that this was a more general difficulty: “It’s quite a hard role to 
demonstrate, I think, a clear impact. 
Erin 
The Agent  
Erin was a PhD level manager with a long history of working in the heath innovation 
infrastructure in her region.  In her role she supported the commercialisation of new 
products and ideas and split her time between NHS Innovations and the network.   
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She described herself as adaptable, loyal and hardworking and was described by others 
as “approachable” and accessible, with a friendly personality. She admitted that she 
could “adapt my personality dependent on who I’m speaking to”. Others saw her as 
motivated “to see that innovation developed for the benefit of patient care” (Link). 
Context  
With a well-defined small geography, the largely rural region with an aging population 
has high levels of deprivation and lower life expectancy compared with UK averages. 
Erin saw benefits arising from size and described herself as “lucky… it’s a small place.  
Everyone knows one another”. She reported that the Board was “very, very powerful” 
comprised of NHS leaders supportive of the network’s ambitions, particularly in the 
wealth creation agenda. Not unlike other networks, political changes at the national 
level were front and centre on the Agents’ minds and they reported an uncertain future 
for the network.  She reported close relationships between the local universities and 
clinical community and a number of well-developed professional networks in the 
region.  
Content 
Erin led on the wealth creation agenda for the network, including developing service 
level agreements, as well as monitoring due diligence and peer review of new products.  
Activities  
Erin operated at a senior-level in the organisation to create linkages and broker new 
relationships across organisations such as small and medium-sized enterprises (SMEs), 
local education partnerships (LEPs) and the Clinical Research Network. She facilitated 
the product development process by working closely with local staff to test and 
challenge their ideas before further resources were invested. She described this as 
“sense-checking” and “idea health checking” to determine “is it worth doing?” and if 
so, whether a UK patent is appropriate.  She described this as demystifying the 
patenting process.  
Erin was supported by a team who provided more of the transactional activities, 
including working with partners to prepare them for Board meetings and providing 
evidence and data to partners to support their market research, product development 
and business processes. The specific kinds of information were detailed as: potential 
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sales volumes, how many hospital events… around the UK, how many cases that have 
happened, where there’s been patients that have been potentially injured”. 
A Link interviewee described Erin’s contribution: 
Link: Erin was able to facilitate meetings and arrangements and we’re now in 
negotiation with the Health Authority about being a proper deliberate partner for 
them and looking at different ways of working with them. 
Erin reported working the wealth agenda at the national level with other commercial 
directors of networks.  
Another key activity was developing funding bids and securing new contracts. Erin had 
been successful in securing matched funding, attracting notable amounts of European 
funding. She also delivered education and training, in particular related to the 
innovation and the Intellectual Property process. 
Clients 
Erin’s senior-level position within the network meant she worked with senior leaders in 
the innovation space from across the various organisations in the network (for example 
SMEs, local education partnerships). 
Outcomes  
The support provided to local SMEs by Erin and her team was seen to be “really, really 
helpful… When we’ve been struggling to get decisions or struggling to get in front of 
the right people, they’ve always been useful on that front”. (Link). Brokering new 
relationships was allowing SMEs to engage at earlier stages of the development process 
with those in the health service who were the intended target for their new products. 
Providing data and information was also valued by local stakeholders. One Link 
interviewee commented: “We knew what we needed but we didn’t know where to get 
the information from. So that was Erin’s team that did that for us”. Having the relevant 
information enabled the Link to “negotiate better terms”.  
In this way, Erin’s work was contributing to a shift in thinking around wealth agenda 
and a normalization of innovation processes. 
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Janice 
The Agent  
Janice was a clinical researcher with experience of conducting primary research, based 
at a local university. She divided her time between a knowledge mobilisation 
Fellowship and completing her PhD. She worked as a clinician for several years before 
transitioning into a research role.  She wanted practitioners to “feel that research is not 
an ivory tower” thing undertaken by people “who are only in that for the paper”. She 
exhibited a belief in co-production and believed in the need to engage service users if 
services are to improve.  
Janice's Line Manager described how she had “always been able to work 
independently,” adding that Janice’s career path necessitated “a certain amount of 
resilience” because “it’s not like there’s lots of handy signposts. You’re kind of making 
it up as you go along really”. She reflected that “a big part of what Janice does well is 
the fact that you can send her in to talk to anyone and she’ll do a good job and that 
she’ll leave a positive impression”. Another Link worked closely with Janice on her 
fellowship project and reflected that “Janice’s communication is really good. … She’s 
really accommodating”. Janice described herself as “enthusiastic about every problem” 
and “slightly relentless”. 
Context 
Janice worked in Wetlands alongside Erin. She commented that people were on 
“redundancy alert” and awaiting the impact of the outcome of the general election. 
In terms of internal context, Janice felt able to act with some autonomy and valued 
being based in a university rather than a hospital. 
Content 
The focus of Janice’s work was engaging with clinical staff and service users, 
specifically about maternity care. 
Activities  
Janice described what she did as “perhaps bringing a bit of reality into academia and a 
bit of academia into reality”. She collated and shared research evidence and information 
with the community of practitioners and service users depending on their needs. This 
involved working directly with the target audience to “decide which evidence the actual 
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people want and which would be useful”. She used existing networks of mothers and 
babies to find out what their interests were and “how to explain research to them in a 
way that would make them want to be engaged with us”. She also presented to 
clinicians and attended local informal meetings to share the results of her work. In 
addition, Janice had a role in supporting fellowship applications. 
Clients 
Janice engaged with maternity clinical staff (for example midwives) and service users. 
Outcomes  
The Links responded positively to Janice.  
Janice informed others of new research in the field as well as “the bigger picture of 
what’s going on at the hospital” (Link). This Link was then able to share this learning 
with her patients: “So that’s been really beneficial in a very practical way for them.  
You know, just to inform and empower and allow them to know what their options are 
which has been really useful”. 
One Link commented that ultimately she would expect to see “tangible outputs, 
resources for people to use in the future”. 
Chloe 
We have limited data on this case study as Chloe had to cease participation in the 
research. 
The Agent  
Chloe was a lecturer at a local university, completing a PhD and working as a 
knowledge agent on a part-time basis. Originally trained as an allied health professional 
(AHP), she had many years’ experience, including management roles and was 
recognised as a leader within her health professional community. Chloe described her 
role as one centred on engagement and increasing the two-way flow of knowledge 
between the university and the community. 
Context 
Chloe also worked in Wetlands. 
Content 
Chloe was a subject matter expert in her allied health field and engaged directly with 
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practitioners in that field within the region to update their knowledge base. 
Activities  
Chloe’s role encompassed a number of related strands, notably identifying knowledge 
gaps, providing training in accessing and using evidence from research to inform 
practice, coordinating events, and supporting colleagues to apply for fellowships and 
other funding in knowledge mobilisation.  
Clients 
Chloe worked with practitioners in the allied health field. 
Outcomes  
The training in using research evidence to inform practice was initiated and led by 
Chloe and appeared to have resulted in learning gains and changed behaviour. Chloe 
reported that practitioners were increasingly incorporating evidence into their practice: 
“I’m seeing people and they’re saying, ‘actually … we’ve changed what we’re doing 
and we’re using the evidence’”. Chloe was able to look at available local data to see 
whether new evidence was being used in practice. 
Molly 
The Agent  
Molly was an experienced programme manager with a background in patient safety and 
quality improvement. She was trained in improvement methodologies and applied IHI 
methods. As a member of the core network staff, her role was expert in patient safety 
and manager of a broad spectrum of the network’s activities.   
 Molly adopted a listening approach, believing in the importance of setting priorities for 
the work programme after hearing what the local population had to say. As a team 
leader, team-building was really important to Molly and she made an effort to work in 
the same office as other members of the team. 
Context 
The region this network site covers has a stable, older, population. Geography can be a 
challenge because other regional organisations have different boundaries than the 
Homefields network and the region itself is large. The region had an established 
CLAHRC with whom they collaborated. The economic pressures were described as 
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“particularly acute here at the moment and much like other regions, our Authority 
partners are struggling” (line-manager). Despite the challenges, one observer noted a 
“very collaborative spirit” in the region. The network benefited from strong, vocal, 
representative and engaged leadership in the form of their board. Challenges also arose 
from the network having to shift its priorities according to central policy and funding 
decisions. For example, the patient safety agenda became one of the main programmes 
during the period with a budget and political importance attached to it. 
There was a notable entrepreneurial spirit within the Homefield team, driven in part by 
their own funding uncertainty and evidenced by a long-term business model with 
sustainability as its goal. The organisational structure was purposely relatively flat 
allowing a more flexible approach and giving individuals scope to experiment. The 
organisation was described by Molly as “complicated”, yet also “a really nice 
organisation to work in”.  
Content  
Integrating care from an individual patient point of view rather than integrating disease 
pathways was the priority. However, Molly also referred to traditional disease-specific 
projects such as strokes and diabetes.  
Activities  
The core network team, of which Molly was a key player, invested their time in an 
early listening exercise before determining the regional priorities.  Molly used the term 
“honest-broker” to describe the role of the network as it functioned as a conduit 
between various silos. Molly and the team were data-driven and strived to connect new 
groups of people in the general field of patient safety. 
Her core role was project management and she led on the patient safety portfolio of 
activity. She worked across what she described as two types of projects, fact finding 
and field testing, and across different levels – macro and miso - in the system. She was 
concerned with how projects were prioritised and how the network achieved regional 
oversight of their activity, given the number of initiatives in the region. Molly looked to 
reduce duplication of improvement activity across the patch and sought to link similar 
initiatives and to collaborate. She described a number of tools that were being created 
by the network, including a public-facing central repository of projects and a project 
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management system. They were developing regional standardised, coordinated 
approaches in patient safety and patient feedback systems. Establishing the regional 
patient safety collaborative across all sectors (not just acute settings) became a 
significant part of Molly’s role during the study. 
Molly was credited with coordinating a series of training sessions in IHI methodologies 
for a large cohort of practitioners. She also performed a range of roles in regional 
engagement events, from speaking at the event to coordinating registrations.  
Clients 
Molly worked with lead clinicians and others (for example project managers) proposing 
an improvement project within the network. 
Outcomes  
Responses to the honest broker role were positive. The line-manager was “impressed” 
with the QI training programme.  
The organisation learned about the community’s priorities and regional improvement 
initiatives. Participants in training developed skilled in QI methods. 
Describing themselves as a listening organisation, Molly and colleagues felt that they 
were contributing to a shift in culture. 
Concluding Remarks 
This chapter has presented an overview of the 13 case study KIT agents. Selected for 
diversity, they highlight both content-specific knowledge transfer challenges as well as 
generic mechanisms that support knowledge mobilisation. These case studies provide 
an opportunity for comparison and cross-pollination of strategies and tactics which are 
explored in the next chapter.
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Table 7: Case study agents: descriptive summary 
Agent & 
Organis-
ation 
Role & Dispositions Context Content Main Activities 
(processes) 
Outcomes 
Reaction Learning Behaviour Results 
James 
(Greenhills) 
 
NHS (within 
network) 
Medical background. 
Unit Director. 
Near retirement. 
Charismatic leader who 
put grit in the system 
High level support. 
Pressure to demonstrate 
worth. 
Some internal territorial 
sensitivities but also 
open. 
Supported by Exec. 
External challenges from 
changing demographics, 
technological 
developments and 
economics. 
Cross 
organisational 
and 
clinical/non 
clinical 
Leadership and QI 
training. 
Brokering. 
Some hostility Leadership, 
QI. 
Less silo-
ed 
Proposals, 
awards, 
projects. 
QI in 
appraisal 
system. 
Organisational 
cultural 
change? 
Grace 
(Greenhills) 
 
NHS (within 
network) 
Nursing background 
with MBA. 
Improvement Unit 
lead. One who makes 
things happen; 
passionate and 
resilient. 
Large NHS organisation 
with Medical School on 
site. 
Seeking better physical 
location for Unit. 
Mixed views on 
Greenhills-wide 
initiatives. 
Patient 
focused; 
clinical and 
non/clinical. 
Linkage and 
brokerage. 
Information 
sharing. 
Supporting 
innovation. 
Funding bids. 
Supporting QI: 
training and 
networking. 
Positive QI capacity 
development 
Using QI 
methods 
Successful 
funding bids, 
awards, 
results from 
QI projects. 
Sophie 
(Greenhills) 
 
NHS (within 
network) 
Clinical background 
with management and 
leadership training. 
Lead for improvement 
and unscheduled care.  
Responsive, tenacious, 
can-do person. 
Diversity across the 
region but patient 
focused. 
Patient flow challenges. 
Supportive line-manager. 
Patient flow. Hands-on daily 
meeting with nurse 
teams, regular 
meetings with ward 
managers and 
multi-disciplinary 
team. 
Disseminates 
performance data. 
Comfortable About 
performance 
Shared 
ownership 
of 
problems. 
Achievement 
of targets. 
Organisational 
cultural 
change? 
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Agent & 
Organis-
ation 
Role & Dispositions Context Content Main Activities 
(processes) 
Outcomes 
Reaction Learning Behaviour Results 
Amy 
(Riverside) 
 
Network 
role within 
NHS host 
Nurse by background, 
on a one year-
secondment.  
Patient safety projects, 
specifically sepsis. 
Active, involved and 
visible. 
Diversity across the 
region. Variable support. 
Overlapping mandates. 
Lack of clinician time for 
QI. 
Immediate team support. 
QI sepsis 
project. 
Sepsis QI lead. 
Improving 
measures, data 
collection. 
Delivering QI 
training and 
mentoring. Other 
supportive activity 
(funding bids, 
visits, events) 
Some 
defensive 
responses 
Sepsis 
performance 
QI methods 
Using QI 
methods 
More data 
driven.  
Organisational 
cultural 
change? 
Isabelle 
(Riverside) 
 
Network 
Policy background and 
past patient. 
Linking patients with 
clinical researchers. 
Hard-working with 
influencing skills. Well 
networked. 
As above Patient 
engagement. 
Building 
relationships and 
connections. 
Mapping PPI. 
Training, 
mentoring, capacity 
building. 
Generally 
positive 
although 
examples of 
negative 
responses. 
Learning 
about patient 
engagement. 
Thinking 
differently. 
Improved PPI 
engagement 
(potentially) 
enhancing 
research and 
practice. 
Award. 
Strategies. 
Fran 
(Riverside) 
 
Network 
role within 
NHS host 
Trainee doctor on a 
one-year fellowship. 
QI facilitator. 
Enthusiastic, 
committed, 
approachable and 
diplomatic. 
 
As above QI projects 
across clinical 
areas 
including 
escalation, 
falls, patient 
safety, 
prescriptions. 
Supporting QI 
projects. 
Training, adapting 
materials. 
Linking staff to 
other related 
support. 
Some 
disinterest 
QI methods. 
Personal 
learning. 
Using QI 
methods 
Enhanced QI 
projects and 
dissemination. 
Awards. 
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Agent & 
Organis-
ation 
Role & Dispositions Context Content Main Activities 
(processes) 
Outcomes 
Reaction Learning Behaviour Results 
Jessica 
(Moorlands) 
 
Network/ 
CLAHRC 
Practice-facing 
academic. 
Evidence review and 
evaluation. 
Supporting knowledge 
agents. 
Pragmatic and 
perceptive. 
Large geographical 
area with variation. 
New network with 
CLAHRC history. 
Collaborative but 
challenged by 
uncertainty. 
Transparent. 
Lack of 
manager/clinician time 
for implementation. 
Commissioned 
and client-
focused 
evidence-based 
reviews 
Leading on 
evidence review 
and evaluation. 
Brokerage between 
practitioners & 
academics. 
Supporting other 
KIT agents. 
Resistance to 
theory. 
Well-received 
reviews. 
From 
specific 
reviews. 
Researchers 
learning tacit 
knowledge 
about NHS. 
Higher 
degree 
programme. 
Shift in 
thinking; 
normalization 
of KIT 
processes. 
Changed 
behaviour in 
light of 
reviews 
(implied) 
Evidence 
reviews (as 
products) 
changing 
decisions 
(implied) 
 
Holly 
(Moorlands) 
 
Network/ 
CLAHRC 
Senior nurse by 
background, working 
one-day-a-week in KIT 
role promoting 
Moorlands work. 
Good communication 
skills. 
As above. 
Challenge of staff 
turnover. 
Practical and 
patient focused. 
Engaging with 
senior leaders and 
managers. Project 
oversight. 
Brokerage between 
NHS and academia. 
Priority setting. 
Information on 
capacity building. 
Responsive. How to 
progress 
projects. 
Information 
on 
opportunities 
Better 
relationships 
Network of 
champions. 
Implementati
on leading to 
improved 
care and cost 
efficiencies 
(implied) 
Daisy 
(Moorlands) 
 
Network 
Nurse by background 
and experienced 
service improvement 
manager, working as a 
Research Fellow 
supporting 
implementation.  
Proactive. 
As above. 
Strong team culture. 
Use of evidence 
and 
implementation 
Clarify user needs, 
contribute to 
evidence reviews 
and facilitate 
implementation. 
Work on 
transparency. 
Useful. How to 
implement. 
Shared 
information 
on work of 
organisation. 
Change 
arising from 
implementati
on (implied) 
Early days 
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Agent & 
Organis-
ation 
Role & Dispositions Context Content Main Activities 
(processes) 
Outcomes 
Reaction Learning Behaviour Results 
Erin 
(Wetlands) 
 
Network 
A manager with PhD, 
experience working 
with SMEs; Intellectual 
Property expertise. 
Approachable, friendly, 
adaptable. 
Small, largely rural 
region with areas of 
deprivation. 
Powerful Board. 
Uncertain future. 
Good local relationships. 
Wealth 
creation 
agenda 
Facilitating product 
development 
process. 
Creating linkages 
and brokering new 
relationships. 
Provision of data 
and information.  
Funding bids.  
Training related to 
innovation and 
Intellectual 
Property processes. 
Useful. Business 
development 
Improved 
SME 
business 
planning 
and 
negotiations 
Shift in 
thinking 
around wealth 
agenda; 
normalization 
of innovation 
processes 
Janice 
(Moorlands) 
 
University 
A clinically trained 
researcher on a 
knowledge 
mobilisation 
fellowship, 
Independent, resilient, 
good communicator, 
relentless.  
As above. 
On redundancy alert. 
 
Clinician and 
user 
engagement, 
specifically 
maternity. 
Providing tailored 
information to 
practitioners and 
service users. 
Creating linkages 
and brokering new 
relationships. 
Positive. Learning 
tailored to 
local 
knowledge 
gaps. 
Changed 
behaviour 
in light of 
evidence 
(implied) 
Improved use 
of research in 
practice 
Chloe 
(Moorlands) 
 
University 
University lecturer & 
part-time knowledge 
agent. Trained allied 
health professional. 
As above. Subject matter 
expert in her 
allied health 
field 
Identifying 
knowledge gaps 
Training in using 
research to inform 
practice. 
Organising events. 
Supporting 
fellowship 
applications 
(no 
information) 
How to 
access and 
use 
knowledge. 
Changed 
behaviour 
in light of 
evidence 
(implied) 
Improved use 
of evidence 
(implied) 
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Agent & 
Organis-
ation 
Role & Dispositions Context Content Main Activities 
(processes) 
Outcomes 
Reaction Learning Behaviour Results 
Molly 
(Homefields) 
 
Network 
Programme manager 
with expertise in 
patient safety and QI. 
Listening approach. 
Team player. 
Stable, older, population. 
Established CLAHRC. 
Mismatched boundaries. 
Economic challenges. 
Collaborative. 
Strong leadership. 
Entrepreneurial.  
Patient safety. Project 
management and 
patient safety lead. 
Coordinating QI 
training.  
Sharing information 
about regional 
improvement 
initiatives. 
Delivering regional 
events and 
engagement days. 
Positive. 
Impressed 
Community 
priorities. 
Improvemen
t initiatives. 
QI methods. 
Improved, 
coordinated 
projects. 
Listening – 
culture shift? 
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Chapter 6. Cross-Case Findings: Facilitating 
Outcomes 
In this chapter, we present details from the case studies to illuminate why the KIT 
agents acted as they did and were successful. Highlights of our findings are the 
importance of being proactive to define the KIT role, how individual dispositions 
outweighed technical knowledge in terms of enabling change and having the time and 
flexibility to develop the role. 
Expectations of the KIT Agent Role 
KIT agents experienced multiple and sometimes conflicting expectations for their role. 
In this section we consider expectations from a number of perspectives, identifying the 
importance of actively defining and clarifying the role with line-managers and links and 
proactively planning for sustainability from the beginning by developing capacity 
within local teams.  
KIT agents’ expectations for their role 
KIT agents performed diverse roles and held many responsibilities that exemplify their 
boundary spanning function. Their primary accomplishment was to link quite different 
communities and individuals. These linkages were made both within their organisation, 
across different departments or levels of management, and between organisations, 
notably linking academic and health services practitioners (managers and clinicians). 
They led change initiatives and challenged local practice by introducing and employing 
different knowledge sets (including both research-based and experiential knowledge). 
Another element of their role was building local capacity around KIT.    
Role ambiguity and learning on the job was common across agents but those who were 
well supported by line-managers (for example James, Janice) were able to actively 
define their role which played a part in their success. In several cases where the role 
was ill-defined or misunderstood, the agent took on work outside their scope or skill-
set, which could lead to feelings of anxiety and inadequacy. For example, Amy 
reflected in her audio-diary how she was being asked to take on too much:  
Amy: So the meeting finished and I felt really anxious really overwhelmed. My boss 
didn’t have time to hang around and catch up with me but I did speak to [Name] and 
I said that I felt really uncomfortable that I was going to be the core person trying to 
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bring all this together, for lots of reasons, ..... I felt way out of my depth, really 
uncomfortable in the job I was doing and really inadequate.  
Another agent at Riverside, Fran, described how she took on work that “wasn’t actually 
meant for me” and ended up doing a lot of the project rather than advising and coaching 
as was intended in the role. She reflected: “I wasn’t there as an extra pair of hands. I 
was there to improve their skills to do it”. 
KIT agents expressed longer-term expectations for their role including changing local 
culture, improving patient care, and improving relationships between academia and the 
NHS. For example, Sophie described how introducing a different format to ward 
meetings helped remove professional hierarchies, encouraging everyone to challenge 
each other. She felt that the process helped people to think differently and reflected that 
“the whole organisation feels different”. This suggests how the KIT role could lead to a 
change in local culture.   
Line Managers’ expectations of KIT agents 
Line-managers had expectations that corresponded with all of the functional 
expectations held by agents. These included the centrality of building relationships as 
part of an engagement role, facilitating change, and building capacity. Line-managers 
also felt that the engagement role should ultimately lead to improved ways of doing 
things and improved patient care.  However, this was viewed as a long-term goal as the 
role developed. James’s line-manager described the first year as one to “raise awareness 
to have some warm feelings” but expected beneficial outcomes arising from year two 
and beyond.  He described these outcomes in terms of empowering others and building 
capacity: “whether people feel that they are empowered to get on with changing their 
individual areas and whether they feel skilled”. He expected that such outcomes could 
be measured: “and I think we can track some of those kinds of measures through” 
(James’ line-manager). Other expectations about outcomes expressed by the line-
managers included the view that outcomes were delivered through a collective 
partnership and not held by one individual (Molly’s line-manager) and that these roles 
do not necessarily generate financial savings but recovering investment was a more 
appropriate framing around costs (James’ line-manager). For this line-manager, 
recovering investment meant that the KIT agent's work would generate a level of 
savings within the organisation over time making the original investment cost neutral. 
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However, measuring improvement or efficiency savings was described as challenging 
by Grace's Link. 
Links’ expectations of KIT agents 
Links also expected KIT agents to make linkages between various parts of the 
organisation and individuals (for example, between operational staff and the executive 
board) and facilitate practice change. Uncertainty about the role and poor 
communication by line-manager were identified as problems. However, links did not 
fault the agents for poor communication but rather reflected that they themselves 
needed to take time to find out more about the agent. 
KIT agents were also seen as experts by their colleagues, either based on their 
professional experience, subject expertise, or experience in the specific organisation 
(for example links of Isabelle and Sophie). One of Amy’s Links expressed anxiety over 
the KIT role and had expectations that “they wouldn’t link in with our usual processes”. 
This hints at the importance of understanding and working within local contexts.  
The KIT role: risks and sustainability 
KIT agent roles are seen as risky and lacking traditional forms of recognition in terms 
of progression and opportunities. Agents who left their clinical or managerial jobs to 
take on these roles expressed concern about future uncertainty:  
Janice: I’m taking a bit of a personal risk, you know, I’ve dropped 70% of a job to 
be able to do this and at the end I have no, you know, I’ve got nothing lined up 
particularly. So I think there’s a real risk. 
This agent goes on to reflect that at the end of the fellowship they might end up back in 
a clinical role where they would be “extremely restricted in how much I could do”. A 
related issue is the lack of a career trajectory as emphasised by Janice’s line-manager: 
“the reality is that people don’t get promoted or don’t get career recognition on the 
basis of these things. Not yet anyway”.  
We also found that academically-oriented KIT agents were taking on a risk in moving 
away from traditional academic outputs and focusing on knowledge transfer and 
mobilisation. Jessica felt relatively secure in her current role but expressed the lack of 
recognition from her university employers: 
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Jessica: But then do my employers recognise that. Not a chance. I’m okay with my 
current [profession]. If my [profession] changes I will be in big trouble about that 
one.  
Another challenge for sustainability and attractiveness of these roles is that KIT work 
seemed to be undervalued and invisible compared to clinical duties. Fran’s Link 
reflected that the work of the KIT agent was something that was squeezed in alongside 
real (“actual”) work: “I think it’s really about finding time to do this because obviously 
you’re doing it while you’re doing your actual work”. The invisibility of the role raised 
challenges around attribution and costing the role against organisational targets. 
Agents on short-term fellowships (Amy and Fran) discussed having trouble finding a 
go-to person for a proper handover at the end of the fellowship. They felt personally 
responsible but others felt it was an organisational responsibility. One of their Links 
suggested that there should be some kind of an agreement from the Trust to fund the 
position after the fellowship: “maybe for sustainability that actually when you enter 
into that partnership within the organisation, …that there’s the agreement that they will 
support the sustainability once that fellow’s gone”. She likened this to the model 
adopted by some pharmaceutical companies who only invest in funding a short-term 
role when the organisation agrees to continuation funding. 
Aware of these challenges (summarised in Table 8), many of our agents adopted 
proactive strategies including planning for hand-over from the onset by training others 
and developing capacity, pursuing other funding opportunities and focusing on 
demonstrating value. 
Table 8: Role expectations, risks and sustainability: summary of enablers and barriers  
 Enablers Barriers 
Expectations 
Supportive line-manager with shared 
expectations 
Agent able to actively define role and 
manage expectations 
Role not clearly 
communicated  
Risk and 
Sustainability 
Planning for hand-over and developing 
capacity  
Organisation commit to sustainability  
Entrepreneurial mindset (e.g. seeking 
own funding, demonstrating value) 
Lack of career 
progression and 
recognition 
Undervaluing KIT 
work  
Invisible role 
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Factors Related to Individual Dispositions 
Although technical knowledge is essential, many participants identified dispositional 
enablers as critical to the KIT role. These include outlook or attitude, having a 
supportive and skilled team, and the status of the individual. Links also described the 
importance of the agents’ leadership skills and interest in the change process. 
Attitude and outlook 
Six of our agents were described by their Links as having a can-do attitude and 
presenting as enthusiastic when working with frontline staff.  One agent (James) 
reflected: “it’s about taking an attitude that this is possible rather than what’s difficult 
about it. To say, ‘this is the way forward, how do we overcome the problems’ rather 
than be deterred by them”. This agent’s approach does not go unnoticed: one of his 
Links described it as “being solution focused, not talking about problems but talking 
about, ‘what are the issues here?’”. 
In line with KIT agents’ own expectations, line-managers expressed how a proactive 
approach to the role was a critical ingredient for success: 
Janice’s line-manager: It’s doing the horizon scanning rather than waiting… 
Someone proactive, I suppose. Yeah… they need to have demonstrated that they can 
be proactive and will be. 
Fran, for example, described how in the first few months in post she had been proactive 
and met with different teams to define her projects. 
Leading change, whether through innovation or implementing research, takes time and 
agents needed to be able to sustain their interest. One Link described Sophie as 
“tenacious”, adding that “it’s not been a one-minute wonder. She’s sustained her 
interest in it”. Large system changes in particular required sustained attention.   
The status of the agent 
Agents with status in the organisation enabled engagement to happen, especially with 
hard to reach groups such as consultants. One agent (James) reflected that being a 
senior doctor and directly accountable to the Chief Executive were two critical factors 
that facilitated his role. Another agent brought along a senior consultant when she 
facilitated a QI session with a group of challenging consultants. This approach proved 
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useful and led to further reflections on the value of bringing together clinicians and 
managers: 
Amy: So it was really useful for her [senior consultant] challenging them and 
making them think.  So we’ve sort of reflected that where possible we need someone 
of that level, ideally a consultant peer in the room. Equally they’re all feeling quite 
frustrated that they have tried to get … quality improvement, but they feel they can 
get blocked by managers... So we’ve reflected that we really need some sort of 
senior manager in the room or they need to bring their managers. 
The agent is unlikely to have the relevant status in all groups; one solution is to directly 
involve others (such as clinicians, managers) to complement the status of the agent. 
Being known and having an established network of contacts within a region enables an 
agent’s capacity for brokerage. Chloe, for example, mentioned how she is often 
approached by members of her profession's clinical network to provide the latest 
evidence on a subject because she is "well known" and knows who to contact within the 
network. Being well-networked also helped agents gain buy-in from the ‘right’ 
individuals.  
Leadership style  
One of the qualities that KIT agents associated with good leadership was being a team-
player. Sophie's line-manager spoke of her leading from the front, saying "[Sophie] 
would pick a trolley up, you know, and help move a patient to a ward, if she was based 
on one of the sites at the tail end of the day". Humility (for example “I demonstrate. I 
don’t always have the answer” Sophie), creativity and celebrating success were valued. 
Another facet was a coaching or nurturing style: 
Grace audio-diaries: You’ve got to make the conditions right, really, for people to 
share, to be transparent, trust and to learn. I think we all know that no one is 
perfect, but actually by working together and by applying improvement methodology 
you can really make change happen.  
However, agents’ style differed and not all our agents felt they were always performing 
as a leader.  Sophie’s style was perhaps less nurturing: “I don’t need that positive 
stroking to get me where I am and I sometimes struggle with other people requiring 
that”. What worked for one agent in one circumstance might not work for another in a 
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different context. Factors related to individual dispositions are summarised in Table 9. 
Table 9: Factors related to individual dispositions: summary of enablers 
 Enablers 
Attitude and 
outlook 
Enthusiastic and positive 
Solutions-focused 
Proactive 
Tenacious and persistent 
Status of the 
agent 
Experience valued by others (e.g. clinical, managerial) 
Seniority 
Being well-known and well networked 
Leadership 
skills 
Team player 
Suiting style to context (e.g. extent of nurturing)  
Organisational and Network (Meso) Factors 
Our study coincided with the initial stages of AHSN and SEWAHSP development.  
Here, we explore the AHSN and SEWAHSP context as it relates to the KIT role and 
organisational factors facilitating or hindering KIT role success.   
Network context 
The agents in our study related to their host network in different ways: 
- Employed and based in the network (n=4) 
- Based in network partner NHS organisation (n=5) 
- Joint appointment (n=2) 
- Employed by a university (n=2) 
Being employed by the network provided the agents with dedicated time away from 
their usual clinical or managerial duties to perform their knowledge brokering work. 
Agents reported a number of other enabling conditions including being based in a less 
hierarchical organisation with an entrepreneurial culture and having a peer group for 
knowledge exchange in their home network. However, the network-based role meant 
job insecurity in the long-term; they needed to demonstrate their added-value and 
secure longer-term funding. They were not performance managing those involved in 
change so sometime had limited influence and the networks were themselves complex 
organisations, as noted by Daisy:   
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 Daisy - So there’s something about the fact of what the AHSN does.  They seem to be 
implementing or looking at issues at lots of different levels within health care.  So, 
surprise, surprise, it’s even more complex and we’ll require a variety of methods, I 
think, rather than one approach 
Agents also reported a competitive environment between the networks at a national-
level. For example, although directors received support from a national network of 
AHSNs, agents reported this support did not extend beyond the senior-level. 
Agents based in partner organisations reported similar enabling/hindering conditions 
and also felt they had to take the initiative to develop and articulate their role within 
their NHS organisation.  
Agents on joint appointments were less susceptible to some of the challenges 
mentioned by those based in the networks but were faced with other issues around 
splitting their time and negotiating the different organisational practices.  Molly 
remarked that “shared posts” were a good idea but “a challenge for whoever fulfils the 
post because the two organisations are so different in terms of the way we work”. 
Being based in a university gave KIT agents access to library resources including 
librarians providing literature reviews and training resources. Both our university-based 
KIT agents had a clinical background which they used to secure buy-in with their NHS-
based clients. Chloe described this advantage as being able to say “I’ve done it” which 
helped remove the barrier of being seen as external to the client’s clinical community. 
Network characteristics 
Case study networks were selected to cover four points of divergence as explained in 
the sampling section in Chapter 3. Here, we briefly explore our findings across the 
different categories of network characteristics. 
Stage of network development  
The stage of network development (ranging from de novo to well-established) did not 
appear to influence the KIT agent’s activities; individuals reported spending their initial 
few months on building relationships and establishing links within their region, 
customising tools and approaches and selecting their priority initiatives.  This 
highlights how the role of a knowledge broker requires similar resources (for example 
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time) regardless of the maturity organisation in which they are based.   
Diversity in regional research infrastructure  
The agents in our study reported mixed views of working with their regional research 
infrastructure (for example established links with CLAHRCs/no CLAHRC; AHSC/no 
AHSC).  In one network (unnamed to preserve anonymity), the agent initially described 
their network as “lucky” to have an established CLAHRC and that they were working 
together on a number of projects. However, over time, the same agent later reflected 
that they “don’t work collaboratively very well” with the CLAHRC anymore due to 
differences in personalities, organisational practices and views on implementation.  
Regarding their differing views on implementation, the agent reported: 
 [The CLAHRC] have a very academic approach to projects which means that they 
have three or five years trying to answer very specific questions.  Whereas we have 
an approach that’s meant to be a very real world interpretation with very rapid 
adoption and spread of what is determined as best practice and those two things 
don’t quite match.  
Another agent reported that CLAHRCs and AHSNs have “come a long way but they 
haven’t been overly successful in taking other people with them.” This demonstrates 
the challenge of harnessing the full potential of regional assets given the complex and 
challenging healthcare landscape.  
Planned KIT roles within the region  
Our agents represent the range of different knowledge broker role arrangements (for 
example part of core team, secondments, fellowships). Interestingly, job security was 
seen as a challenge and risk for all regardless of whether they were employed as part of 
the network’s core team or on a fellowship. The difference was that for some the 
uncertainty related to the network’s five-year term compared to those on a one-year 
fellowship who were already transitioning to a new role before their fellowship ended.  
Geography 
As expected, KIT agents in regions with fewer organisations or smaller geographical 
footprints remarked on this being less of a challenge compared to other regions. For 
example, these agents mentioned that engaging with their partners was easier because 
they only had a handful of clinical commissioning groups compared to another region 
with over 20. We did not observe any regional patterns in terms of north-south network 
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characteristics. 
England/Wales differences 
There were several noteworthy differences between the network set-up across agents in 
England and Wales. Agents in Wales operated across a smaller geography in their 
network roles and the partnership, compared to AHSNs, did not operate as a separate 
entity. They were in more permanent posts (i.e. not on a short-term contract linked to 
the five-year term of AHSNs). James reflected: 
We’ve got it easier, much easier here but we’re local because we’re part of the 
organisation.  Some of those relationships are already there.  People are expected to 
relate to us and we’re expected to relate to them.  
In England, the uncertainty around national priority areas and themes for the networks 
and the complexity of the AHSNs played a hindering role on agents in terms of long-
term planning and general feelings of job security. Molly commented that “as the 
resource requirements are becoming clearer we’re still constantly adjusting it”.  In 
general, agents did not feel that being external or independent as an AHSN was a 
disadvantage to knowledge brokering roles by positioning the network as a conduit 
between silos. 
Regardless of how the individual related to their regional network and network 
characteristics the KIT agents’ clients were based in healthcare organisations faced with 
a resource-constrained environment. Indeed, there was resistance from both frontline 
practitioners unable to free-up their time and also from management unable to see the 
immediate benefits of the knowledge work. We next consider resources to support KIT 
work, organisational leadership and organisational culture.  
Resources to support KIT work 
Time 
Having the time and space for KIT work is described by agents and line-managers alike 
as a key enabler.  Indeed, “I think freeing people up for the time” was James’ line-
manager’s response to a question about the most important thing that his organisation 
does to support KIT. Agents reported insufficient resources within their departments to 
provide backfill for clinicians/managers to be involved in KIT work. Jessica described 
it as “icing” and the challenge is that clinicians and managers can get on with their 
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practice without it: “you can eat cake without having icing on it, and research and 
evidence on daily practice is like icing”. The practitioners that KIT agents worked with 
were under pressure, to “deliver within the financial envelope, making sure that their 
targets are met” (Holly).  At Homefields (Obs 2.7.14) we heard a reflection from a 
presenter that the clinical team had time for nothing other than delivering service; no 
time to review, evaluate, or improve.   
The amount of time agents had for the KIT role was a limiting factor. Typically they 
were a small resource serving enormous organisations and could “only invest so much 
time in very few projects” (Grace’s Link). Unsurprisingly agents working on large scale 
change projects found that the scale of these projects mean they could only “skirt 
across” the wider organisation (Sophie).  
Physical space 
Another manifestation of organisational resource was a physical home for those in KIT 
roles. Grace felt the lack of a physical space hampered her team’s ability to support 
improvement. This prevented her from initiating an open door culture where tools such 
as idea boards would be visible to all. That visibility she thought would contribute to 
creating “an energy which encourages and supports and nurtures a culture for 
improvement and innovation”. 
Teams 
Our Link interviewees highlighted the importance of the team who work closely with 
the agents and the role they play in supporting KIT activity. Often set up deliberately 
by the agent based on a project’s needs, the team could bring together complementary 
skills.  Grace’s Link commented: “People matter. You also need a really great team and 
it needs to be people who are going to be essential to getting what you need done. 
Another Link reflected on how the agent established a “fascinating” team structure 
comprised of groups with a specific remit: “You’ve got a process group, a 
mathematical modelling group, one focused on safety, one focused on leadership, and 
that gives real clarity to what support you can give” (James’ Link). In this way teams 
could exhibit the required skills and experience for their projects. We heard from 
another of James’ Links that beyond simply having relevant skills, the team were 
“approachable” and people in the organisation felt they could trust them.  
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Data 
A number of challenges arose around data to support KIT work, including its 
collection, accuracy, sharing practices, beliefs and skills required to apply it. One 
meeting we observed centred entirely on the challenges of obtaining accurate and 
timely admissions data. Staff discussed the concerns with using mean length of stay, 
specifically its accuracy and meaningfulness, yet its use in practice continued and 
consequently the agent’s team had to ensure that those using the data actually 
understood the figures (Sophie Obs 7.10.14).  
A related issue is that performance data differs from the type of information KIT agents 
require to evaluate their efforts. To illustrate, James reflected in an audio dairy: “So I 
think one of the messages from me is how important data is for improvement and not 
performance data firstly, but the right data to understand the work. And we just don’t 
have that”. 
Organisational leadership and support 
Agents reported that support from the Executive Boards and their line-managers helped 
them to achieve desired change. Board and executive leader support was mentioned as 
enablers by several agents: 
Isabelle: I think the Exec leadership in that particular organisation is an enabler 
because it’s visible, it’s palpable. …The Chief Exec is around all the time saying 
hello to people.  
 
Erin: The change, certainly the change in attitude for the Chief Executives…and the 
support that they give is massive, and I can’t stress how important it is to have such 
a strategic Board.  
James outlined the importance of getting senior decision makers interested and engaged 
at an early stage.  He also emphasised the importance of developing leaders through 
targeted training programmes and reflected that his unit’s leadership programme was 
“probably the most important thing we’ve done”. 
Molly’s line-manager was inspired by some of the more innovative and entrepreneurial 
companies that provide their employees with freedom and he reflected “I think we’ve 
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got to be in that space”.  He created a relatively flat team structure and tried to avoid 
heavy top down management.   
Organisational culture and receptiveness 
We heard from many agents that the organisational culture supports KIT work. One 
line-manager (for James) described his guiding philosophy as valuing the input from 
grassroots: “…rather than feeling that we [Executives] are always right…the best value 
you can do is listen to your frontline staff who often know the best way of doing these 
things”. Another site (Homefields) very deliberately became a ‘listening’ organisation 
and used feedback from partners and the community to prioritise their work 
programmes. Agents reflected that organisations that do not listen to the needs of their 
stakeholders will erode trust and “set the relationship back” which undermines the 
change programmes (James audio-diaries).  One Link reports how Sophie helped to 
create a culture where people were encouraged to question members of their team, from 
the doctors to the porters: “Well now everyone will challenge everyone, which is very 
healthy.  It’s very, very, very well done”.  
Aspects of the local culture that were described as unhelpful included a “very silo 
approach” (Grace), failure to cascade information from leads to the frontline, and 
overlap of departmental missions leading to role confusion and duplication. Agents 
were challenged by the conflict between national and local policies. James, for 
example, described the “separate” but overlapping initiatives: “People working on 
[improvement initiative] project internally and then there’s the national [improvement 
initiative] but they’re separate and we’ve met quite a lot of resistance to trying to 
refocus the people internally, from one or two people who are quite senior”. Another 
challenge was described as “initiative-itis” by Moorlands line-manager. Juggling 
different projects simultaneously without any additional resource was judged to be 
disabling for all concerned. 
Interestingly organisational culture was not seen as set in stone or immutable. James’ 
line-manager spoke of redefining the Executive team’s core values and introducing the 
improvement unit was part of an organisational “recalibration”.  In Sophie’s site, the 
line-manager explained how the creation of a space for professionals to meet and ask 
questions of each other had contributed to an organisational ethos that underscored the 
patient as central focus, not the professional hierarchy. 
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Organisational receptiveness, or lack of, influenced KIT agent activity.  Jessica 
reflected that receptiveness towards researchers was “the greatest one that we’ve 
found” when asked about barriers to KIT. Molly’s line-manager summed up the idea of 
working with the willing: 
Molly – line-manager: People when they want it and embrace it, that’s where you 
get change happening.  So, you know, if you look at some of the projects… where 
they’ve been successful is because the organisation wanted change and where they 
commissioned that piece of work, and that’s when they drive it.  When they don’t 
want it, it’s just... it’s painfully, painfully difficult. 
Organisational enablers and barriers are summarised in Table 10. 
Table 10: Organisational factors: summary of enablers and barriers 
 Enablers Barriers 
Network context 
and characteristics 
Less hierarchical organisation 
Peer group support 
Job insecurity 
Competition between 
networks 
Resources to 
support KIT 
Time for practitioners to engage in KIT 
Time for KIT role  
Physical home 
Approachable KIT team with relevant 
skills 
Availability and usability of data 
Frontline staff having no 
time for anything other 
than service delivery 
 
Organisational 
leadership 
Board-level and line-manager support 
Early engagement 
 
Organisational 
culture and 
receptiveness 
Listening 
Openness to challenge 
Receptive to research 
Working with the willing 
Professional silos 
Confusion between 
missions and ownership 
‘Initiative-itis’ 
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External (Macro) Factors 
Constraints manifest at the meso level often emanated from pressures in the wider NHS 
context. We consider briefly the influence on the work of the KIT agents of national 
politics and the culture at the system level.  
Politics 
National policy drivers are seen as both enabling and constraining. A key barrier was frequent changes to national 
policy. Table 11 summarises policy changes in England and Wales alongside key network developments. Table 11: 
Timeline of key policies and network developments 
Time 
period 
Key national policy developments in 
England 
Key national policy 
developments in 
Wales 
Key network events in 
England & Wales 
2008 - 
2010 
2008: NHS Next Stage Review 
published(211): confirmed the 
commitment of the DH to developing 
a more systematic approach to the 
spread of innovations and the creation 
of a network infrastructure to support 
research translation in the NHS. Key 
to this was investment in knowledge 
partnerships between universities and 
NHS organisations. 
 
2008: Establishment of nine NIHR 
Collaborations for Leadership in 
Applied Health Research and Care 
(CLAHRCs). 
 
2009: Establishment of 17 Health 
Innovation & Education Clusters 
2010: Welsh 
Assembly 
Government, 
Economic Renewal – 
A New Direction (214): 
included encouraging 
innovation through a 
R&D intensive and 
knowledge-based 
economy as one its 
five priorities for 
Wales 
 
2011 -
2012 
2011: Life Sciences Strategy published 
(212)
 
 
2011: Innovation, Health & Wealth(27) 
– signalled a change to the innovation 
landscape, including the designation of 
AHSNs. 
 
2011: Welsh 
Government, 
Together for Health: 
A Five Year Vision 
for the NHS in 
Wales(215) 
 
2011: SEWAHSP, Developing 
an Academic Health Science 
Partnership in SE Wales - an 
Outline Strategy(218) published. 
 
2012 -
2013 
2012: Health & Social Care Act(213) 
 
2012: Science for 
Wales(216) published 
laying out a plan for a 
step-change in 
Wales’ academic 
performance across 
the sciences 
 
2013: Innovation 
Wales(217) published. 
2012: AHSNs submitted their 
detailed network prospectus 
and draft business plans to 
NHS England. 
 
2012: SEWAHSP, Five Year 
strategy(206) published laying 
out priorities for the period 
2012-2017. 
 
2013: Licensing of 15 AHSNs 
in England. 
 
Erin expressed concern about the consequences of political change: 
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Erin: HIECs had just come into force.  They’d just got up and running.  … If there’s 
a change in Government, will the AHSNs be scrapped? 
A shortfall in central government funding for the networks was mentioned during the 
meetings and events we attended (for example Homefields-Obs 2.7.14). Delays in 
licensing meant network teams risked spreading themselves too thinly early on. During 
the course of our study we witnessed how the networks in England shifted their original 
plans as they responded to new programmes of work making them, as Molly observed, 
“incredibly chaotic”.  
The different geographical boundaries introduced by recent national policies in England 
presented another barrier. For some agents the boundaries varied across different 
organisations within a region.  The landscape that agents operated within was complex 
and constantly changing. 
On the other hand, the political scene could be enabling, for example if the agent could 
position their work within an emerging priority. Jessica observed: “So, you know, 
politics can hinder but equally can be an amazing driver for something to happen both 
nationally or at a micro level”. Molly was able to take advantage of the patient safety 
initiative to grow her contribution. 
System-level culture 
The culture at the system-level in the NHS also affected the KIT agents. The culture 
was characterised as one which was: focused on short-term budgeting rather than better 
quality of care in the long run; dominated by command and control/hierarchical 
structures; driven by targets and performance instead of understanding patients and 
demands; and a relationship between primary and secondary care which was negative 
and competitive (James). Another agent (Sophie) drew attention to what she described 
as a “risk averse” culture which mean that patients could not be discharged until the 
potential risks at home had been solved, yet, they are running similar risks in the 
hospital on a daily basis. Table 12 presents a summary of external barriers and enablers. 
 
 
Table 12: External factors: summary of enablers and barriers 
 Enablers Barriers 
100 
 
Politics Initiative drivers 
Pressures on the NHS 
Frequent policy change 
Funding shortfalls 
Delays in licensing 
Complexity of landscape and geographical boundaries 
Culture at 
system 
level 
 
Short-term budgeting 
Command and control culture 
Driven by targets 
Relationship between primary and secondary care 
Risk adverse 
Content 
Agents adapted their language and knowledge approaches to the local context and 
found some hooks by simplifying the process of knowledge mobilisation or by using 
metaphors to engage their clients.  
Concepts and definitions  
Language difficulties 
Some agents reported that getting agreement over definitions was a challenge early on 
in their role. The message from the agents is that terms like knowledge 
transfer/translation/mobilisation are not useful in practice. Grace noted how they mean 
“a zillion different things to every individual person”.  Another issue is that these terms 
are rooted in academia. Jessica talked about the unhelpful potential to “baffle them with 
the theoretical science” and the need to use language that practitioners understand: 
Jessica: We had a particular… model of how we did translation, and it said that we 
were going… to use principles, organisational science and organisational learning.  
It was brilliant because it was just going to work because that was the mentality of 
the person that originally wrote it, without understanding actually the people who 
would be physically following that model are clinical academics and they had no 
idea what he was talking about and were particularly unreceptive. I think, yes, it 
was… rubbish.  
She went on to describe her approach: 
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We talked to them about being change agents because they understood that term in 
the NHS. We talked about being ambassadors. We talked to them about being like 
pieces in jigsaw puzzles, you know building bridges between people and groups. 
So… it’s about… trying to make it so it’s meaningful for the people that are having 
to do that work. 
Instead of using academic terminology the KIT agents sought to simplifying terms, 
choosing language that is rooted in an understanding of the local context, as Jessica 
described. They also used metaphors to convey what they do: 
Amy: “Getting people to light bulb moments” 
Jessica: “Planting seeds of receptive thought and watering them”  
Few agents emphasised patient involvement in KIT. However, many felt there was 
room to improve how patient input was solicited, and that insight gained from patients 
could translate into improvement (Isabelle). Speaking about “coproduction”, James 
reflected that “If we are going to get coproduction right we need to have a very 
different conversation between patients and professionals”. He criticised professionals 
for thinking “they have a right to own the knowledge they have got and share it out as 
they see fit”. 
Innovation 
Few agents in our study directly employed the term ‘innovation’ in their practice.  
James was one exception.  
James: A new territory is innovation and that involves new narrative, new dialogue 
and new strategic dialogues and a new discourse. So it’s who do we need to sit down 
and talk to rethink how we deliver this, and re-engineer it completely.  So start from 
scratch, say we’re no longer doing it like this anymore.   
He described innovation as the result of bringing different “troops” together to create a 
third troop. He was clear that innovation is transformative whereas improvement alone 
cannot deliver the necessary changes in the NHS. Grace and Erin were other 
exceptions. They both saw innovation more as a product that can be patented. For 
example, Grace, acknowledging that innovation “means lots of different things to lots 
of different people”, explained that it usually occurs when a clinical member of staff 
comes up with a novel process, technique or technology that requires Intellectual 
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Property.  When prompted if managers could come up with an innovation, Grace 
replied “Yeah, predominately clinicians because it’s probably much more around 
people at the coal face who can actually see I’ve got a problem with how I cut open this 
wound or whatever else”. She differentiated an Intellectual Property-based innovation 
from improvements achieved through process changes like improved flow. These she 
saw as not having the potential to generate income or efficiency savings in the same 
way as a new technique or technology.   
Similarly to Grace, innovation for Erin is grounded in Intellectual Property and new 
technology. Erin was at ease discussing the innovation process and “happy” that the 
NHS had “ramped its game up with innovation”. National attention on innovation had 
helped her to put an infrastructure in place and she believed that most Trusts were 
developing strategies in the area.  
Project-level factors 
Agents (Amy and Molly) mentioned a number of enabling factors at the project-level, 
including starting from the beginning of a project rather than halfway through, setting 
clear boundaries for deliverables, timing (for example engaging with junior doctors 
once they had had chance to settle in) and working on a tangible or visible change 
project.  Also, having a shared set of outcomes with other professional groups working 
on the project is referenced as an enabler to keeping all parties engaged or accountable. 
Some agents mentioned logistics as a barrier in terms of travelling across their 
geography on certain projects. 
Customising evidence 
Tailoring emerged as a common strategy across agents. We found KIT agents focused 
on understanding the local context and the knowledge needs of their clients or partners.  
Janice described how she interviewed her clients to understand the context around use 
of evidence: “where the people do use evidence and how they use it and when they use 
it, and why they use it and what’s important to them about it”. She stressed the 
importance of understanding the content from their point of view so that “when we’re 
taking it back to them then we have a much better understanding about how it could be 
useful to them”.  
Moorlands introduced evidence summaries as a tailored response to questions from 
their partners on topics not well evidenced in the academic literature. Daisy described a 
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similar approach to the evidence summary work and emphasised the importance of 
context and knowing what was needed: “I think it’s just about having an awareness and 
understanding what’s going on in each of those Trusts, what that person wants”. She 
explained that the role was not simply about producing the summaries but the “pre-
work” which involved having a conversation with the individuals requesting the 
evidence to find out what practices were currently used, whether they have the capacity 
to act on the evidence and what other things do they need to consider. 
Despite customisation efforts, Links could still be challenged by the volume of 
information. One of Janice’s Links mentioned that with 400 emails a day, and Holly’s 
Link mentioned looking for one-liners to peak their interest. For a summary of content-
related factors see Table 13.  
Table 13: Content-related factors: summary of enablers 
 Enablers 
Concepts and 
definitions 
Using meaningful language 
Avoiding academic language 
Understanding the local context 
Recognising that innovation will be interpreted differently 
Project-level  
Agent involvement from the beginning of a project 
Clearly defined deliverables and project scope 
Knowing when to initiate a project  
Project visibility 
Engagement with others 
Customisation Understanding local context, needs and barriers 
Conducting KIT Activities 
This section explores the factors that helped or inhibited the KIT agents in carrying out 
their role. It is noteworthy that more than half our sample of agents (n=7) were 
applying quality improvement methodologies, sometimes described as continuous 
improvement. This is in contrast to four who focused more on implementation of 
research knowledge and two on engagement. The importance of being able to engage 
others was a common observation across the agents. James commented, “most of this is 
about engagement”.  
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Engaging others 
Supporting and encouraging were key means by which the agents developed 
engagement.  
Fran: I feel like my relationship with everybody I’ve worked with has been much 
more of a support motivator, providing clarity, positivity, holding hands, a lot of 
holding hands with people, coaching them, encouraging them.  Sort of really saying, 
‘you’re doing well, you’re doing well’.  Saying to people, ‘you know the Board know 
you’re doing this and that’s really good’.  
Amy was described as visible, attending every meeting and visiting frontline teams to 
help progress the project. She acknowledged the challenges the team were facing in 
terms of low morale as a result of a vacant unit lead role. One of her Links reported 
how she brought doctors and nurses together in the morning. 
The importance of “going out to where people are” and making them feel valued was 
echoed by Janice.  She describes herself as “enthusiastic about every problem that’s put 
to me, because I think you have to be because… if you can’t be enthusiastic then you 
can’t expect anyone else to be”. The danger of having a charismatic individual leading 
the change is that they become the face of the improvement or innovation and their 
departure is a risk to the overall success of the initiative.   
Several agents reflected that although the tendency is to send emails or telephone, there 
is no substitute for face-to-face engagement. Isabelle mentioned scheduling quarterly 
visits to the Trusts in her region as one method to “keep up the contacts and 
relationships”. Amy described how building relationships was central to get clinicians 
to participate in training or capacity building. Another agent, Jessica, reflected that her 
efforts to meet with a project lead early on in the process contributed to them 
developing a productive relationship: 
Jessica: Even though it’s just like a two hour journey to it, I physically went and met 
the person.... I had to wait I think an-hour-and-a-half… until he actually turned up…  
Even though it basically wiped out the day, it was a valuable thing to do because... 
we have developed a relationship.  
Our Link interviewees highlighted how being responsive to requests helped KIT agents 
achieve positive engagement. Ignoring or not paying attention to requests made by 
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those involved in the change process inhibited success. One agent (James) described a 
situation where a professional group requested a paper to go to them prior to 
publication but this request was not granted. James reflected on the consequences: 
“This feels like a common theme, that we don’t pay enough attention to what other 
people want and deliver on it when we say we will and this leads to a lack of trust”.   
Engagement facilitated further engagement: agents described an approach which 
encouraged frontline staff to come up with ideas which they then take forward. Such 
ownership enabled them to “take it forward in a much more meaningful way” (Amy). 
Challenging 
Much in this section suggests that agents should be amenable, encouraging and 
responsive to requests (see Table 14 for a summary). 
Table 14: Conducting KIT activity: summary of enablers 
 Enablers 
Engaging 
others 
Supporting, encouraging, nurturing 
Enthusiasm 
Going out to where people are 
Face-to-face engagement 
Responsiveness 
Developing ownership 
Challenging Asking questions /being an irritant 
 
Such tactics seemed to facilitate engagement and from this position, practitioners could 
be encouraged to progress things themselves. However, there was also an argument for 
agents to adopt a more challenging stance, as some did (for example Sophie, James). 
James clearly articulated the tension between nurturing and challenging: 
James: What we’ve got to be careful of we just don’t become part of the same fabric 
as everybody else because the whole point of this is that we’re an irritant to the 
system. We shouldn’t be in bed with the system. We should be poking it. Asking it 
difficult questions, saying, ‘why are you still doing this?’  So there’s something 
around how you manage that tension, if that makes sense. 
106 
 
Revisiting our KIT Agent Typology 
Despite the variability in our sample we found that agents expressed similar accounts of 
the enablers (and barriers) operating at the micro (individual), meso (organisational) 
and macro (political and system) levels. We also noted similarities in expectations for 
the role amongst agents.  In addition, agents equally acknowledged and accepted the 
risk in taking on a KIT role compared to a traditional career path with known 
progression and recognition. Given our work in developing a typology for KIT agent 
roles, we were somewhat surprised by this degree of commonality, especially as our 
agents differed by: level of seniority, length of time in post, amount of their time 
dedicated to KIT work and also in terms of the focus of their approach (for example 
service improvement, innovation, knowledge mobilisation).  We found the frequency of 
linkage, engagement and knowledge management roles across all agents did not make it 
easy for us to apply the typology to differentiate our case study agents.  
These findings demonstrate that, although roles vary, the enabling factors that help us 
to understand how KIT agents achieve desired outcomes could be applicable across a 
range of settings and contexts. We explore the factors associated with outcomes and 
impact in more detail in Chapter 8. 
Concluding Remarks 
By looking across agents at the enablers operating at various levels, this chapter sheds 
light on the shared expectations of the role, how KIT agents might be supported and the 
influence of the organisation and wider political context on the role. Similar role 
expectations were held by agents and the Links and line-manager in terms of what 
agents do (i.e. linking, engagement and knowledge management), but defining the role 
emerged as a key enabler as did shared expectations between the agent and their line-
manager. Key means of role support included funding not only for the agent but also 
for their Links (for example frontline staff) to facilitate their time on the project, line-
manager and team support, having a physical home and having access and the means to 
use data for improvement. The organisational and political context were seen as 
challenging to agents. Agents were not only addressing local barriers such as the 
professional silos in their own organisations but also navigating regional or national 
policies that resulted in further organisational instability and reduced resources, 
ultimately threatening KIT roles. However, we found that organisations with Board-
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level support for knowledge mobilisation together with a culture of reflection (listening 
to the grassroots), openness to challenge and receptivity to research were enabling KIT 
agents to achieve desired outcomes.  
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Chapter 7. Assessing the Outcomes of Knowledge 
Brokering Activity 
Introduction 
The question that we explore in this chapter is how the outcomes of KIT agents’ 
activity might be assessed or measured. We do this in three ways. By working with a 
panel of experts (nominal group) we sought to identify a set of measures. We then 
turned again to our case study data to report how outcomes of our agents’ work were 
being identified, assessed or measured. Finally, we looked to the wider literature to 
inform our conclusions.   
Findings from the Nominal Group 
The nominal group process is described in Chapter 3. The question for the nominal 
group was posed as ‘how do we assess or measure the success of the work of 
knowledge brokers’?  However, other questions needed to be considered prior to this 
question to establish a context for the main discussion. In total, the five questions we 
discussed were: 
1. With whom should knowledge brokers connect? 
2. What outcomes should knowledge brokers try to achieve? 
3. What should knowledge brokers do to contribute to the achievement of outcomes? 
4. How can we measure the achievement of these outcomes? 
5. What data do we need? 
We report the results of the five questions that were discussed. 
Question 1. With whom should knowledge brokers connect? 
The first question was amended slightly from ‘who do knowledge brokers serve?’ The 
panel agreed that our focus should be on the ideal (‘should’) rather than what might 
happen in practice (‘do’) and ‘connecting with’ was thought to be a better reflection 
than the more subservient and limited term, ‘serve’. 
A large number of responses (n=30) was given to this question. Following discussion, 
items 24 and 30 were combined into item 17 prior to voting. The participants were 
given six voting cards (two 3-point cards; two 2-point cards; and two 1-point cards). 
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Thus if all eight panel members used all their cards, a total of 96 voting points would be 
assigned. The results of the voting are displayed in Table 15. Each response was 
assigned a number reflecting the order in which it was suggested. The table is ordered 
by the results of the first round of voting. The two items that were combined (29 and 
30) are marked with an oblique (/) and a dash (-) is recorded in the voting columns. In 
the first voting round, the item attracting most votes by some margin was ‘frontline 
clinicians’ (22 votes). The next highest number of votes was 8; five responses attracted 
7 or 8 votes in the first round of voting. Nine responses attracted no votes.   
The pattern of voting changed markedly between the voting rounds. Although ‘frontline 
clinicians’ still came out on top, the number of votes reduced from 22 to 13. Two items 
attracted the next highest number of votes, 11: service users and other knowledge 
brokers. In this second round of voting, two new items entered the top five: 
organisation and development change agents (9 votes) and researchers (8 votes). 
Table 15: Responses to ‘with whom should knowledge brokers connect?’ and voting results  
Q1 With whom should knowledge brokers connect? 
# Response Vote 1 Vote 2 
1 Frontline clinicians 22 13 
4 Service users 8 11 
19 Other knowledge brokers 8 11 
12 Policy makers 8 6 
18 Managers 7 7 
22 Everybody necessary 7 6 
10 Organisation and development change agents 6 9 
5 Researchers 6 8 
21 Improvement agents – Clinical Governance, Pt safety etc. 4 2 
26 The population 3 5 
7 Those who are/maybe at risk of knowledge deficit 3 2 
11 Carers 2 3 
29 Government and wider society 2 3 
15 Those with knowledge that others should be aware of or have 2 2 
2 Chief Execs/Leaders 2 0 
16 Research networks 2 0 
20 Potential future/next generation 2 0 
6 Information analysts 1 1 
14 National bodies 1 0 
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# Response Vote 1 Vote 2 
9 Students 0 0 
3 National expectations 0 3 
27 The media 0 1 
17 Sponsoring bodies (e.g. Health Foundation, NISCHR) funders, commissioners 0 0 
13 Educators 0 0 
8 Industry 0 0 
23 Knowledge brokers themselves 0 0 
25 Communications team/social media 0 0 
28 IT/Tech support/Web developer 0 0 
24 Funders of knowledge brokers - - 
30 Commissioners of knowledge broker activity - - 
 
Total 96 93 
We note that one panel member chose to not use 3 votes (hence vote 2 totals 93). 
In summary, on the basis of two rounds of voting, the panel thought that knowledge 
brokers should connect with: 
•  frontline clinicians 
•  service users 
•  other knowledge brokers 
•  organisation and development change agents 
•  researchers 
•  managers 
•  policy makers 
•  everybody necessary 
Question 2. What outcomes should knowledge brokers try to achieve? 
The second question was amended slightly, to keep the focus on the ideal (‘should’). 
Forty responses to this question were provided. Item 33 was discussed and deleted prior 
to voting as it was a duplicate of item 11. The results of the voting are displayed in 
Table 16. Between the voting rounds there was some consolidation of voting: although 
there was no change to the top two ranked items, the votes were spread between fewer 
items (24 on the first vote; 15 on the second). In the first voting round, the two items 
attracting most votes by some margin were ‘safe, effective and efficient treatment and 
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services’ (17 votes) and ‘better quality of life for population’ (16 votes). No other item 
attracted more than seven votes.  
In the second round of voting, these two items pooled 19 and 16 votes respectively and 
were joined by ‘build capacity and capability (around knowledge mobilisation, use of 
knowledge)’ (16 votes). Four items were awarded six to eight votes (‘informed decision 
making/policy making’; ‘adoption, spread, scaling up at pace’; ‘evidence of 
improvement’). No other item attracted more than three votes. 
Table 16: Responses to ‘outcomes knowledge brokers should try to achieve?’ and voting results  
Q2 What outcomes should knowledge brokers try to achieve 
# Response Vote 1 Vote 2 
6 Safe, effective and efficient treatment and services 17 19 
1 Better quality of life for population 16 16 
18 Service improvement 7 3 
7 Build capacity and capability (in knowledge mobilisation, use of knowledge) 6 16 
31 Increase research use and impact 6 6 
36 Evidence of improvement 5 7 
3 Informed decision making/policy making 4 8 
22 Adoption, spread, scaling up at pace 4 7 
35 Stronger economy 3 3 
20 Avoiding duplication (between knowledge brokers) 3 2 
12 Diversify the ownership of knowledge 3 0 
16 Creating a culture supportive of change 2 2 
24 Continued investment in knowledge creation, research 2 2 
28 Organisational culture change 2 2 
10 Behavioural change (individual) 2 1 
8 Exploring and reflecting population need 2 0 
17 Satisfied staff 2 0 
25 Professional development for knowledge broker 2 0 
26 Empowering critical engagement with evidence 2 0 
29 Organisation learning, resilience 2 0 
11 Best value, value for money 1 2 
5 Empowerment 1 0 
9 Organisational advantage 1 0 
19 Communicating the limits of knowledge – risk, uncertainty 1 0 
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# Response Vote 1 Vote 2 
13 Horizon scanning 0 0 
14 Prioritisation 0 0 
15 Acknowledgement that knowledge mobilisation is integral 0 0 
2 Increased knowledge 0 0 
4 Challenging perspectives to achieve mutual comprehension 0 0 
21 Knowledge of implementation science/best way to mobilise knowledge 0 0 
23 Embedding routinely sharing of info 0 0 
27 Making connections with reality “What we do” 0 0 
30 Kudos and social capital 0 0 
32 Challenging knowledge hierarchies 0 0 
34 Identify knowledge mobilisation champions 0 0 
37 Enabling utilisation of different sorts of knowledge 0 0 
38 Up, down, across, inter-professional: the acceptance of knowledge broker as norm 0 0 
39 Involvement of people who need to be involved 0 0 
40 Focused attention/space 0 0 
33 Value for money - - 
 
Total 96 96 
In summary, on the basis of two rounds of voting, the panel thought that knowledge 
brokers should try to achieve: 
•  Safe, efficient, effective treatment and services 
•  Better quality of life for population 
•  Build capacity and capability (around use of knowledge, knowledge mobilisation) 
•  Informed decision-making/policy-making 
•  Adoption, spread, scaling up at pace 
•  Evidence of improvement  
•  Increase research use and impact 
Question 3. What should knowledge brokers do to contribute to the 
achievement of outcomes? 
The third question was amended (from ‘what do knowledge brokers do to achieve these 
outcomes?’) to keep the focus on the ideal (‘should’) and ‘contribute’ was added, to 
recognise that knowledge brokers might be only a part of a process. 
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This question elicited 42 responses. On discussion, items 10, 13, 15, 20 and 21 were 
identified as personal skills or attributes and so seen as part of item 1 (‘personal skills 
and credibility to make connections -interpersonal, being present and known’). In 
addition, overlap between items 28 and 38 was noted. These were combined but on 
further discussion added to item 5 (‘motivating others to use knowledge’) prior to 
voting.  The leadership part was added to item 12.  
The results of the voting are displayed in Table 17. Items which had amendments or 
additions are marked with a star (*). In the first voting round, the item attracting most 
votes by some margin was ‘personal skills and credibility to make connections 
(interpersonal), being present and known’ (22 votes). The next highest number of votes 
was for item 12 (‘teach, train, support, mentor, counsel, lead’). It is perhaps not 
surprising that these attracted most votes as they each included a number of elements.  
In the second round, a further two items attracted notable numbers of votes: item 5 
(‘motivating others to use knowledge’; 17 votes) and item 3 (‘facilitate access to 
knowledge, evidence, information’; 12 votes). No other item attracted more than six 
votes. We note that not all panel members chose to use all their votes in the first round 
(hence vote 1 totals 88). 
Table 17: Responses to ‘unique things knowledge brokers should do to contribute to these 
outcomes?’ and voting results  
Q3 What are the unique things that knowledge brokers should do to contribute to the 
achievement of these outcomes? 
# Response Vote 1 Vote 2 
1* Personal skills and credibility to make connections (interpersonal), being present and known 22 23 
12* Teach, train, support, mentor, counsel, lead 13 17 
5* Motivate others to use knowledge 9 17 
3 Facilitate access to knowledge, evidence, info (inc. published, tacit) 6 12 
4 Engage and involve people 5 3 
34 Think and work in systems 5 2 
24 Be clear about scope – target what matters 4 6 
37 Be ready to step outside the box and give an alternative perspective 3 4 
11 Present knowledge in easily accessible formats at point of need 3 3 
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# Response Vote 1 Vote 2 
27 Collaborate 3 1 
16 Use a range of communication methods to reach different groups 3 1 
26 Organise and make sense of knowledge 3 0 
36 Engage with the policy community 2 1 
7 Mobilising networks to influence desired change 2 0 
9 Know the key drivers for health improvement 1 4 
17 Know your influencers, champions, potential blockers, early 
adopters 1 0 
31 Have access to sources of knowledge 1 0 
33 Practice what they preach, be the role model 1 0 
40 Narrate, showcase others’ experience 1 0 
15 Act as translators between different groups and organisations 0 1 
35 Invest time-to build trusted relationships for giving/receiving info 0 1 
6 Highlight relevance in research evidence, research synthesis 0 0 
8 Facilitate or run experiential training events 0 0 
14 Organise cross professional information sharing events 0 0 
18 Be willing to ask stupid questions 0 0 
19 Save time for frontline staff 0 0 
22 Be knowledgeable about measurement and evaluation 0 0 
23 Celebrate success 0 0 
25 Scrutinise all perspectives equally 0 0 
29 Horizon scan, trouble shoot and plan, plan, plan 0 0 
30 Demand the inclusion of knowledge mobilisation in 
organisational policy statements 0 0 
32 Take people with you when brokering relationships 0 0 
40 Advise individuals and teams 0 0 
41 Facilitate dialogues 0 0 
42 Identify resources 0 0 
10 Listen well - - 
13 Persist - - 
15 Positivity and a ‘can-do’ attitude - - 
20 Be flexible and adaptable - - 
21 Respect your client - - 
28 If appropriate, lead - - 
39 To make what you do a priority for others - - 
 
Total 88 96 
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In summary, on the basis of two rounds of voting, the panel thought that to contribute 
to the achievement of outcomes, knowledge brokers should: 
•  use their personal skills and credibility to make connections 
•  motivate and influence others  
•  teach, train, support, mentor, lead 
•  facilitate access to knowledge, evidence 
Questions 4&5. How can we measure (by proxy) the achievement of 
outcomes? 
The panel decided to take the fourth and fifth questions together as they felt that 
discussion of ‘how to measure’ could not be separated from ‘what data’. Before 
suggesting responses, the panel commented on it being a highly complex question and 
that direct measures would be difficult to identify. They decided to allow for the 
inclusion of ‘proxy’ measures.  
There was extensive discussion around the need to focus on one specific outcome when 
suggesting responses to this question. As a consequence, measures were suggested just 
for the most important item from question 2 (‘what outcomes knowledge brokers 
should try to achieve?’): thus the suggestions and subsequent voting was in relation to 
how we can measure the achievement of ‘safe, efficient, effective treatment and 
services’. In principle the group could have repeated the exercise for the other main 
outcomes for question 2 (i.e. ‘better quality of life for population’, ‘build capacity and 
capability (around use of knowledge, knowledge mobilisation)’, ‘informed decision-
making/policy-making’, ‘adoption, spread, scaling up at pace’, ‘evidence of 
improvement’, ‘increase research use and impact’). This was not feasible in the time 
available. The important generic point of note was the need to relate the measure to 
specific intended outcomes. 
Twenty-eight responses were given to ‘how can we measure the achievement of safe, 
efficient, effective treatment and services’. On discussion, ‘of knowledge broker 
services’ was added to item 17 to clarify that these self-reported outcomes from ‘users’ 
were in reference specifically to the services provided by knowledge brokers. The 
results of the voting are displayed in Table 18. Three items pooled between 13-15 votes 
each. Four other items attracted between six and 8 votes. 
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Table 18: Responses to ‘how can we proxy measure the achievement of outcomes?’ and voting results  
Q4 How can we measure (by proxy) the achievement of outcomes? 
# Response for: Safe, efficient, effective treatment & services Vote 1 
2 Mortality rates 15 
1 Patient reported outcome measures (PROMs) 13 
9 Reduction in reportable adverse events  13 
5 Baseline measures and plan-do-study-act (PDSA) cycles 8 
19 Decrease in unwarranted variation  7 
21 Achievement of targets 6 
22 Case studies of change 6 
3 Continued investment in research and evaluation 4 
8 More evidence-based policies emerging 4 
25 Cost effectiveness (benefit?) comparison between knowledge broker and 
other improvement investments   4 
4 Evidence of new working collaborations  3 
23 Increased patient satisfaction in their interactions with clinicians 3 
11 Continued investment in knowledge broker roles in organisations  3 
27 Number training sessions, contacts  2 
10 Increased knowledge about knowledge mobilisation (capability, capacity) 1 
14 Job description & CVs 1 
16 PPI involvement in training and evidence use 1 
17* Self-reported outcomes from ‘users’ of knowledge broker services 1 
18 Increased awareness of research 1 
6 Reach of knowledge broker within an organisation and within priority areas 0 
7 Requests for knowledge broker input 0 
12 Training awards gained, publications 0 
15 Improved pace of change 0 
24 Acquisition of new knowledge or new connection 0 
13 Knowledge Mobilisation in: Continuing Professional Development, 
revalidation, role profiles 0 
26 Requests for knowledge summaries 0 
20 Funding bids won 0 
28 Contribution analysis of knowledge broker (formative evaluation) 0 
 
Total 96 
 
Considerable discussion followed the first round of voting and the group decided 
against a second round.  Points of discussion included the following: 
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•  The challenge of causality: the work of knowledge brokers may only be indirectly 
related to impacts; for example, it is not possible to attribute causal links between 
their work and mortality rates. An attempt to relate their activity to impacts 
encounters too many confounding intervening variables making causal 
relationships untenable. Here we note that more discussion of the difference 
between more immediate ‘outcomes’ and wider ‘impacts’ might have re-focused 
attention away from measures related to patient or population groups. 
•  The value of case studies: in the context of indirect relationships between impacts 
and knowledge brokering activity, the panel highlighted the value of case studies. 
•  The need to link specific goals to outcomes: again the panel emphasised the need 
for measures to be specific to intended outcomes. They rejected the idea of generic 
measures. 
•  Who determines the knowledge broker role? Leading on from discussion of the 
need for measures to be specific to intended outcomes, the panel discussed how the 
work of knowledge brokers varies and is determined by whoever decides on the 
role specification.  
•  Context and complexity: the complexity and relevance of context in determining 
the success or otherwise of knowledge brokering activity was raised: what works in 
one context might not in another. 
•  The unmeasurable – e.g. influence: the panel recognised that an inherent risk in 
presenting responses to this question was that attention would necessarily focus on 
what might be ‘measureable’ which would ignore important ‘unmeasureables’. 
This was an important discussion and resonated with findings from the case studies. 
Insights from the Case Studies 
To add further to our understanding of this assessment challenge, in this section we 
draw in relevant data from our case study KIT agents. Simply put, very few, formal 
assessment measures were used by agents or their managers. None had formally 
developed metrics for the role. Agents referenced outputs, such as completing a 
strategy document or drafting implementation plans or completing a literature 
summary. Daisy, for example, described the creation of a community or network of 
champions as another deliverable. When asked how she judged success, Daisy reflected 
that it is difficult: “That’s a really, really interesting question because I’m really not 
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sure”. In a similar fashion, James admitted that he “still [didn’t] know the answer to 
that question because I think there’s lots of dimensions to it”. He elaborated and added 
that in his opinion even the Executives did not know what outcomes they expected 
from him and the team. Another agent, Grace, was quite vague and suggested that 
positive changes could be expected from having a consistent approach. Janice 
explained that she was going to ask the clinical community and the service user 
community what they value but she had yet to do that.  
Despite an evident lack of clarity, we distilled a number of categories of measures 
which we group according to Kirkpatrick’s evaluation levels: learning, behaviour and 
results. 
Learning 
Link interviewees highlighted the importance of the agent’s role in achieving increased 
capacity. This was sometimes spoken of in general terms and sometimes more 
specifically related to improvement methodologies. For example, one of the 
interviewees linked to Fran referred to the “growth” she created in others. One of 
James’s Links described what he saw as the low skill-set in quality improvement 
methodology which “is ill-understood in the frontline and very rarely utilised”. In his 
view, the number of people or projects using QI methodology was a good metric. An 
agent at Moorlands described how she planned to track downloads of their evidence 
reviews to understand spread of the product and seek qualitative data on how they were 
being used. 
Behaviour 
A number of agents watched for signs of cultural change within the organisation as a 
result of their role. They looked for changes in behaviours – people doing things 
differently. Chloe, for example, saw her success in terms of “evidence of people 
incorporating evidence and to put it into practice”.  More rarely agents mentioned 
specific behavioural change measures: 
Amy: I’m looking for how well we’re doing at sepsis to get that looking better.  That 
was our aim. That’s why I was brought in.  
Implicit in Amy’s example is the importance of relating the measures to the intended 
outcomes. Erin provides another example of measures linked to intentions: 
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Erin: We’ve already attracted £600,000 worth of European monies…. So I think 
really I’m probably the one individual… that is responsible for business 
development and bringing in, attracting in other contracts.  
According to one of Isabelle’s Links, she saw that as the KIT role related to 
“influencing organisational strategy… influencing training and development,” it should 
be measured by “how people change their behaviour or change what they’re doing as a 
result of interacting with her role”. Isabelle herself admitted to “struggling” with 
measurement and drew attention to some of the easier to measure things such as “the 
number of people that are reaching out or the number of interactions that are going on”. 
Chloe saw her role as engagement and judged it appropriate to look at “the number of 
collaborative projects… between the university and the community”. Sophie also 
approached the question from an engagement perspective and referred to things that 
could be easily measured: “number of people willing to work with them”, “being 
invited to chair regional groups and lead on external reviews”. In a similar vein, Amy 
counted relationship building as a measure of success: “when I walk into the A&E 
department people say, ‘hi Amy’, that they know who I am.  They say hello to me”. Of 
course these do not report anything about how such interactions change what people 
then do, a gap that was identified in the nominal group and by participants in Mansfield 
and Grunewald’s223 workshop (discussed below).   
Some agents spoke in terms of changed norms or ways of thinking: 
Sophie: The level of conversation that now starts with... ‘what about these patients, 
they’re delayed. How can we work together to change that part of it?’  It’s no longer 
the muddle. There’s still loads to do. This is probably one year of about a five year 
change process, but it’s... people are engaging all the time now.   
Janice: I was hoping to make… people kind of feel that research is not an ivory 
tower, people who are only in that for the paper, but there is a role for people to 
work together.  
Results  
At this level, measures would relate to improvements in organisational performance. 
These were rarely identified although Sophie described outcome measures at this level:  
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Sophie: I think the outcomes that have come out of this piece of work have been 
enormous and far reaching to the point of organisational reputation as well.  So, you 
know, I can pull up umpteen graphs around our four-hour, eight-hour, twelve-hour, 
for months. I can look at the 15-minute handover. I can look at how many 
operations. So there’s those outcome measures but actually the fact that the whole 
organisation feels different. The fact that we are viewed very differently by… 
Government because we’re delivering on what we said we’d deliver on.  
Of course the risk associated with narrowly equating the impact of the KIT agents’ 
work with ‘results’ is that it underplays their contributions, and as we have argued, 
learning and behaviour are also forms of impact.  
We summarise these KIT agents’ suggestions in Table 19.  
Table 19: Assessing knowledge mobilisation activity: suggestions identified by KIT Agents 
Kirkpatrick level Outcome or impact 
Learning Increased capacity (general or specific) 
Behaviour 
Cultural change/doing things differently 
Increased engagement or interaction 
Changed norms or ways of thinking 
Results 
Improved systems  
Improved organisational reputation 
Insights from the Wider Literature 
To check out the wider applicability of our findings, we turned to the literature to 
explore publications directly related to some of the questions discussed in the nominal 
group and explored in the case study data. 
NHS Education for Scotland (NES) has developed a “capability framework” for their 
knowledge broker network.224 This sets out the knowledge, skills, values and 
behaviours needed to “create a coordinated knowledge broker network… to support 
practitioners to apply knowledge in frontline practice, and to embed knowledge in 
healthcare improvement”.224 The framework comprises five capability statements and 
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31 learning outcomes sub-divided into 81 (of which 25 are deemed core). The five 
capability statements relate to the knowledge broker network: building capacity and 
capability for using knowledge; coordinating and connecting; identify knowledge needs 
and presenting knowledge; delivering and creating knowledge and embedding 
knowledge in healthcare systems so that application of knowledge becomes routine; 
and exchanging and disseminating knowledge. There is notable overlap between the 
capabilities in the framework and the response of the nominal group to question 3 (what 
knowledge brokers should do). The responses attracting the most votes related to 
making connections, motivating and influencing, training and developing others and 
facilitating access of knowledge. These activities also closely resonate with our case 
study findings. 
The Public Health Agency of Canada225 produced a ‘Knowledge Translation Planning 
Primer’. This is largely a ‘how to’ document but it includes an appendix which sets out 
potential indicators for monitoring and evaluating the impact of knowledge products 
and services. Indicators of reach include recording number of copies distributed or 
downloads and referrals (for example web posts). Indicators of usefulness include user 
satisfaction data and product or service quality data (such as awards). The document 
includes a list of indicators that measure use – such as number of users using an 
information product to improve practice – but nothing is said about what data could be 
used for this indicator or how it might be collected. Similarly, suggestions of indicators 
that might measure collaboration and capacity building are suggested – such as number 
of instances of sharing knowledge at local, national or global level – but again, no detail 
is given about what data might be collected or how. 
Mansfield and Grunewald223 report on the use of indicators for the monitoring and 
evaluation of knowledge management and knowledge brokering in international 
development. This report summarises the outcomes of a workshop event focused on the 
challenge of measuring the impact of knowledge brokering activity. In common with 
the outcomes from our nominal group and findings from the case studies, Mansfield 
and Grunewald223 report that measuring the impact of knowledge brokering work and 
“proving that this work had led to changes in knowledge attitudes, policy, practice and 
action” faces “multiple challenges”.  To trigger discussion at the workshop, participants 
were presented with a 100 potential indicators. Most of these related to things that 
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could be counted (e.g. number of user enquiries, number of knowledge products created 
and so forth) or percentages of staff who agreed or strongly agreed with various 
statements (e.g. ‘I feel encouraged to share my knowledge with colleagues’, ‘I am able 
to find the knowledge I need quickly and easily’). Other suggested indicators related to 
knowledge activities or success cases (e.g. number of staff able to provide an example 
of how knowledge activities have contributed to organisational performance, number of 
staff who believe their organisation is a learning organisation). Further indicators were 
grouped under headings such as: policy and strategy (e.g. is there a knowledge 
brokering strategy?); human resources, training and development (e.g. percentage of 
staff inductions which make staff aware of knowledge brokering policy and processes); 
or finance/resource costs (e.g. number of examples of ‘where the organisation re-
invented the wheel’). 
Members of the workshop discussed the challenges of measuring impact. In accord 
with our findings, one participant commented “while it is easy to measure activities, 
e.g. number of enquiries received/answered/followed up, it is extremely challenging to 
bridge the gap between how many people you reach with an activity and the impact that 
has had” adding that “it is unfeasible to verify what people have said they will do”. 
Amongst their conclusions, Mansfield and Grunewald223 emphasise the importance of 
context, arguing that indicators should be tailored to context.  
The project entitled ‘supporting policy in health with research: an intervention trial 
(SPIRIT)’226 hypothesises that an organisation’s response to something that catalyses 
knowledge use is shaped by its capacity to engage with research, and that research 
enrichment actions can support research use. The SPIRIT team propose a number of 
tools can be used to measure these three elements: capacity, research engagement 
actions and research use. They suggest an individual policy maker’s capacity, research 
engagement actions and research use can be assessed using an online survey tool called 
‘SEER’ (seeking, engaging with and evaluating). For assessing capacity at the level of 
organisation policy level, they recommend ‘ORACLe’ (organisational research access, 
culture and leadership) which collects data from interviews and documentation. Finally, 
‘SAGE’ (self-assessment of engagement with evidence) is a tool they suggest can be 
used to measure research engagement actions and research use evidenced in policy 
documents. SAGE uses interview and documentation. They argue that “together these 
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tools provide detailed measures of each concept in the SPIRIT Action Framework and 
generate data to test the hypothesised relationships”. However, the reliability and 
validity of these tools has yet to be confirmed. 
Tools have been produced by other organisations. For example, Research in Practice 
for Adults offers an organisational audit for evidence-informed practice which supports 
a process of bench-marking and action planning.227 The CIROP Measure228 is a 
questionnaire tool designed to collect data from community members on the impact of 
research partnerships. The Canadian Foundation for Healthcare Improvement has 
produced a self-assessment tool which asks ‘is research working for you?’.229 This is 
another survey instrument comprising a set of statements which respondents rate on a 
five-point scale from strongly agree to strongly disagree. Dwan et al.132 developed a 
self-report Likert-scale evaluation tool containing six statements addressing three 
domains: effectiveness (in broadening knowledge and stimulating thinking; relevance 
(usability); and research receptivity (use in the past and next 12 months). 
Although there are a number of tools in existence, measuring knowledge use and 
determining what approaches work is in its infancy.91 Our study has usefully teased out 
some of the complexity of measuring the impact of knowledge brokering activity and 
underscored the need for measures to relate to specific activity. Our findings serve to 
consolidate prior work and lend weight to the call for more research and development 
in this area. 
An Approach to Measuring Outcomes of Knowledge Broker Activity 
In lieu of proposing a set of generic measures, we identify a set of principles to guide 
more specific measures of knowledge broker impact and then build on the work of 
Morton(230) to suggest a framework for measuring outcomes of knowledge broker 
activity. 
Principles • Distinguish between measuring what agents do and the effect of their actions on 
the behaviour of others. • Relate the measures to role specification and specific intended outcomes (rather 
than more distant population health improvements). • Do not try to claim causality: the work of knowledge brokers will be indirectly 
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related to outcomes and confounded by other factors. • Take account of context: the success of knowledge broker activity will be 
facilitated and inhibited by local internal and wider external factors. • Tailor measures to specific circumstances. • Do not ignore the un-measurable (e.g. a knowledge broker’s influence). 
 
Framework 
Drawing on experience of case study preparation for the Research Excellence 
Framework 2014,(160) Morton(230) developed a framework designed to explain and 
evidence how research contributes to policy and practice. Based on logic modelling, the 
framework sets out a pathway from inputs and activities to change in practice and 
finally outcomes.  
Morton(230) acknowledges that the process of research utilisation is complex and that 
assessing research impact is challenging. In recognising the “context-specific and 
variable nature of impact” she endorses the value of a case study approach. In addition 
to context challenges, she describes attribution as a key difficulty in the assessment of 
research impact: the results of research are integrated into practitioners’ existing beliefs 
and practices and moulded to particular circumstances which makes it problematic to 
attribute outcomes to research in a causal fashion. Thus her framework is based on the 
principle of research contribution.  
Although Morton’s Research Contribution Framework is intended to be used to assess 
research impact whereas our focus is on the impact of knowledge brokers (which may 
be one factor in a research impact pathway), there is considerable value in considering 
the framework, and adapting it in the light of our research, to devise an approach to 
measuring outcomes from knowledge broker activity. We decided to use Morton’s(230) 
framework to inform our own because it accords well with our proposed principles. 
Also, we note similarities with Kirkpatrick’s(199) model of programme evaluation. 
We set out our framework Table 20. It is organised around five areas of contribution: 
inputs, activities, capacity development, behaviour and outcomes. In the second column 
we add a brief description about what each area concerns and in the subsequent three 
columns we provide example indicators, evidence and likely barriers and enablers to 
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the achievement of desired outcomes. 
Concluding Remarks 
This chapter directly addresses research objective 5 which was concerned with 
generating a set of ‘impact’ measures for assessing KIT activities. By working with our 
nominal group and informed by the literature we sought to propose a set of measures 
for use in assessing the outcomes of knowledge mobilisation activity and explore their 
feasibility as part of our analysis of case studies. In our study proposal we described 
this goal as measuring impact. However, ‘impact’ is a problematic and somewhat 
limiting term if narrowly interpreted as effects on target populations (such as better 
health for patient groups). This unhelpfully diverts attention away from consideration 
of the more direct outcomes of KIT agents’ knowledge brokering activity. We have 
also suggested that reactions, learning and behaviour within the Kirkpatrick model can 
each be understood as a form of impact. Having said this, it is, nonetheless, easy to 
present a rationale for considering the questions we posed for the nominal group: it may 
help to determine what we might expect or hope for from knowledge brokers; it may 
help to identify how their work might be linked to organisational goals; having 
measures to demonstrate their value can help in the development of cases for further 
investment; it may assist in the identification of factors that help or hinder the 
achievement of outcomes.  However, the nominal group raised critical and challenging 
questions and we recognise that the exercise alone could not provide definitive answers. 
What it did achieve was progress towards answers and we do not underestimate the 
value of clarifying the task through the identification of precursor questions and the 
discussion of issues related to causality, linking outcomes to intentions, the risk of 
overlooking the un-measurable and the relevance of context.  
126 
 
Table 20: Measuring outcomes of knowledge broker activity: a framework informed by Morton’s Research Contribution Framework 
Contribution Description Example Indicators Example sources of evidence Known barriers and enablers 
Inputs 
Human, financial, technical 
resources invested in 
knowledge brokerage 
Aims and intentions of the 
knowledge broker role 
Knowledge broker time, funding 
available 
 
Accounts 
Job description 
Individual disposition, 
background of knowledge broker 
Context factors: Internal 
organisation support 
Activities What knowledge brokers do and with whom 
Meetings 
Collaborators and connections 
Presentations: seminars, conferences 
Research briefings 
Training 
Attendance records (and those not 
reached); 
User feedback / post-event 
evaluations (reactions) 
Observations 
Participant reflections 
Content factors: nature and 
relevance of change 
Process factors: networks and 
relationships 
Context factors: Internal 
organisation support; 
organisational readiness 
Capacity 
development 
Development of 
practitioner and policy 
makers’ knowledge and 
skills 
Engagement with mentoring, 
training events and materials 
Measures of learning gains 
Participant feedback 
Participant commitment to change 
Content factors: nature and 
relevance of change 
Process factors: networks and 
relationships 
Context factors: Internal 
organisation support; 
organisational readiness 
Behaviour 
Changes to policy, 
practices (e.g. adoption and 
spread of named processes 
or products) 
New practices, policy 
Audit and Improvement projects 
Scores from self-assessment tools 
Citation in policy /strategy 
documents 
Case studies 
Content factors: nature and 
relevance of change 
Context factors: Internal 
organisation support; 
organisational readiness 
Outcomes Better treatment or service Less unwarranted variation Achievement of targets 
Policy and contextual analysis 
National or local indicators 
Investment 
External factors: e.g. 
government policy, national 
programmes 
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These messages have been corroborated by others as we demonstrated in our discussion 
of relevant literature and our integration of findings from the case studies underscored 
the importance of relating the measures to intended outcomes. It also highlighted that 
very few, formal assessment measures were employed by agents or their managers and 
a lack of distinction in practice between measuring what agents do and the effect of 
their actions on the behaviour of others. 
What the nominal group suggested about the place of case studies might prove to be 
particularly valuable and is worthy of future investment.  In the longer term, any 
measures would need to be validated; a significant amount of context-sensitive 
qualitative case study work would seem to be a necessary step in that process. This 
would provide data on what kinds of goals are agreed locally and reflections on the 
achievement of outcomes.  
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Chapter 8. A Discussion of the Findings from a Social 
Marketing Perspective 
Illuminating how KIT agents bring positive outcomes and impacts to healthcare 
practice would allow future activities to be planned accordingly which would help to 
maximise their benefit. This section of the discussion, therefore, uses a social marketing 
framework to draw together key features within a ‘reusable’ single analytical 
framework which can be employed in planning and evaluating future KIT agent 
activities. 
What is Social Marketing Theory? 
Social marketing attempts to apply techniques from commercial marketing to social 
outcomes.231 It seeks to learn from commercial marketers’ success in changing 
behaviour, and is an increasingly important aspect of the public health agenda in 
England and elsewhere. It has been applied with some success to health promotion and 
has been proposed as an effective technique to promote behaviour change in 
practitioners.204 Although social marketing borrows heavily from commercial 
marketing, it faces a number of additional challenges which commercial marketing 
typically does not. Most relevant here is that social marketing frequently promotes an 
outcome that is uncertain and intangible, and where the benefits often accrue to third 
parties. 
Social marketing theory is formed of a number of overlapping principles (see figure 1). 
Broadly these principles are: • Know your client and their needs (customer insight) • Know the competition (including context) – what do people do now, why, 
what/who stops them doing something else? • Understand the importance of exchange – what do they want in exchange for a 
change in behaviour? • Segment and target – are there different groups within the market who require a 
different approach? Should they be approached differently? • Use the 4Ps of marketing to design interventions: 
o Product – how does what you do satisfy a need? This includes issues such as 
function, features, quality, variety, brand, credibility, wraparound services. 
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o Price  - most likely reducing costs in this context 
o Place – how people can access the service – channels, locations, logistics. 
o Promotion – how the service is promoted, personal selling, peer-to-peer, social 
media etc.232 
o And, Policy (an extra, “fifth P”) – how laws (smoking bans), fiscal 
arrangements (tax on tobacco and alcohol) and other levers (drug treatment 
services in prisons) available to governments can be used to encourage 
behaviour change. 
Figure 1: Principles of social marketing theory 
 
This approach begins with generating “insights” into actors’ current practices, beliefs, 
and preferences which influence their choices which can then be used to develop more 
effective interventions. It is focused on understanding why people (for example NHS 
managers) do what they do now (in relation to innovation and knowledge) and what 
“competition” the new behaviour faces (which can be informed by barriers identified in 
the literature). Social marketing theory recognises that this may vary by subgroups and 
may require different kinds of support (“segmentation and targeting”).  These insights 
can be used for “creating attractive exchanges” which can encourage the effective 
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uptake of the new behaviour. In commercial marketing the offer is characterised by 
what is called a “mix” - product, price, place, and promotion. Social marketing theory 
differs from commercial marketing in that it also takes account of the environment in 
which the actors operate and adds a fifth component to the “mix”, which is policy.   
In this discussion, social marketing theory is used as an organising framework for 
linking outcomes and impact with processes, treating the KIT agent as the product or 
service. If the a priori categories are found to be relevant in the context of KIT agents, 
they may also be used to develop future programmes. 
Applying Social Marketing Theory to KIT Agents 
The earlier discussion (in Chapter 6) has demonstrated the importance of KIT agents 
developing insight. Whilst none of them expressed it this way, they all referred to a set 
of behaviours designed to understand their client. Listening was mentioned by KIT 
agents as part of the role, and Links saw this as a strength and something to look for in 
future KIT agents. Other studies of these roles have emphasised the importance of “soft 
skills” such as listening and empathy.178, 233 Implicit here is that listening leads to 
something else: understanding. The extended period of interactions, working alongside 
practitioners within their organisations or projects, hearing of or experiencing 
organisational difficulties or individual and organisation aspirations, providing 
opportunity for practitioners to discuss issues and options in a “safe” environment 
(“giving permission” to staff to step away from service provision to think more 
strategically), understanding what motivates the client, are all relevant to developing 
insight. 
The KIT agents discussed insights entirely in the context of adapting their offer to the 
specifics of the client. This is discussed in more detail below. Broadly, the sort of 
insight highlighted issues around how to talk about knowledge and innovation transfer 
(that is, not using the terminology), how organisational features influenced clients (for 
example, poor communication or coordination between levels within the organisation), 
attitudes towards home-grown or imported interventions, lack of time, issues around 
access to information, individual motivators and opportunities for change.  
Social marketing focuses on behaviour change. Some argue that it is only behaviour 
change that counts, and factors such as changes in attitude or knowledge do not. Most 
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of the KIT agents were seeking behaviour change at some level but this did not always 
result in a measurable patient care outcome. Changes in knowledge and attitude are 
perhaps essential precursors to behaviour change, itself a potential precursor to 
improved outcomes. Within the time-limits of the KIT support it is perhaps too much to 
expect consistent changes in behaviour, not least because achieving outcomes is likely 
to require some experimentation and adaptation for practice. The focus on behaviour 
change for improved outcomes is useful to keep however. It has a number of benefits: 
one, it provides motivation to participants; two, it encourages an explicit articulation of 
how the pieces fit together and what needs to happen to exploit the potential; and three, 
it provides intermediate measures on which to base feedback. 
In order to articulate how the pieces fit together, and to develop an appropriate “offer”, 
it is necessary to understand the competition. This is a major purpose of gathering 
insight. Competition refers to anything that competes for an individual's attention, 
willingness and ability to change and therefore prevents new behaviour. It assumes that 
doing things differently comes at a cost – otherwise we would be doing it anyway. 
Impediments to change include habit, inertia, lack of awareness and/or belief in 
alternatives. Competition can be multi-faceted and subject to external control. For 
instance, I might learn about QI methodology, but I (or my boss) might lack the faith in 
its ability to help patients. 
Whilst never called “competition” by the KIT agents, identifying and addressing 
competition was a major preoccupation of all the KIT agents. (What enabled, or 
inhibited, the impact of their work on Links’ ability to change their behaviour is 
covered in detail in Chapter 6). Between them, the KIT agents identified the following 
competition: lack of relevance of research and lack of access to research; pressures 
which limited the time available to acquire knowledge of new approaches, let alone 
implement them; lack of specific skills (for example QI methodology, evaluation); lack 
of knowledge (for example knowing the market, potential solutions, helpful people or 
networks); lack of confidence to make changes; politics and territorialism; lack of 
alignment between different organisations within the area and between national and 
local progammes; reported lack of leadership support and guidance; lack of willingness 
to share practice and experience; and the sheer size of the task being undertaken 
coupled with the need to keep up with the job in hand. 
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Many of these factors are familiar issues in knowledge mobilisation literature. 
However, the experience reported in this study differs in a number of ways that are 
helpful in moving forwards. Chief among them is the KIT agents identifying what 
mattered to their clients (insight) and being empowered to devise a means of working 
with them that responded to those specifics and not theoretical or generalised others.   
Whilst general lists provide useful sensitisation to potential issues, social marketing 
theory would suggest it is the specifics that matter. 
The specifics are used to develop an “exchange” – one in which “the benefits of change 
are so compelling and the costs so minimal that everyone will comply”.234 A focus on 
exchange recognises that changing behaviour comes at a cost (financial, emotional, 
social, time, loss of preferred behaviour) and this requires some compensation 
commensurate with the cost. Again, insight is necessary to know what would be valued 
and motivating as this will vary. The exchange is expressed through the “offer”, a 
combination of the marketing mix. It takes insight about the client - their needs and 
character - and considers how best to meet that need with the least cost to them. KIT 
agents provide capacity, build capability and skill, support (listening, practical help, 
coaching), make local projects more visible to staff who might contribute or learn, 
make linkages within the organisational hierarchy and with people beyond who can 
help (such as patent writers, manufacturers, and researchers). 
The product (here a service) is what is being offered to people. It is meant to meet a 
need, but could address a demand that is negative or non-existent. This is often the case 
in health promotion for example, where men do not wish to receive advice on healthy 
eating,235 and children do not decide whether to wear cycle helmets – their parents do. 
A distinctive feature of the KIT agents is how they developed their own product within 
this context. In some cases, they worked with people who did not want them (and 
described themselves, for example, as “an irritant”) or they went to work with someone 
who had not been asked if they wanted to work with a KIT agent (Amy and Fran). 
Whilst in some cases this is not ideal, the lessons learned from this experience are 
similar to those where the KIT agent was initially welcomed. 
Most of the KIT agents adapted their content to meet the specific needs and context of 
their clients. They worked with clients to help define and clarify the need and then 
address it. This explains the range of activities found in the study. They also reported 
133 
 
adapting their services in other ways. They looked to make their services relevant, 
attractive and convenient to use. Part of this related to their use of language. A number 
of KIT agents reported adapting their way of talking about the work to make it salient 
to clients. This often meant avoiding the formal language of knowledge mobilisation 
and innovation – not “baffling” practitioners with academic terminology, giving it a 
“pragmatic” and relevant focus (perhaps at the expense of academic standards), 
“getting people to think” and “have ideas”. The importance of language is perhaps 
better recognised in commercial marketing than social marketing. Finlinson et al.,236 for 
example, point out that if participants cannot relate to the terms (in their case around 
sexual identity), they will not make use of a sexual health programme. In social 
marketing the importance of how the topic is presented is often linked to peer-
education. For example, Stephenson et al.237 report how school students described peer-
led sex educators as “having greater relevant expertise and respect for pupils, holding 
more similar values about sex, [and] using familiar language”. 
Those dealing with formal research evidence worked to tailor it for the needs of those 
who would use it, recognising that research papers are often not accessible and time 
pressures likely to drive out thoughtful consideration. In other cases where clients were 
busy or distracted, KIT agents undertook tasks directly, preparing and sending out 
agendas for clients in order to keep things moving for example. (These KIT agents 
stressed the importance of keeping ownership firmly with the client however). Another 
KIT agent reported timing a specific piece of work to dovetail with the evolving 
execution of the client’s project, and others reported using a stepped approach to 
knowledge and skills development as client experience grew. Demonstrating the 
importance of understanding specific client groups, there are examples of KIT agents 
who used national programmes locally with success (for example patient flow), and 
others who worked with small local teams to ensure salience and ownership and to 
increase the likelihood of diffusion across the host organisation. Again, this technique 
is used in health promotion, where target audiences are invited to help develop their 
own solutions to problems. A recent example is the Spanish arm of a European study to 
reduce childhood obesity.238 The approach is also used with adults, particularly if 
formal services are absent.239  
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Further themes relating to product (or service) that are employed in marketing are 
relevant and useful here, including the perceived quality of the product (and branding); 
its compatibility with existing products; and the scope for personalisation. In terms of 
quality, there was an expectation that KIT agents should be competent in the area where 
they gave support. This finding has been reported elsewhere.60 We found clinical and 
managerial experience was valued as it was felt to give the KIT agent credibility and 
made them more difficult to dismiss. In some cases this was direct experience of the 
problem being tackled, but was mostly about being able to understand the context in 
which clients operated. Where KIT agents had direct experience of the issue at hand, it 
is a potential challenge to avoid superimposing their experience on the current problem 
their clients face, in order to ensure that clients take ownership of ideas and solutions.  
In commercial marketing the idea of “homophily” is considered helpful. This is the 
extent to which people in a relationship are similar in terms of demographic variables, 
attitudes, beliefs and values. Extending this, peer outreach which makes active use of 
social networks has been used successfully in public health240 and fits well with the 
observed preferences of healthcare practitioners.35,241-244There were a number of 
examples of similar networks in the study. For example, Amy, Fran, James, Grace, 
Sophie, Holly, Daisy, Chloe and Janice all spoke of their clinical backgrounds and how 
it helped them understand, but also be taken seriously and listened to. This was 
generally confirmed by the Links. 
Branding is also an issue in commercial marketing which may be relevant in the 
context of KIT agents. Each of the individuals was attached to a network organisation 
which may have enhanced credibility. In practice, this was little mentioned and the key 
thing seems to have been the individual’s reputation: it may be that this was taken-for-
granted given their affiliation. Branded products were also used - IHI quality 
improvement and Sepsis Six campaigns – providing short-cuts to interventions and 
support materials. This said, some sites complained of the difficulties of tying in their 
work with existing programmes. Branding would seem to require planning if it is to 
provide an advantage and the branded product must be adaptable to local needs. 
One factor that seems crucial to success is the feedback function offered by KIT agents. 
The timeliness of feedback on performance and recognition and appreciation was 
motivating to some people. Some Links mentioned prizes or awards for their work, 
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others showed evidence of improvement with evident satisfaction. Others mentioned 
the KIT agents providing them with renewed confidence at times when they felt 
challenged. In a number of cases the KIT agent was also acting as the link between 
service staff and senior managers. Reporting success up and approval down was 
considered an important aspect of motivating staff and sustaining new behaviour. 
Place or positioning is used to refer to where the service is offered and how. Many 
KIT agents commented on the importance of being “visible”, the need for face-to-face 
meetings in order to agree objectives and to build relationships. Being out-and-about 
and handy, sometimes even co-located with clients, all seem to have contributed to 
success. The importance of this is reflected in some comments from Links when they 
expressed frustration at the KIT agent being a shared resource so not always present. 
Another expressed a loss of the support once the relationship had come to an end, and 
another suggested more proactive client management as an improvement to an 
otherwise excellent service. One site also adopted what might be called a ‘pyramid 
approach’ of training the trainer. This was intended to embed the skills within the host 
Trust and reach a greater number of people.  
In marketing, promotion refers to how the service is advertised and people encouraged 
to take part. This issue did not feature strongly in this study. However, where it did 
come up, this was often in relation to the KIT agent already being known and 
promoting their service personally through contacts and networks, or the KIT agents’ 
line-manager being well-known and connected and offering the KIT agent’s services 
directly to would-be clients. In some cases it fell to the KIT agent to find appropriate 
clients once the line-manager had agreed to work with particular organisations. None of 
the KIT agents complained of lack of demand for their services, but understanding the 
best means of promotion in the context of KIT agents remains little understood. This 
may become more germane if services are expected to be revenue generating.  
The other element in the social marketing mix is policy – a legal ban on smoking in 
public places, alongside fiscal measures and improved access to smoking cessation 
programmes for example. In the context of KIT agent, enabling policies were 
identified. Some spoke of the benefits of renewed policy interest in innovation and the 
roles themselves, sponsored by research networks, fitted into the wider policy. Some 
KIT agents and Links talked about the increased emphasis on cost-saving or particular 
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patient safety targets providing an impetus to do things differently. This element of 
social marketing brings attention to the macro and meso levels and prompts assessment 
of the likelihood of success and points to necessary changes. It encourages a more 
comprehensive assessment and planning of how the KIT agent might be expected to 
work, and to highlight opportunities for change within the wider infrastructure (an 
element of competition). For example, one major barrier to change identified in a 
number of cases was the sheer pressure on the healthcare system.   
The final principles of social marketing relate to segmentation and targeting. These 
would encourage KIT agents to divide their potential clients into different groups and 
tailor their marketing mix to each. One advantage of this is that it allows scarce 
resources to be concentrated where they are most likely to have an impact.  If these 
groups are successful they can be used to support future efforts. Several KIT agents 
took this approach. They talked of working with the willing, not pushing projects that 
failed to get off the ground, and working with clients who seemed viable. In time, some 
were also able to build a portfolio of success stories to attract other clients.  
To illustrate social marketing theory we applied it to an example from the case study 
data and this is presented in Appendix 9. 
Strengths and Limitations of Social Marketing Theory 
The strength of applying social marketing in this context is it allows existing 
knowledge of real-life processes around KIT to be anticipated and addressed in 
planning. In turn, these expectations can be matched to outcomes in evaluation, and 
thus provide better insights into their relationship in practice. Thirdly, social marketing 
theory offers KIT actors a structured means to identify likely causes of success and 
failure and to plan for them. We note here that our proposed framework for assessing 
the impact of KIT activity signals the need to recognise barriers and enablers to the 
achievement of desired outcomes.  
Social marketing theory’s comprehensive focus goes beyond identifying the 
shortcomings of non-adopters;(245) rather, it seeks to understand their position and 
constraints and to factor them in. This seems to be missed by a number of critics(246) 
who assume that lack of congruence between the social marketing “offer” and the 
audience is a result of the theory rather than a weakness of a particular programme. 
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However, understanding the client is fundamental to making social marketing work.(247) 
In our study aspects of social marketing were used to interpret how KIT agents worked 
with clients in goal setting: participants identified local priorities and were supported to 
work towards them rather than attempting to change basic beliefs.(248) This is not 
inevitable but requires conscious use.  
Social marketing, like commercial marketing or social capital, is a tool that can be used 
towards different ends, for good or ill. One limitation is that the “principles” of social 
marketing overlap and this can be distracting – which should I do first, segmentation or 
targeting, when is promotion price? In practice, it matters less about being able to place 
something into a discrete category and more about having thought about the 
“principle”. Again, how the techniques are applied is not a theoretical question, but a 
moral one. There are other limitations. In our case, we used it only to analyse the 
relationship between the KIT agent and their “client”, but the approach could have been 
to analyse the relationship between the KIT agent and their home organisation as well. 
This process might be usefully applied to the planning of future programmes.  
Concluding Remarks  
This chapter has provided a necessarily brief discussion of the study’s findings to 
illustrate the potential utility of applying social marketing theory to the planning and 
evaluation of KIT agent posts. Analysis of the study through the lens of a social 
marketing framework has highlighted a number of key points which are associated with 
impact in the work of the KIT agents (objective 3), and also pinpoints key areas where 
the KIT programme could be strengthened. Although these results were somewhat 
apparent without the use of this framework, it is the linking together of these ideas, with 
a focus on behaviour change, which is the major benefit of this approach. Social 
marketing theory helps explain why the KIT agents were able to support change and 
provides a useful checklist for future examples. 
What social marketing theory does not do is bring attention back to supporting the KIT 
agents themselves and this is important for future healthcare practice. The role KIT 
agent, variously named, is increasingly common in knowledge transfer and 
mobilisation programmes in health and our study helps to illuminate what they can 
involve, how they can be made to be successful and what makes them vulnerable to 
disappointing results. Not only are they undertaken with some risk to the individual, but 
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they could suffer dilution of effect as KIT agents look for funding and need to 
demonstrate worth. Yet they tend to be short-term posts with ambitious aims. The roles, 
and people who occupy them, will need to be given time and support if they are 
expected to realise outcomes and impact rather than simply that potential.  
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Chapter 9: Further Discussion and Conclusions 
Introduction – Our Study’s Contribution 
The title of our project highlights our underlying aim to help NHS practitioners and 
managers “get the most out of” available knowledge and innovation for service 
improvement and patient benefit.  This study is timely because of the increasing use of 
KIT roles by Academic Health Science Networks and partnerships,60 and the relative 
lack of evidence for their effectiveness94 although the literature on knowledge brokers 
has grown significantly in the last few years with the publication of evaluations of 
CLAHRCs39,42,44,60,244,249,250 and other initiatives.90  The complexity of the role and the 
environment in which it is played out justifies the need for more research on knowledge 
brokers.42,54 Our research contributes to that body of evidence. It focuses exclusively on 
this role as it operates within Academic Health Science Networks and in England and 
partnerships in Wales to show how individual dispositions, processes and content 
contribute to desired outcomes.  Oborn and colleagues82 report that the journal 
Implementation Science “explicitly calls for papers which include more details around 
the context and developmental process of moving research knowledge into practice”. 
Our attention to context looking at common facilitators and barriers as well as the 
specific features of the KIT activities in Chapter 6 moves in this direction. 
There is a growing recognition that “research use is an intensely social and relational 
process”.90 We build on these known relational aspects of knowledge mobilisation by 
highlighting the preparatory work undertaken by our case study agents, who build the 
relationships that are vital to knowledge uptake.  For example, James focused on 
building trust with practitioners by visiting their sites and meeting their teams. 
Similarly, agents at Moorlands met with potential knowledge users, not only to discuss 
their needs, but also their capacity to use knowledge. In both these cases, the agent(s) 
developed a relationship before starting the knowledge exchange phase. This finding 
suggests that achieving knowledge mobilisation goals from short-term fellowships 
might be particularly challenging, especially if the KIT agent is new to the organisation. 
Our research finds that it is the generation of ‘insight’, as discussed in the previous 
chapter, which enabled KIT agents to develop more effective interventions. This 
finding advances our understanding of how best practice is socially constructed86.  
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Agents need to develop an understanding of local context, by listening and building 
relationships, so that they can adapt their ‘offer’ to their clients of various forms of 
knowledge (i.e. organisational data, benchmarking, experiential and local knowledge as 
well as research evidence). Research evidence is one of many other ways of knowing, a 
phenomenon described by Gabbay and May242 as “mindlines – collectively reinforced, 
internalised, tacit guidelines”. Our use of social marketing theory, a new contribution to 
this field, provides a framework for addressing key points and for maximising the 
contribution of research, by considering more than simply the competing forms of 
knowledge but also its place, positioning and quality (amongst other factors).  
The Study’s Strengths and Limitations 
Strengths 
The qualitative approach taken with KIT agents and their clients (the professionals we 
have called Links for the purposes of the study) provided rich data on their real-life 
experiences. These data enabled us to better understand their role and the context of 
their practice. By setting the study in a complex, natural environment, we achieved high 
ecological validity.251 Our engagement with agents typically extended over more than a 
year, from negotiating access to final report back discussions. This gives our experience 
of agents a longitudinal aspect which was facilitated by the KIT agents’ audio-diaries. 
For agents who kept these, these captured the experience and reflections after initial 
interviews and proved to be a valuable way of providing a more comprehensive 
coverage of their experience. Data from the audio-diaries served to confirm and extend 
information gathered from interviews. We triangulated our data from agents with data 
from other sources: the observation of meetings and events; documentation research; 
and semi-structured interviews with KIT agents’ line-managers and Links. The validity 
of our findings was further strengthened by engaging nine case study agents in three 
networks in checking the analysis and interpretation of their case studies. Any bias due 
to the Hawthorne effect was reduced by conferring anonymity on the respondents.  
The use of existing theoretical frameworks to guide study design, data gathering and 
analysis enhanced our consistent approach. These included the Kirkpatrick 
framework199 and Walker et al.’s classification of factors influencing change128 and 
have been reported in Chapter 3. In data coding and analysis we took measures to 
ensure internal consistency and as a research team we regularly reviewed and discussed 
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our interpretation of the data and periodically took data to the advisory group for 
discussion. Our advisory group was strengthened by the contribution of two service 
users who kept us focused on patient outcomes. We used their feedback to draw our 
attention to the lack of consistent approaches to patient engagement across the AHSNs 
(advisory group meeting 04.02.14) and to help us understand why patient and public 
involvement (PPI) did not feature prominently in most sites. The PPI advocate in the 
nominal group ensured that within that process the question ‘what does this mean for 
patients and the public?’ remained in the foreground. More by chance than design, the 
main focus of one case study agent (Isabelle) was to help others work out how to use 
insight from PPI.  
Limitations 
The degree to which individual KIT agents participated in the process was variable and 
therefore the amount of data gathered for each differed in quantity. Some KIT agents 
gave several interviews, others only one. Participation in audio-diaries was relatively 
low. We asked diarists to submit a short recording (2-3 minutes) per week for 4 months. 
Four case study agents submitted no audio-diaries, although one of these did provide a 
written account. Of the nine who submitted audio-diaries, despite weekly reminders, 
the number of entries ranged from two to 18 and lasted eight to 115 minutes. In terms 
of observations, some organised several but others were not able to coordinate a single 
observation within the timeframe of the fieldwork. One KIT Agent withdrew from the 
study after the first interview for personal reasons. Lack of time was an expressed 
concern of most of the participants, and was a key reason for not running the action 
learning sets as planned and set out in the original protocol. The varying degrees of 
commitment might reflect how the KIT agents were recruited, that is, through senior 
staff at the network rather than directly. However, this method of recruitment was the 
preference of the AHSN leadership as the teams were in the early stages of setting up 
their networks.  
Our access to the KIT agents’ network also varied. In total, five line-managers of the 
KIT agents (one of these line-managed three agents) and 22 Links were interviewed. In 
no case did anyone refuse to participate, but finding time to meet was very difficult. 
This is not surprising, given the challenges that the service faced at the time of our 
study, combined with the newness of the networks.  
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Despite notable disparity of data collection across agents, we have data from at least 
three of five sources (agent interviews and diaries, observations, line-manage interview, 
Link interviews) for all agents expect the one who withdrew from the study (Chloe). 
For ten agents we collected data from at least four sources. We recognise that we had 
least data from Wetlands.  
Another limitation of the study relates to the cross-sectional nature of data collection 
with regards to Links and line-managers. Whilst effort was made to follow up the KIT 
agents and use the audio-diaries to keep track of change, the line-manager and Links 
were interviewed only once. It is likely therefore that the findings reflect how the 
process was working at the time for the line-managers and Links. This “snapshot” 
perspective was mitigated by the research design, which permitted a time-lag between 
the initial interview with a KIT agent and their line-manager/Links. Where line-
managers attended feedback sessions, they were invited to offer further reflections. 
Links were not part of those meeting. Had resources permitted, it would have been 
helpful to re-interview the Links in particular to provide additional insight on questions 
about sustainability. However, the study took longer to set up than planned for several 
reasons besides the participants’ lack of time.  Reasons included delays in the 
establishment of AHSNs; reluctance on the part of some senior gatekeepers (KIT 
agents’ line-managers or above) to involve staff in the study; and a concern on the part 
of some KIT agents about the impact of them taking part in the research on their link 
organisations. Some were particularly concerned about anonymity. This led to an 
additional process of permission-seeking and negotiation. Delays within the AHSNs 
meant that some KIT agent programmes planned for inclusion in the study were not set 
up in time. 
A further potential limitation of the study is the lack of ‘objective’ measurement of 
outcomes and impact. They tended to be self-reported and potential, rather than actual. 
Some line-managers and Links gave relatively superficial appraisals of the agent and 
the role, focusing on personal characteristics in place of harder information about how 
they perform their role. We might have had more robust responses had we asked line-
managers and Links to comment on how they perceived social marketing concepts as 
fitting with the role. Instead we chose to use social marketing theory in our 
interpretation. We did this because the timing of our study meant that the networks 
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were in the early stages of formation and we anticipated that our interviewees might 
struggle to interpret the agents’ work through a social marketing lens.  
Whilst it was not the intention of the study to measure predefined outcomes, some will 
see it as a weakness. The study itself brings insight to the difficulty of objective 
measurement of outcomes and impact in two ways. First, data gathering and analysis 
was structured around an explicit and therefore transparent evaluation approach used in 
continuing professional development.70 Second, one objective was designed to address 
the question of how success could be measured. This part of the study used the nominal 
group technique to develop group consensus. We also addressed this question with KIT 
agents and their line-managers and Links during the interviews. Both sets of data 
highlight the difficulty in devising a set of generic measures and the risk that the 
application of a formal approach might not capture ‘softer’ outcomes such as enhanced 
relationships, capacity development and shifts in organisational culture. It is hard to 
measure the effect of the KIT agent, for example, who is the ‘grit’ in the system or the 
one who works across ‘silos’ to break down barriers. However, being mindful of such 
difficulties does not rule out the possibility that broad measures could be identified that 
might be evidenced using a combination of quantitative and less formal qualitative data, 
and tailored to particular circumstances. To this end we have proposed a set of 
principles and suggested a framework for measuring outcomes of knowledge broker 
activity. 
With these limitations in mind, we report how the study has addressed the research 
questions. 
How We Addressed Our Research Questions 
What are the commonly shared expectations of the KIT agent role? 
The question  can be answered in two ways: the ways in which the expectations were 
shared by the agents in our study, and, adopting the language of social marketing, how 
the KIT agents’ expectations were shared with their ‘clients’ – line-managers and 
Links. In this study it appears that, despite variation in specifics, the broad expectation 
of the role was largely shared across both groups. In short, despite ambiguity at a 
detailed level, the role was about engaging with practitioners to help them develop their 
service in order to improve it for patients and, in some cases, to also save money. The 
focus of KIT agents’ work was on supporting and helping practitioners develop, rather 
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than doing things for them (although sometimes the former was a goal they were 
moving towards). The results of our nominal group exercise (Chapter 7, question 3) 
show that the group also agreed with role expectations around making connections, 
motivating and influencing others, teaching and training and facilitating access to 
knowledge. 
This result differs from earlier studies252 on research partnerships and knowledge 
brokers which showed a degree of mismatch in goals and expectations between parties. 
It may be that this is linked to the straightforward focus of the KIT agents in taking on 
the role within a network – in general the KIT agents studied here appeared to be 
motivated to improve healthcare provision, rather than, say, explore career options.66 
The literature on intermediary roles in health groups their functions into three broad 
categories: ‘knowledge management’, ‘linkage and exchange’, and ‘capacity 
building’.97,112  Our findings overlap with these three functional categories but provide 
additional insight into the challenge of undertaking a KIT role and the necessity to 
define role expectations on an ongoing basis so longer-term expectations are realistic. 
Others16,110,152,155,163 have also reported the importance of agreeing roles and 
expectations.    
What, in practice, do the KIT agents do? 
It was possible to answer this question in some depth and breadth because the sample 
was selected for maximum variation based on each network’s declared intentions for 
the roles. KIT agents were identified as such by network senior staff. In many cases the 
specifics of the role developed over time. Details are provided in Chapter 5, but the 
overall pattern of what the KIT agents did is summarised here. 
Only one agent (Erin) focused directly on the growth agenda, although others included 
industrial partners in their engagements as a source of learning and another agent 
(Grace) supported Intellectual Property development. The activities of Erin included 
providing market research, signposting people around the innovation systems, and 
linking people developing a service to commissioners. Two teams (Moorlands and 
Wetlands) were closest to more mainstream ideas of knowledge mobilisation 
(7,54,57,108,169,253,254) 
 and provided formal research evidence to clinical/management 
teams. Some teams (Greenhills, Riverside, Homefields) were responsible for 
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introducing or developing approaches to healthcare management, such as QI 
methodologies and patient and public involvement approaches through formal training 
and support of topic-specific networks (for example leadership, new research, or 
evaluation approaches, for example). Other KIT agents (for example Chloe, Amy, Fran) 
worked directly with practitioners on local projects. Most often these were related to 
QI. A number of KIT agents did more than one of these activities. 
Recent studies of the CLAHRCs in England also found that mixed approaches to 
knowledge mobilisation were used by those in KIT roles.180,,60 These included service 
improvement, converting evidence into practical products, implementing national 
and/or local guidance into practice and mobilising local evidence.60  
Some KIT agents worked with people in different roles who focused on a single issue 
(for example patient safety). This meant that the agents thus linked not only with 
doctors but also PPI leads, for example in the case of Molly and Fran. Others worked 
with people around a particular project (for example doctors, nurses and managers 
addressing the issue of the deteriorating patient - Amy). Several linked academics and 
healthcare practitioners, sometimes around a specific project (for example Jessica, 
James and Grace). Others dealt with non-NHS service providers, or providers of 
services which were not NHS based (for example, patent experts and ante-natal groups 
– Isabelle and Janice). Most linked with multiple levels of organisations and, in some 
cases, provided links between levels of organisations for whom they did not work (for 
example Grace). 
All the KIT agents were involved in bringing people to new knowledge with the 
intention of helping them work differently (i.e. better). This was accomplished by 
providing that knowledge themselves, drawing people into an engagement where they 
could acquire this knowledge from other people or documents, or signposting people to 
others from whom they could learn or who could learn from them. 
Despite the difference in content of the KIT agents’ experiences, they shared a number 
of features.  It is perhaps these features that differentiate the KIT agent approach from 
more traditional “information-deficit” models255 of knowledge transfer and may in part 
account for their relative success in achieving desired outcomes. The KIT agents and 
Links reported a series of repeated and ongoing interactions, and the details of the 
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actions taken were tailored to the needs of the Links (‘clients’). The importance of 
tailoring has been reported by others.180 Repeated interaction also gave the KIT agents 
opportunities to provide feedback to Links and update their learning.  
Building relationships was a critical part of KIT agents’ work.  As one KIT agent put it 
“you have to build relationships and there’s no substitute and knowledge transfer 
happens in the context of a relationship. It doesn’t happen in the middle of the ether” 
(James). Rycroft-Malone et al.60 also found that building relationships was a central 
ingredient in the success reported by knowledge brokers in CLAHRCs. Yet these 
relationships were typically intended to be finite. Most engagement aimed to embed 
knowledge, a set of skills, approaches, or set of contacts that would stay with the Link’s 
organisation beyond the interaction. In other words, the KIT agents entered the 
engagement with a view to the succession or termination of the engagement. Whilst 
supporting Links in a practical way (teaching them about QI methodology, for 
example) they were consciously trying to extract themselves for more direct support 
(for example Erin, Isabelle, Fran) and develop the Links’ independence so they could 
continue the work when the KIT agent moved on. Many repeatedly reminded Links that 
this was their project, their data, their responsibility (Fran, Amy). A successful KIT 
agent is one that is no longer needed by specific links.  
How does the work of KIT agents impact on healthcare practice? 
Despite the recognised challenges of understanding what impact means and 
demonstrating it, we are able to point to a number of direct ways in which the work of 
KIT agents impacted on healthcare practice (“results” in the Kirkpatrick framework). It 
is in no small measure problematic to do this, as discussed, but we are able to draw 
attention to the few specific projects with measureable outcomes to which agents 
contributed. These include working with a team to reduce ambulance handover time 
significantly (Sophie); improvement in compliance with the sepsis care pathway which 
was reflected in mortality outcomes (Amy). Others reported a reduction in cancelled 
elective surgeries, reduced delays in patient flow, a reduction in the number of patient 
complaints, decreased infection control rates and a decrease in the number of patient 
falls. In these cases, the KIT agents worked with Links to gather data, analyse the 
problem, develop the intervention, and measure its success. One team (Wetlands) was 
reported to have assisted the development and commissioning of a new rehabilitation 
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centre (and a new approach to care). This has been described as providing quality care 
for patients and being cost-effective in an external evaluation. One of Sophie’s Links 
reported that by tracking patient flow to social workers, which was characterized by 
long wait times, they were able to secure more resources for these professionals.  
A number of KIT agents also worked alongside practitioners to develop skills and 
organisational capability to improve care. One team (in Riverside) trained and 
supported audit staff in QI methodology. The team manager reported that the team had 
refocused their efforts, away from audit (counting) and towards improvement. They 
asked all staff who presented with an audit idea to consider it from an improvement 
perspective. The team offered training to staff to support them in this goal. Another 
Link (one of Janice’s) reported how useful she had found working with an academic 
team. This relationship gave her access to information about service provision, which 
she could then use with clients who were making choices about their own care.  
KIT agents and their Links also reported outcomes not directly related to healthcare, 
but showing potential for future practice. This included the development of research 
proposals and Links thinking differently about how to use feedback from patients to 
redesign the service.  There were specific outcomes around improved capacity, 
including training staff in QI methodology and QI becoming part of the performance 
system.   
How can KIT agents be best supported? 
Our study provides useful pointers on how KIT agents can best be supported. Before 
considering this in more detail, we highlight some of the features of the role that make 
it unusual and potentially challenging. Similar to findings in previous studies,136,140,244 
the roles are largely temporary, do not fit into a recognised career structure with 
progression and rewards, and do not always allow KIT agents to return to their original 
posts. Some KIT agents were working in, or with, organisations which did not employ 
them and over which they had no managerial control. Some reported a degree of 
disconnect with their employing organisation as well. A number of KIT agents also 
covered large geographical areas requiring travel and were isolated. It is noteworthy 
that all bar one of the KIT agents in our study were women. This raises questions 
around whether knowledge brokering is a gendered role in healthcare. Alongside this, 
most of the KIT agent roles could be characterised as requiring some emotional 
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labour,245 providing significant support to individuals and substantial effort to 
understand the needs of others and adapt to them. References to “hand holding” and 
managing hostility and the need for resilience were commonly mentioned and have 
been reported elsewhere.179 Some KIT agents also felt under-equipped for aspects of 
their roles although this was not reported by their Links.  
KIT agents could benefit from better assistant support and a team approach: this 
addresses the implication of them wanting to engage with colleagues face-to-face which 
is time consuming and makes them unavailable to others at that time. Given the 
geography of some networks, travel time was not insignificant. Support from senior 
colleagues is essential, both directly and in helping the KIT agent keep their ‘clients’ 
motivated. Support from “the Board”, “the Exec Team” and similar was consistently 
mentioned as being of help, a finding echoed in the literature.3,43,144 In most cases, but 
not all, where there was more than one KIT agent in a network, individuals commented 
on the value of being able to draw on each other’s support (a finding similar to that 
reported by Chew et al.)140. This support did not necessarily relate to the specific 
content of the role (the details of the QI methodology, for example), but was more often 
about managing a difficult relationship or issue and having the opportunity to express 
concern. Ensuring that KIT agents do not feel emotionally isolated is likely to be a 
useful support.  
Flexibility with respect to how the KIT agent is managed is a related concern. The KIT 
agents were successful because they could be responsive and adapt their role and way 
of working to the needs of the Links, a finding echoed by Chew et al.140 In most cases 
this may have been necessitated by a lack of detailed planning about the role and work, 
but it seems to have worked well in these cases. KIT agents therefore require senior 
level agreement to work flexibly and with a degree of independence to meet local needs 
whilst also actively engaging in their work. It appears that the role depends on a level of 
openness to the identification of projects. On paper this might look like excess capacity 
since the KIT agent is not recruited to do a specific job, and the potential for erroneous 
perception needs to be managed. 
Timely training (for example within the first couple of months in post) was identified as 
a necessity for KIT agents who felt less confident in discharging some aspects of their 
role. For example, Fran and Amy both reported a sense of vulnerability at times as they 
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were using approaches that were new to them and in some instances with people who 
had not sought their help. Others however (for example James) embraced challenging 
others and being the “grit” in the system. 
What measures can be used to assess the impact of KIT activity? 
This study suggests that generic measures, despite their attractiveness, would not 
adequately assess the impact of KIT activity as KIT agents do a number of things 
towards different goals. Roles are difficult to measure and evaluate in the short-
term,140,171 and a generic measure is likely to be too non-specific to provide any 
meaningful measurement. Further, KIT agents should only be measured against those 
things over which they have control (i.e. proximal to their work, rather than distal 
outcomes). Findings from the nominal group and interviews suggest ways forward. 
Like the KIT agent themselves, a system to measure results or impact most likely needs 
to be flexible. It needs to link processes to outcomes; specific actions linked to what the 
KIT agent and their clients agree they are trying to achieve, and the steps being taken 
towards it. Logic models171,203,257 might provide a useful tool for planning and 
evaluation. This process would have the additional benefit of requiring the active 
parties to articulate what they would like to achieve, how they would like the KIT agent 
to help, and the role of wider constraints, and provide a basis for review. 
Implications for Effective Knowledge Brokering 
Within the context of Academic Health Science Networks and partnerships our study of 
KIT agents suggests five important implications for knowledge brokering.  
1. Individual dispositions such as listening and attitude, a proactive approach to both 
defining the role and the work, and status (i.e. a relevant background, notably 
clinical) were centrally important to KIT agent success. This suggests screening, 
recruitment and HR processes related to these posts would benefit from a person 
specification reflective of these attributes. Seniority and visibility to the Board, 
conditions we found linked to agent success, also need to be considered; if not held 
by the KIT agent then they require senior management buy-in. 
2. These roles take time and require flexibility on behalf of the organisation in order to 
develop and begin to see desired outcomes. Individuals in these posts are action-
oriented through their repeated interactions with individuals across boundaries and 
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their attention to the change process. This has implications for measurement and 
reveals that longer-term views to assessing the roles are necessary, which we note 
might be in tension with short-term fellowships. However, this is true across other 
successful change initiatives where a requirement for time and space is recognised. 
A potential medium-term approach, as discussed by our nominal group, might entail 
the use of case studies. Case studies provide an in-depth, holistic understanding of 
events. They can be specific in focus and draw on various sources of data – 
quantitative and qualitative – to narrate the processes undertaken that led to desired 
outcomes and demonstrate the role of the knowledge broker within this. They can 
also highlight the challenges encountered (and overcome) and how things might be 
done differently in future (see Appendix 9).  
3. The feelings of isolation reported by some of our KIT agents highlight potential to 
connect those in these posts across the still relatively new structures. Learning from 
the experience of CLAHRCs in this regard would be a fruitful avenue to explore 
how national communities of practice could be developed within the context of 
competitive networks. Furthermore, Q, the initiative led by the Health Foundation is 
one such effort in terms of QI fellows which could include some KIT agents in their 
community. 
4. The confusion at the level of the organisation related to who leads and supports QI 
should be addressed, because it is a challenge for KIT agents and possibly others.  
For example, we found one site where there was a Quality Department, 
Organisational Development team, Research and Innovation team, Audit team as 
well as the KIT agent’s own team all working within the same space.  This not only 
led to confusion but duplication of effort, territorialism, frustration and wasted 
resources. 
5. Multiple competencies are required around producing and using local data for 
improvement. These are not necessarily held by the KIT agent but are required to 
support the change initiatives within KIT, whether QI, implementation or otherwise.  
Many agents saw this as their contribution – i.e. supporting local teams to become 
“data driven”. This suggests that organisational capability in the use of data is 
central to these roles and requires investment not only in generating meaningful 
figures but training practitioners in its application to service improvement. 
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Future Research  
We suggest a number of areas for future research to further our understanding of the 
use of knowledge broker roles in healthcare.  
There is a growing recognition that the knowledge brokering or boundary spanning 
roles are held within a team rather than by an individual.54,60,180 Future research might 
focus on how these roles are negotiated, maintained and transferred within a team 
setting and the related outcomes and impacts achieved. This could offer insights for 
leaders in setting up their teams (i.e. composition, HR implications, sustainability). 
Another fruitful area of future inquiry might consider a longitudinal study of KIT roles 
to answer the following questions: are the perceived risk of taking on these roles (lack 
of career progression and recognition, time away from clinical or managerial duties) 
valid? What career options are available after leaving the KIT role? Are KIT agents lost 
in the system (i.e. do they return to clinical or management roles with limited potential 
to enact KIT) after receiving training and support? There is significant scope to follow 
up on agents that have been studied across a number of projects (not only this study but 
also within the CLAHRC evaluations and the SDO management fellows). This could 
also address the issue of sustainability.  Specifically, what is the evidence that the 
results of KIT work are sustained? 
Challenges related to career progression and recognition are exacerbated if the KIT role 
is the only component of the work.  Those in hybrid roles (working in dual clinical-
knowledge-broker roles) may benefit from retaining membership and accountability 
within their profession.182,258,259 However, further research is needed to understand how 
competing priorities can be managed successfully to ensure that the knowledge 
brokerage role is not squeezed. Such research could explore the differing challenges 
related to the career structure for nurses, doctors, academics and policy-makers.  
Social marketing offers a new approach in this area and insights from the theory might 
be included in question schedules for knowledge brokers, their line-managers and 
Links. This would enable exploration of whether social marketing concepts guided KIT 
practice. 
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The emerging trend in the application of improvement approaches rather than 
approaches/tools typically described in knowledge mobilisation/transfer (for example 
use of guidelines, appraised evidence) deserves further attention. This trend might be 
explained in the UK through influential national training initiatives (for example 1000 
Lives) and think tanks resourcing the improvement science discipline through 
fellowships, training and, most recently, the Q initiative (Health Foundation). The 
influence of the IHI Improvement approaches championed by Berwick has been made 
more visible in the UK via his recent report.64 This is not to say that all our agents were 
applying improvement science per se but even when they did use theoretical 
frameworks developed in the knowledge mobilisation literature, they didn’t describe 
them as such (see Chapter 6 for discussion on how KIT content was framed and 
tailored). The issue of QI and more traditional notions of research use co-existing 
within the context of the same policy and funding streams needs to be unpicked. 
More work is clearly needed in understanding impacts and assessing how success is 
identified, credited or measured. The nominal group has started the debate on measures, 
whilst social marketing theory could provide a suitable theoretical framework for 
pushing this work forward. 
The nominal group exercise raised the importance of knowledge brokers linking with 
service users (ranked second after frontline clinicians) and other knowledge brokers. 
However, we rarely observed our KIT agents interacting with either of these groups in 
our study. A select few of our KIT agents worked directly with service users (for 
example Isabelle, Janice) and even fewer mentioned linking with others in KIT agent 
roles. One proposition that has been posed is whether patients themselves can take on 
knowledge broker roles.260 
Finally, a comparative (country, sector, knowledge-based private sector) study of any 
similar roles which are deemed attractive and embedded merits consideration. It would 
be helpful for those in the healthcare field to learn from other contexts where the roles 
are not perceived as risky. This might also reveal lessons for continuing professional 
development and how to foster learning organisations. 
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Concluding Remarks 
The case studies in this research project show that knowledge and innovation transfer in 
organisations is still perceived as an add-on activity to clinical care but is moving 
steadily towards being integrated into the fabric of organisations. It has its own 
confusing language and identity as a sphere of work but its strong association with 
quality and continuous improvement strategies is helping in that respect.  
Our sample of 13 KIT agents differed in their professional backgrounds, experience and 
expertise. Most had to ‘learn on the job.’ Some did not have a clearly defined or 
agreed-upon role. Nevertheless they pursued similar goals to change the culture of their 
organisations, build capacity in knowledge and innovation transfer, improve the 
relationship between the NHS and higher education and ultimately improve patient 
care. To achieve these goals they frequently challenged the status quo, used a wide 
range of quality and continuous improvement methods to support colleagues in 
achieving change projects and coordinated activities within their organisations.  
Historical, organisational and policy factors also exerted an influence. These factors 
related to the culture of organisations and the degree to which it supported new ways of 
working and were patient centred. The place of the KIT agent in the organisational 
structure appeared a less important factor if they were able to draw on senior-level 
support. The extent to which KIT agents could build on previous related work (for 
example CLAHRCs) featured less prominently than we had anticipated. Agents in 
regions with established CLAHRCs demonstrated they learned from the collaboration’s 
experience but we did not encounter them directly building on a CLAHRC’s existing 
work programme. Policy undoubtedly helped to drive change in knowledge and 
innovation transfer but also hindered change by forcing the service to be driven by 
financial needs and targets. 
The complexity and uniqueness of the KIT agents’ roles, and the skills and qualities 
needed to manage it were striking to observe. They were clearly valued by those they 
supported for their expertise and qualities of leadership, flexibility, proactive approach 
and ‘can do’ attitude. They were seen as making a difference. Yet some felt isolated 
and thought that the role was not always valued in their organisations. The role could 
be difficult in organisations with strong protected professional boundaries and staff 
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averse to change. A common complaint was that there was not enough dedicated time 
or resources at their disposal to make the best of their role which was often short-term 
and lacking in career structure.   
One over-riding conclusion is the need for further research on knowledge brokers.42,54 
Rycroft-Malone, Wilkinson et al.42 observe that “we know very little about how 
bringing the users and producers of research closer together might affect their 
capability to implement”, or what might work, for whom and in what context.3 Linear 
approaches to evaluating what works best are arguably insufficient and more 
interpretative approaches are needed.82,261 The impact of the work of KIT 
agents/knowledge brokers is hard to measure and although there are existing 
frameworks and tools, there is ample scope to explore this question in further studies.  
In conclusion, the role of KIT agents is varied, complex, time consuming and evolving. 
The stage they are at in achieving their objectives differed greatly on account of 
individual, local and policy related factors. Given the sheer scale of the task and the 
environment in which they currently operate, the effectiveness of KIT agents needs a 
long-term view. They require senior-level commitment and support in organisations, 
training and networking opportunities with others in a similar role to share good 
practice and reduce isolation. Secondments should be long enough to allow them to 
achieve their objectives. A clearly-defined career structure and succession planning will 
help to sustain the progress in knowledge and innovation transfer that is being realised. 
In Appendix 10 we provide a summary of our findings in presentation format. This is 
designed to be shared with practitioner audiences of KIT agents/knowledge brokers, 
managers, and others.  
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Appendix 1. Literature Search Strategy 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
* Searches were carried out using appropriate configurations of the terms:  
• Knowledge AND transfer/translation/mobilisation/exchange AND healthcare • Knowledge AND broker*/intermedia* AND healthcare • Knowledge AND implementation/evidence AND healthcare 
**   Exclusion criteria: not addressing knowledge mobilisation/knowledge brokerage 
(variously named), not healthcare, addressing organisational change or knowledge 
management (for example patient records), not in English language. 
*** Implementation Science and Journal of Health Services Research & Policy.
2697 articles screened by title/abstract 
Search conducted via Web of Science & Ovid MedlineR using a series of relevant keywords* 
419 full articles received and reviewed 
136 duplicates removed 
2142 papers excluded 
128 papers excluded 
113 papers gathered from other 
sources (snowball, opportunistic) 
Search continued with PubMed, Scopus, CINAHL via EBSCO and Google Scholar 
10% of papers cross-checked for inclusion, 
good level of agreement. 
2075 articles screened by title/abstract 
1898 papers excluded** 
6 articles sourced from hand search*** 
410 articles reviewed 
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Appendix 2. Advisory Group Members and Meetings  
 
Sue Denman (Wales Government, Chair Wales Knowledge Transfer Task & Finish Group) 
Anita Kothari (overseas academic) 
Jo Rycroft Malone (academic) 
Martin Marshall (academic) 
Nick Mays (academic) 
Lars Sundstrom (academic, SARTRE and West of England AHSN) 
Wendy Warren (NHS Manager) 
Matt Westmore (NIHR HS&DR) 
Dot Williams (service user, Wales) 
Edmond Brookes (service user, England) 
 
Table 21: Meeting dates and main focus of discussion 
Meeting Date Main focus 
1 20/09/13 Introductory meeting. 
2 19/11/13 Critical feedback on the draft literature review; discuss 
understanding of the KIT agent role. 
3 04/02/14 The draft typology and site selection criteria for potential case 
studies. 
4 03/04/14 
The typologies and dimensions developed to characterise the 
varying KIT agent roles and a discussion of the fieldwork 
process. 
5 17/06/14 A series of vignettes based on the sites used to stimulate discussion of types of knowledge being brokered. 
6 22/09/14 
A series of adapted verbatim accounts from case study agents to 
stimulate discussion: brokerage of knowledge within 
organisations rather than across; KIT and Quality Improvement 
and what type of knowledge is being brokered. 
7 22/01/15 Measuring the impact of knowledge mobilisation. 
8 21/05/15 Coding frame and approach to data analysis.  
9 01/10/15 Writing up the case studies. 
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Appendix 3. Semi-structured Interview Schedule for 
Mapping Exercise  
 
1. Introductions 
2. Briefly describe project and respond to any questions 
3. Ask respondent to describe their local strategy for knowledge and innovation 
transfer 
i. Any significant changes in direction of travel with relation to knowledge and 
innovation transfer from prospectus document? 
ii. Ask about plans for KIT agents  (who is involved in knowledge brokering 
and mobilisation schemes (specifically whether managers are included) and 
the types of activities planned: 
4. Refer to points in spread sheet for their network’s proposal re KIT agents – is this 
still planned? and if so: 
i. How many?  
ii. What are the main features of their role? (expectations) 
iii. What structures are in place?  
iv. How do they connect to CLAHRCs and other structures? 
v. Can you refer us to KIT leads within your network?
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Appendix 4. Summary of KIT Intentions Across AHSNs and SEWAHSP  
Network 
(Random 
reference 
number) 
Proposed KIT 
roles Summary of proposal 
Structures supporting 
KIT roles 
553 
Translators 
Core team has KIT 
roles 
Organisations in the regions to identify a “translater” to champion 
innovation and research translation and to act as a contact point for the 
central network team. Funding for their time will come from partner 
organisations, not the network. 
The network’s small core team who, as part of their role, support KIT 
through horizon scanning, identifying funding opportunities, offering 
business advice, creating collaborations and facilitating communications. 
Core team members have backgrounds in industry and academia and 
expertise in grant application and translational research. 
Quality improvement 
campaign in region 
307 
Fellowships 
Exchanges of staff 
across sectors 
A fellowship programme for senior NHS and social care staff from 
around the region released on a-day-a-week, followed a taught 
curriculum on innovation involving local university departments. An 
apprentice model with health researchers and an action learning set.  
The network aimed to expand and coordinate this approach within the 
regions to create capacity and capability for innovation. 
CLAHRC Fellowships 
in place since 2011 
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Network 
(Random 
reference 
number) 
Proposed KIT 
roles Summary of proposal 
Structures supporting 
KIT roles 
779 
New unit to support 
implementation and 
KT 
A highly flexible, bespoke and co-produced model of diffusion, building 
on both regional and national CLAHRC models. Opportunities for 
diffusion will be offered to clinicians, academics, managers and 
practitioners from the NHS, academia and industry.  
A new unit with the capacity and capability to support adoption at a local 
level is proposed. 
Building on CLAHRC 
learning 
296 Fellowships 
A suite of improvement capability programmes to support staff in the 
development of competencies in improvement science and change 
management methodology. 
Build on region’s 
academic programmes 
for clinicians interested 
in QI  
345 
Fellowship 
programme 
Secondments 
Integration of leaderships and improvement courses with fellowships and 
exchange schemes. Working with industry and relevant voluntary sector 
organisations to build on fellowship programmes. Staff seconded across 
sectors to foster cross-fertilisation and innovation as well as gain 
appreciation of differences in cultures. 
Future leaders be supported through a knowledge exchange programme 
with staff within organisations and between the NHS, industry and 
academic partners. 
Integrate existing 
leadership and 
improvement courses 
 
Build on fellowship 
programmes developed 
by the local Trust and 
CLAHRC. 
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Network 
(Random 
reference 
number) 
Proposed KIT 
roles Summary of proposal 
Structures supporting 
KIT roles 
510 Support existing 
staff 
A critical mass of people who create innovation, and increase 
competency and skills to deliver innovation will be supported. The 
network to capture what has already been achieved in supporting staff to 
do this and bring together best practice from existing programmes. 
  
839 Support existing 
staff 
Using the knowledge and experience of clinical staff to act as change 
agents to adopt and diffuse new practice across organisations.  
580 
Change 
practitioners’ 
community  
Change practitioners to share experiences and to increase their skills in 
the processes of innovation and change management. The establishment 
of a common vocabulary across the network which will facilitate joint 
working and communication. This community will connect and share 
ideas through event programmes, best practice workshops and webinars. 
Peer-to-peer support systems encouraged and possibility a mentor 
programme developed. 
Peer-to-peer support 
systems 
Build on  Health 
Innovation and 
Education Cluster 
667 
Fellowships for 
clinicians and 
managers to work 
on service 
improvement 
projects 
Involve NHS clinicians in research by building on existing local NIHR 
fellowship schemes and the use of honorary university contracts. The 
research fellowships will enable NHS clinicians to spend time in the 
academic department undertaking service improvement projects. To be 
extended to NHS managers, and those working across sectors and 
providers involving local business schools. 
NIHR Fellowship 
Schemes exist/ 
honorary university 
contracts 
Collaborative learning 
networks  
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Network 
(Random 
reference 
number) 
Proposed KIT 
roles Summary of proposal 
Structures supporting 
KIT roles 
762 Network for service improvement leads  
A team of trust innovation leads, experts in service improvement, will be 
centrally coordinated and supported. Support for service improvement: 
training and development of new innovation leads; sharing methods for 
achieving change across Trusts and sectors; contributing to network 
communications; working with academic members to evaluate 
implementation efforts; contributing to the development of a positive 
culture for innovation. 
Innovation leads responsible for implementing AHSN plans and spread 
of high impact local or national innovations and NICE guided 
innovations across the Network. 
Grow researchers in underrepresented professions to increase research 
use and variety of questions being asked 
Closely linked to 
CLAHRC. 
750 
Improvement 
Fellows in each 
theme 
Community of local 
champions 
Improvement fellows working with each theme, supporting 
organisational and professional behaviour change through improvement 
science. Contributing to an evaluative and learning culture, providing a 
key linkage between research and education priorities. 
A community of local champions leading innovation including fellows 
who support the delivery of innovation and change in the priority areas 
across the AHSN. These fellowships may be part funded by industry to 
encourage the cross fertilisation of ideas.  
 
299 Fellowship Programme 
The fellows, on 12-18 month secondments, deliver health improvement, 
wealth creation and educational projects within the network’s 
programmes. They receive professional development through an 
accredited programme based on the Darzi Fellowship model. 
Region has AHSC and 
AHSN Quality and 
Evaluation Fellows 
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Network 
(Random 
reference 
number) 
Proposed KIT 
roles Summary of proposal 
Structures supporting 
KIT roles 
341 NIHR body to lead 
The AHSN delivers research and innovation across partner organisations 
and workforce change via NIHR body investment. Expansion of research 
active staff across the AHSN constituency and training for more NHS 
staff to engage in research. 
  
690 Fellowships Knowledge mobilisation fellowships, based on the NIHR model to 
strengthen NHS /research exchange at middle management level. 
Work closely with 
CLAHRC. 
699 Communities of practice 
A large number of clinicians, managers, patients, academics as associates 
recognised by time and title to build linked communities of practice at 
scale using peer-led learning to promote grassroots involvement.  
Secondments and joint 
appointments 
728 Fellowships  Secondments 
Development of strong cross-boundary networks, including secondments 
and fellowship opportunities. The Theme Leads are part-time 
secondments.  
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Appendix 5. Semi-Structured Interview Schedules for 
KIT Agents 
 
5.1 Questions areas for first interviews 
1. Exploration of role  
a. What do you do in the role? 
b. Who do you connect with? Who do you reach and how (interpersonal 
linkages between people or units). Who’s in the network? Patterns of 
network activity? Similar/different professional groups? Hierarchy, power? 
c. The quality of the relationships: trust, respect? Obligation and reciprocity? 
Do members of the network value cooperation? Trust one another? (this 
facilitates KT) 
2. What time for the role? Training? Support? 
3. Expected outcomes: shared vision and goals? 
a. What outcomes are expected from the role in general? From specific 
activities? 
b. How do you know if you are successful in their role? (what performance 
measures are used, if any?)  
c. From this, what’s your understanding of knowledge, innovation and 
transfer? 
4. Exploration of barriers and enablers to KIT 
  
186 
 
 5.2 Questions areas for follow-up interviews 
The interview provides an opportunity to follow up on progress and tie up loose ends or 
clarify earlier comments. The interview will necessarily be tailored to the case study. 
Topic areas might include: 
• Update on activities (including reference to specific projects, events, 
developments)  • Judging ‘successes. What measurements are used (in terms of the KIT agent’s 
actions and/or related to specific projects)? What outcomes are important?  • Staffing update including what next for the case study  • Sustainability and future funding (in AHSNs this might link to money for patient 
safety) • Our next steps: feedback event; invoicing for the funds; collection of recorders  There may also be further events for us to observe or link interviews  Explore interest in joining an action learning set 
 
Thank you for your participation. 
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Appendix 6. Semi-Structured Interview Schedule for 
Line Managers and KIT Agent Links  
 • What do you do in your role?  • How do you connect in with the case study(ies)?  • How would you describe the quality of that relationship?  • What is the benefit/value of their work? How do they contribute to outcomes that are 
important to you? How do you judge the success of what they do? • How are your expected outcomes agreed? • Thinking of the future, is their work/role sustainable? • What are your thoughts on what helps or hinders the transfer and mobilisation of 
knowledge 
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Appendix 7. Information Sheets and Consent Forms 
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7.1 Information sheet for case study participants 
   
            
    
   
Information Sheet for participants linked to the Case Studies 
Please read this information sheet carefully before deciding whether or not to participate.  If you 
decide to participate then, before you consent you will have an opportunity to ask questions 
about the study and your participation in it.  If you decide not to take part there will be no 
disadvantage of any kind and we thank you for considering our request. 
What is the aim of the study? 
The study of knowledge transfer is about looking at how research evidence reaches practitioners. 
Research identifies better ways of providing healthcare yet this knowledge often fails to reach or 
influence those responsible for patient care. This is an international problem. In this study we 
aim to analyse and report on the work of what we call knowledge and innovation transfer (KIT) 
‘agents’. We will learn more about what KIT agents do and how they can be better supported in 
their work.     
 
Why have I been asked to participate? 
We are carrying out case studies of 10-12 KIT agents. In England, these will be linked to 
Academic Health Science Networks (AHSNs); in Wales they will be identified from the South 
East Wales Academic Health Science Partnership (SEWAHSP) organisations. We know that 
managers in the health service who have a role in the transfer of knowledge and innovation go by 
a variety of names and include ‘diffusion fellows’ and others with similar roles in CLAHRCs. 
You have been asked to participate either because you have a role in the transfer of knowledge 
and innovation (in other words, a KIT agent) or you are a manager, practitioner or researcher 
who links with a KIT agent. 
What will happen if I take part?  
The KIT agents who agree to be case studies will make a significant contribution to the study. 
With permission we will collect data from role descriptions (e.g. job descriptions, contracts and 
expected outcomes), interviews, observation and audio-diaries.  
 
The interviews will be with the case study KIT agents, their principal line-manager and those 
who link with KIT agents (other managers, practitioners and researchers). These interviews will 
be individual face-to-face or telephone interview, as preferred.  These will last up to one hour 
maximum.  Prior to the interview, you will be informed of the question areas. The interviews 
will be semi-structured which means that the precise questions have not been determined in 
advance, but will depend on how the interview develops. In the event that the line of questioning 
develops in such a way that you feel hesitant or uncomfortable, you may decline to answer any 
particular question(s). The timing of all interviews will be individually negotiated and agreed.  
All those who are interviewed will be asked to sign a consent form. With permission, we will 
audio record the interviews.  The audio recordings will be transcribed, anonymised and 
destroyed at the end of the study.   
Getting the most out of knowledge and innovation 
transfer (KIT) ‘agents’ in healthcare: a qualitative 
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Approximately three activities of each case study agent will be observed and selective audio-
recordings made, with permission. We expect that the activities will vary and may include, for 
example, making presentations of research and innovation to workplace colleagues, meetings 
with research teams, running journal clubs.  
 
KIT agents will be asked to keep a log of activities and audio-recordings of their reflections on 
events and meetings. We will explain the purpose of the audio-diaries and how to make 
recordings at our first face-to-face meeting. We will provide a personal Dictaphone or you may 
choose to use your own equipment to make digital recordings.  You will be requested to record 
at least one diary entry per week, over a period of four-months. We will provide regular prompts 
via text messaging or email, as preferred. Selected parts of the audio recordings will be 
transcribed and anonymised.  All case study KIT agents will be asked to sign a consent form. 
 
All participation is voluntary and you are free withdraw from the project at any stage. By 
agreeing to participate, you will offer an invaluable contribution to this study.  
Will my taking part be kept confidential? 
Data from the interviews, audio recordings at KIT events and audio-diaries will be confidential 
to the project team (listed below). Only three members of the research team (Alison Bullock, 
Emma Barnes and Zoe Morris) will have access to the raw data.  The recorded data will be 
transcribed and anonymised.  All data will be stored securely in locked cabinets and on 
password-protected computers. In accordance with Cardiff University guidance, the data will be 
kept for a minimum of 5 years, or at least 2 years post-publication. It will then be destroyed.   
Can participants change their mind and withdraw from the project? 
You may withdraw from participation in the project at any time.  If you chose to withdraw after 
participation, your data will be excluded from analysis. 
What use will be made of the collected data? 
A feedback event will be organised in each of the case study’s home organisations. The full 
written report will make recommendations for knowledge transfer developments.  A full copy of 
the report will be publically available and a summary will distributed to all participants. The 
report is scheduled to be available by 31 December 2015.  Additionally we aim to publish the 
results in peer-reviewed journal articles and present them at conferences.  It is important to note 
that any data included will be anonymous and not individually identifiable.   
Are there any advantages or disadvantages to participating in the study? 
The study has been designed to have actionable findings which should benefit the healthcare 
community. Benefits will arise from sharing good ideas and activities that 'work', as well as 
challenges and ways to overcome these.  Good practice will be identified locally as well as from 
the international literature. These will be reported at a feedback event based in each case study’s 
workplace. 
 
The disadvantage of participation is the time that is involved, particularly for the KIT agent.   
There is a small amount of funding available to each case study to compensate for loss of time 
from work (approximately £2000).  
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Who is organising the study? 
This project has been funded by National Institute for Health Research (NIHR) and is endorsed 
by the South East Wales Academic Health Science Partnership (SEWAHSP).  Cardiff University 
is the study sponsor.  
Who has reviewed the study? 
This project has been reviewed and approved by a Cardiff University Research Ethics 
Committee and local NHS Research and Development Offices 
What if there is a problem? 
If you have any study specific concerns or complaints, please contact Alison Bullock or Emma 
Barnes, details below. If you wish to raise a concern or complaint with someone independent of 
the project, please contact Mr Chris Shaw, Research Governance Coordinator- Research, 
Innovation and Enterprise Services, Cardiff University; Tel: 02920 879131 or email 
resgov@cardiff.ac.uk  
What if participants have any questions? 
If you have any questions about our project, either now or in the future, please feel free to 
contact: 
 
Professor Alison 
Bullock 
Emma Barnes Dr Zoe Morris 
bullockad@cardiff.ac.uk barnesej@cf.ac.uk zoeslotemorris@gmail.com 
Tel: 02920 870780 Tel:  02920 875506  
 
Cardiff Unit for Research and Evaluation in Medical and Dental Education (CUREMeDE),  
University of Cardiff School of Social Sciences, Glamorgan Building, Cardiff CF10 3WT 
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7.2 Consent form for case study participants 
                      
 
      Consent Form: Case Studies                 Please initial: 
1. I have read the Information Sheet concerning this project and understand 
what it is about. 
2. Any questions I had have been answered to my satisfaction. I understand that I 
am free to request further information at any stage. 
3. I understand that my participation in the project is entirely voluntary. 
4. I understand that my participation should not lead to any potential harm or 
discomfort. 
5. I understand that I am free to withdraw from the project at any time without 
any disadvantage. 
6. I agree to take part in an interview and understand that the interview will be 
audio-recorded. I understand that the recording it will be kept in accordance 
with research governance policies and any raw data on which the results of 
the project depend will be retained in secure storage. 
7. I understand that I have the right to decline to answer particular question(s). 
8. I agree to keep an audio-diary for a period of four months. I understand that 
the recording it will be kept in accordance with research governance policies 
and any raw data on which the results of the project depend will be retained in 
secure storage. 
9. I agree to be observed carrying out three knowledge transfer-related activities 
as part of my job role. 
10. I understand that the data may be used in a report or publications but my 
anonymity will be preserved. 
11. I understand that in the event that a serious patient issue is identified, this will 
be reported and may affect my confidentiality 
12. I agree to take part in this study. 
 
 
Your contact details    
Name: _________________________ Signed: ______________________ Date: ___________  
 
Email: __________________________ Tel: ___________________                                                                                    
Our contact details  
Professor Alison Bullock bullockad@cardiff.ac.uk Tel: 02920 870780  
Emma Barnes barnesej@cf.ac.uk Tel: 02920 875506 
CUREMeDE, University of Cardiff School of Social Sciences, Glamorgan Building, Cardiff CF10 3WT  
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7.3 Information sheet for links/line-managers  
     
    
 Information Sheet:  
For participants working with knowledge and innovation transfer (KIT) ‘agents’ 
Please read this information sheet carefully before deciding whether or not to participate in the 
study.  If you decide to participate, then, before you consent, you will have an opportunity to ask 
questions about the study and your participation in it.  If you decide not to take part there will be 
no disadvantage of any kind and we thank you for considering our request. 
What is the aim of the study? 
The primary aim of the study is to identify the benefits that KIT agents bring to healthcare 
managers or practitioners, and to explore any challenges and lessons learned. This is intended to 
help address the problem of how knowledge which could improve healthcare often fails to reach 
or influence those responsible for patient care. We will learn more about what KIT agents do and 
how they can be better supported in their work.   
Why have I been asked to participate? 
We are carrying out case studies of 10-12 KIT agents who are responsible for some aspect of 
knowledge and innovation transfer to learn how best to support the process. You have been 
asked to participate in the study because you are connected with the work of a KIT agent. You 
will be providing unique and critical information about how the KIT agent role worked in 
practice and how it can be improved in future. Only people who have direct experience of KIT 
agent services can provide the information needed to evaluate them. 
What will happen if I take part?  
You will be asked to take part in a one-to-one interview with an independent evaluator. 
Interviews will be individual face-to-face or via telephone, as you prefer.  The location and 
timing of all interviews will be negotiated and agreed with you. They last up to one hour 
maximum. Prior to the interview, you will be informed of the question areas which will focus on 
your experience of connecting with the KIT agent. If you are not happy to answer a particular 
question, you will be free to say so. All those who are interviewed will be asked to sign a consent 
form. With permission, we will audio record the interviews.  
Will my taking part be kept confidential? 
Data from the interviews will be confidential to the project team (Alison Bullock, Emma Barnes 
and Zoë Morris). The information gathered from your interview will be anonymised and 
combined with other interviews for analysis and presentation so that no individual person or 
organisation can be identified. 
All data will be stored securely in locked cabinets and on password-protected computers. In 
accordance with Cardiff University guidance, the data will be kept for a minimum of 5 years, or 
at least 2 years post-publication. It will then be destroyed.   
Can participants change their mind and withdraw from the project? 
You may withdraw from the study at any time.  If you chose to withdraw after participation, your 
data will be excluded from analysis. 
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What use will be made of the collected data? 
Data will be analysed to identify the benefits that KIT agents bring to healthcare managers and 
practitioners, and to explore any challenges and lessons learned. A feedback event will be 
organised in each of the KIT agents’ home organisations. The full written report will make 
recommendations for KIT agent roles and activities in the future.  A full copy of the report will 
be publicly available and a summary will be distributed to all study participants. The report is 
scheduled to be available by 31 December 2015. Additionally, we aim to publish the results in 
peer-reviewed journal articles and present them at conferences.  It is important to note that any 
data included will be anonymous and not individually identifiable.   
Are there any advantages or disadvantages to participating in the study? 
The study has been designed to provide actionable insights which should benefit the healthcare 
community. Benefits will arise from sharing good ideas and activities that 'work', as well as 
challenges and ways to overcome these.  Good practice will be identified locally as well as from 
the international literature. The study can also provide organisations with early feedback from 
independent evaluators if desired. It can provide an opportunity to ‘showcase’ their work should 
they wish. In previous studies, we have also found that individual participants can benefit from 
having the opportunity to talk through the issues with a neutral person who can help them clarify 
and shape their own thinking and actions. 
The disadvantage of participation is the time that is involved. Participants are asked for up to an 
hour of their time. 
Who is organising the study? 
This project is funded by National Institute for Health Research (NIHR). Cardiff University is 
the study sponsor.  
Who has reviewed the study? 
This project has been reviewed and approved by a Cardiff University Research Ethics 
Committee and local NHS Research and Development Offices. 
What if there is a problem? 
If you have any study specific concerns or complaints, please contact Alison Bullock or Emma 
Barnes, details below. If you wish to raise a concern or complaint with someone independent of 
the project, please contact Mr Chris Shaw, Research Governance Coordinator- Research, 
Innovation and Enterprise Services, Cardiff University; Tel: 02920 879131 or email 
resgov@cardiff.ac.uk  
What if participants have any questions? 
If you have any questions about our project, either now or in the future, please feel free to 
contact: 
Professor Alison Bullock Emma Barnes Dr Zoë Morris 
bullockad@cardiff.ac.uk barnesej@cf.ac.uk zoeslotemorris@gmail.com 
Tel: 02920 870780 Tel:  02920 875506 
 
Cardiff Unit for Research and Evaluation in Medical and Dental Education (CUREMeDE),  
University of Cardiff School of Social Sciences, Glamorgan Building, Cardiff CF10 3WT
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7.4 Consent form for links/line-managers       
    
   Consent Form: Links/Line managers                  Please initial: 
1. I have read the Information Sheet concerning this project and 
understand what it is about. 
2. Any questions I had have been answered to my satisfaction. I 
understand that I am free to request further information at any stage. 
3. I understand that my participation in the project is entirely voluntary. 
4. I understand that my participation should not lead to any potential 
harm or discomfort. 
5. I understand that I am free to withdraw from the project at any time 
without any disadvantage. 
6. I agree to take part in an interview and understand that the interview 
will be audio-recorded. I understand that the recording it will be kept 
in accordance with research governance policies and any raw data on 
which the results of the project depend will be retained in secure 
storage. 
7. I understand that I have the right to decline to answer particular 
question(s). 
8. I understand that the data may be used in a report or publications but 
my anonymity will be preserved. 
9. I understand that in the event that a serious patient issue is identified, 
this will be reported and may affect my confidentiality. 
10. I agree to take part in this study. 
  
Your contact details  
Name: _________________________ Signed: ________________________ Date: ___________  
Email: __________________________ Tel: ___________________  
 
Our contact details  
Professor Alison Bullock bullockad@cardiff.ac.uk Tel: 02920 870780  
Emma Barnes barnesej@cf.ac.uk Tel: 02920 875506 
CUREMeDE, University of Cardiff School of Social Sciences, Glamorgan Building, Cardiff CF10 3WT  
Getting the most out of knowledge and innovation transfer 
(KIT) ‘agents’ in healthcare: a qualitative study 
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Appendix 8. Thematic Analysis Coding Frame 
Node Description Sub-themes 
Ba
ck
gr
o
u
n
d 
Relevant background 
information about the KIT 
agent, their team and their 
working practices 
Any relevant prior experience 
Any existing networks that they brought with 
them to their KIT role 
Their status within their organisation 
How their team was set-up/how their team 
operates 
Other roles they may carry out 
Time in their current post (length/allocated time 
if have more than one role) 
Where the agent is located (university, health 
board, over one or more offices, etc.) 
Training 
Sustainability/future of the agent’s role 
R
ol
e Information and perceptions 
of the agents’ role 
Expectations 
Support 
Sustainability 
Other 
C
o
n
ce
pt
u
a
l/ 
D
ef
in
iti
on
a
l How the participant defines 
or demonstrates their 
understanding of 
“knowledge” and 
“innovation”.  
What is knowledge? 
What is innovation?  
In
di
v
id
ua
l 
di
sp
o
sit
io
n
s/ 
qu
a
lit
ie
s The agent, line-manager or 
links’ personal 
understanding, receptivity 
and approach to KIT work.  
Leadership style 
Values 
Commitment/motivation  
C
o
n
te
x
t -
 
In
te
rn
a
l Factors within the organisation that influence 
KIT agents’ work, such as its 
culture and ethos, leadership 
and infrastructure (clear 
pathways and systems; 
whether linkage was 
encouraged or whether silo 
working dominated). 
AHSN/(SEW)AHSP/UHB 
The organisational culture of the 
workplaces/organisations that they are working 
with  
Infrastructure support 
Budgets/resources available for their work 
Professional silos 
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C
o
n
te
x
t -
 
Ex
te
rn
a
l 
The influence of factors 
outside the organisation such 
as government policy, 
national programmes and 
other external factors on the 
KIT work. 
1000 Lives Plus programme (Wales)/QI 
Patient Safety (England) 
HEE (England) 
Health Foundation 
Prudent Health (Wales) 
CLAHRC (England) 
Patient Flow (Wales) 
C
o
n
te
n
t 
The content or focus of the 
evidence being translated. 
The nature of knowledge/innovation: 
Implementation  
The intended target audience (e.g. managers, 
practitioners) 
Its relevance to patients 
New knowledge/innovation or maintenance of 
professional standards 
Pr
o
ce
ss
es
 -
 
W
ha
t K
IT
 
a
ct
iv
ity
? 
Factors around the process of 
carrying out their KIT work.  
Facilitation/Challenge 
Linkages and brokerage 
Information sharing/dissemination 
Events 
Meetings 
Education and training 
Mentoring or shadowing 
Collecting, analysing and presenting data 
Develop networks 
Development of products (e.g. literature 
summaries; funding bids, etc.). 
Implementation  
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Im
pa
ct
 a
n
d 
O
u
tc
o
m
es
 
(F
o
rm
a
l/I
n
fo
rm
a
l) 
The changes, outcomes or 
events that have occurred as 
a result of the KIT agents’ 
work.  
Action plans; Policy development 
Products (e.g. literature summaries; funding 
applications) 
Training awards gained 
Engagement via meetings/events 
Developed networks for information sharing 
Established new working collaborations  
Enhanced existing relationships 
Capacity development 
Improved dissemination of Knowledge & 
Innovation (vague) 
Implementation: Examples of evidence of 
knowledge /innovation use; Improved ways of 
doing things; Targets achieved. 
Infrastructure changes 
-     Micro 
-     Meso 
-     Macro 
Personal impact on the kit agent themselves 
Organisational culture changes (e.g. 
receptiveness to research/change) 
Barriers Barriers to the KIT agents’ work  
Enablers Enablers of the KIT agents' work  
Key 
Messages Any key messages that emerge  
Other   
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Appendix 9. A Worked Example of an Application of Social Marketing Theory  
 
Reported outcome 
(s) Insights Competition Exchange 
Segmentation and 
targeting 
Intervention 
Product, place, price, 
promotion, policy 
Measureable 
improvements to 
implementation of 
the Sepsis Six 
patient care 
pathway which 
resulted in 
improved 
morbidity and 
mortality.  
Understanding what had 
been tried, what the 
barriers were to change, 
what the motivators 
were to change, 
recognised how the 
organisation wanted to 
do things for themselves 
and not “import 
solutions”, what was 
feasible for the 
organisation and how 
the team and 
organisation could be 
supported to develop 
and test an intervention.  
Recognised that the 
team needed support in 
running the project – 
planning meetings, 
gathering data, 
analysing and reporting. 
Helped the team 
generate insight, and 
design and test 
solutions.  
The service team 
lacked specific 
knowledge of how to 
address the problem, 
time to engage 
people to think about 
it, time and the 
capacity to run a 
project, and perhaps 
felt vulnerable and 
unsupported. Staff 
were also reluctant to 
take part in 
something new and 
challenging.  
Measures to reduce 
the cost to the project 
team included: 
helping to set a team; 
organise meetings; 
support data 
gathering, analysis 
and so forth; help 
build links with 
relevant national 
programmes. 
Measures to increase 
the benefits to the 
project team: 
providing feedback 
on performance 
demonstrating to the 
project team that 
they were having an 
impact on patient 
care; helping to 
improve reporting 
within the Trust 
hierarchy thus 
increasing project 
profile, feedback etc.  
Chose a high-priority 
narrowly focused issue. 
A hospital-wide 
intervention was 
specifically avoided. 
Worked with Medical 
Director to identify, 
establish and support a 
team who were 
necessary or willing to 
take part. 
Worked with a small 
team and local 
enthusiasts. Hoped that 
this team could spread 
good practice in time 
(home-grown solutions, 
tested in their Trust). 
Focused primarily on 
activities that were 
necessary to achieve the 
task. 
Provided a reporting 
conduit between the 
team and Trust senior 
management Team. 
Product – tailored project 
support focused on client need 
(what they were trying to 
achieve, with what resouces, 
from what position). This 
included QI methodology, 
project management previous 
relevant experience, and coming 
from a credible organisation. 
Place – the KIT agent worked 
alongside the practitioners 
addressing the problem.  
Price – the KIT agent reduced 
the cost of taking part in the 
project, and offered “free” 
support in terms of planning 
meeting etc. 
Promotion – the KIT agent 
recruited people to the project 
directly with the Medical 
Director. Being a clinician with 
relevant experience helped. 
Policy – Sepsis management is a 
national priority. 
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Appendix 10. Summary of Findings in Presentation 
Format 
A series of slides have been designed for presentation to user groups including 
knowledge broker, managers and other practitioners. 
Knowledge mobilisers - their challenges and support needs. Insights from the KIT 
Agents project. Presentation slides.pptx 
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